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Abstract 
Plants produce a wide range of complex secondary metabolites that have many applications, 
for example as pharmaceutical agents. Gene discovery and the elucidation of these unique 
biosynthetic pathways is challenging since many of the enzymatic transformations are 
unprecedented. In Catharanthus roseus, the sole producer of the valuable anti-cancer 
compounds vinblastine and vincristine, the biosynthetic pathway for these alkaloids is highly 
complex and crucial steps are still unknown. Recently, the tight transcriptional co-regulation of 
the early part of this pathway enabled discovery of some of the central enzymatic steps by 
analysing the gene co-expression patterns and testing potential candidates using virus induced 
gene silencing. Additionally, it has become apparent that some plant secondary metabolite 
pathways exhibit physical clustering of pathway related genes in the genome. This thesis 
highlights how both strategies of gene discovery can be applied for the targeted discovery of 
genes for missing steps in biosynthesis of non-model plants. Co-expression analysis to identify 
candidates and subsequent testing of these candidates using virus induced gene silencing has 
led to the discovery and subsequent characterisation of the enzyme tabersonine 3-oxygenase 
(T3O), a key oxidation step in vindoline biosynthesis. This thesis furthermore reports the first 
C. roseus whole genome sequence. Additionally a BAC library was obtained and selected BACs 
sequenced. Analysis of the combined sequencing data established that gene clustering does 
indeed occur for alkaloid biosynthesis in C. roseus and yielded a new set of candidates for so 
far unknown pathway enzymes. Selected candidates have been tested by silencing or 
expression and results are discussed. The sequence information provides a valuable resource 
for the wider community, available as a searchable, publically available database 
(http://medicinalplantgenomics.msu.edu/). The work presented in this thesis highlights how 
next generation sequence data can be exploited to elucidate complex secondary metabolic 
pathways. 
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1 Introduction 
Natural products, also called secondary or specialised metabolites, unlike primary metabolites, 
do not directly contribute to essential growth and development of the organism. Instead these 
molecules have other key functions such as mediating the interaction between plants and their 
environment 1. Additionally, many plant specialised metabolites have served humans for 
centuries as traditional medicines and still pose a unique resource for today’s pharmaceutical 
industry (Figure 1). The staggering amount of not yet investigated plants and compounds 
promises a diverse and largely untapped space of discovery 2. 
 
Figure 1 Selected plant derived bioactive specialised metabolites and medicinal application 
 
Specialised metabolites are often structurally complex (Figure 1) making chemical synthesis for 
large-scale commercial production challenging. Efforts to alleviate supply issues in an 
economical way has led to research into alternative production systems including plant cell 
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cultures 3,4 and heterologous expression in microbial hosts 5. The latter, however, requires a 
detailed understanding of the biosynthesis of the desired compound in the native plant. Most 
importantly, this approach requires the knowledge of which genes encode the biosynthetic 
enzymes responsible for the production of the target compounds. 
Discovery of enzymes involved in a particular secondary metabolic pathway has in the past 
exploited many different approaches. Recently, the combination of metabolomic data with 
gene expression data has been shown to pose a powerful strategy for gene discovery and 
pathway elucidation 6. This approach combines the knowledge of occurrence and distribution 
of target compounds in different plant tissues, whole plants or related plant species, with gene 
expression information. Correlating the presence of genes with the presence of the metabolite 
of interest can provide clues to identify candidate biosynthetic genes. A second widely used 
approach examines the genomic organisation of secondary metabolite biosynthesis. This 
strategy is based on the observation that in some plant secondary metabolite pathways the 
responsible genes are physically co-localised into a genomic cluster 7. Notably, both of these 
approaches benefit greatly from increased availability of plant transcriptome and genome 
sequencing data due to decreasing sequencing costs 8.  
To facilitate compilation of a short list of biosynthetic gene candidates from these data, the 
anticipated pathway chemistry is used to predict the enzyme class of the missing steps in 
metabolite biosynthesis. Yet since many plant-sourced biochemicals arise only from a narrow 
phylogenetic space, and involve unprecedented chemical transformations, making these 
predictions can be challenging. Investigation of the biosynthesis of a single metabolite or a 
specific group of plant-derived compounds therefore requires a detailed study of the individual 
metabolomic, transcriptomic and genomic data. Ultimately, progress in the dissection of the 
complex network of secondary metabolite biosynthesis helps not only the understanding of 
the production of a specific compound, but also delivers new tools and knowledge for 
discovery of new pathways and the manipulation of existing ones. 
1.1 Monoterpene indole alkaloids of the medicinal plant Catharanthus roseus 
1.1.1 Plant natural products 
Plants produce a wide range of natural compounds with a multitude of different functions. 
While primary metabolites are essential for the survival of plants, secondary, also called 
specialised metabolites or phytochemicals, are non-essential. Nevertheless in many cases 
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these natural products have an important function for plant survival and fitness by for example 
contributing to plant reproduction 9 and plant protection 10. 
According to their biosynthetic origin, plant natural products can be grouped into classes, such 
as terpenoids, alkaloids and phenylpropanoids and other phenolic compounds. All natural 
products are derived from building blocks provided by primary metabolism such as acetyl 
coenzyme A, shikimic acid, mevalonic acid, amino acids and 1-deoxyxylulose 5-phosphate. 
1.1.2 Alkaloids 
More than 12000 of the over 50000 known natural products belong to the group of alkaloids 
and evidence for their use as medicine by humans reaches back more than 4000 years 11.  
Most alkaloids are biosynthesised via complex enzymatic pathways often comprising 20 or 
more steps. Alkaloids are a heterogeneous class of secondary metabolites containing a basic 
nitrogen, and are usually derived from amino acids. These metabolites can be grouped into 
subclasses such as indole or quinoline alkaloids that are derived from tryptophan, benzyl 
isoquinoline alkaloids that are derived from tyrosine, piperidine alkaloids that are derived from 
lysine, pyrrolidine alkaloids that are derived from ornithine, phenylethylamine alkaloids that 
are derived from phenylalanine and imidazole alkaloids that are derived from histidine 12 
(Figure 2). 
 
Figure 2 Selected plant derived alkaloids of different subclasses and medical application 
 
Alkaloids frequently possess pronounced biological activities that play a role in, for example, 
defending plants against herbivores 13. Additionally, many alkaloids are well known for their 
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poisonous and/ or medicinal attributes. The benzylisoquinoline alkaloid morphine can be used 
as an opiate type pain medication 14 while cocaine is a strong stimulant but can be used as a 
local anaesthetic 15. Quinidine, a stereoisomer of the well-known antimalarial drug quinine, is 
an antiarrhythmic agent 16. Ephedrine is structurally related to the amphetamines and known 
in Chinese traditional medicine since BC 17. 
1.1.3 Monoterpene indole alkaloids 
Approximately 3000 different monoterpene indole alkaloids (MIAs) can be found in Nature 
dispersed over six plant families, mainly the Apocynaceae, Loganiaceae, and Rubiaceae but 
also in the Icacinaceae, Nyssaceae, Alangiaceae familes. All MIAs originate from a convergent 
pathway that utilises tryptamine, provided by the amino acid tryptophan (shikimic acid 
pathway) and secologanin, a monoterpene moiety derived from geranyl-pyrophosphate (GPP) 
via the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway18. Many MIAs have been exploited 
for their potent pharmacological activities (Figure 3). 
 
 
Figure 3 A selection of monoterpene indole alkaloids and their medicinal application 
 
1.1.4 Catharanthus roseus 
Catharanthus roseus or Madagascar periwinkle, a major producer of MIAs, belongs to the 
genus Catharanthus that comprises eight species of herbaceous perennial plants. Of these 
seven are endemic to the Island of Madagascar. C. roseus has long been used in traditional folk 
medicine.  
C. roseus has glossy, dark green and oval leaves. The wild plant has a pale pink flower with a 
purple “eye”. It is a popular plant due to its moderate to high drought tolerance and 
ornamental value. Intensive breeding efforts have yielded a huge variety of different flower 
colours and growth shape (Figure 4). 
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Figure 4 Flowers and leaves of three C. roseus varieties 
The C. roseus varieties “SunStorm Apricot” (left), “SantaFe” (middle) and “Little Bright Eyes” (right). 
 
C. roseus displays a rich specialised metabolism, and is particularly well known for its alkaloid 
profile. C. roseus produces MIAs, which, like all MIAs, are produced from a central 
intermediate, strictosidine, that is derived from both tryptophan and the monoterpene 
secologanin (Figure 5) 18. Many C. roseus derived alkaloids, such as ajmalicine, an 
antiarrhythmic, and serpentine, an antihypertensive, have been widely used as prescription 
drugs in the past 19. However, intense, longstanding scientific interest in C. roseus is driven 
primarily by the discovery of the anti-cancer properties of its bisindole alkaloid metabolites 
vinblastine (Figure 1) and its oxidised congener vincristine. These compounds are bisindole 
alkaloids which form in C. roseus as a result of the dimerisation of the two MIAs catharanthine 
and vindoline. Vinblastine and vincristine were originally discovered when screening traditional 
medicinal herbs for their therapeutic properties in the early 1960s 19. These alkaloids bind to 
microtubules and consequently arrest the cell cycle, which makes them powerful 
chemotherapeutic drugs, and are primarily used against Hodgkin’s lymphoma and breast 
cancer. Semi-synthesis using vinblastine as a starting precursor has yielded vinorelbine 20 and 
vindesine 21, which are also now used in the clinic as anti-cancer agents. Further chemical 
modification of vinorelbine yield anti-cancer compounds such as vinflunine 22,23. 
The demand for vinblastine and vincristine is still satisfied by extraction from C. roseus plants. 
However, the extraction of vinblastine and vincristine, or their precursors catharanthine and 
vindoline, from C. roseus plants is a laborious and costly task. Yet the complex chemical 
synthesis is even less economically viable, which explains the ongoing interest to either 
increase alkaloid production in C. roseus itself or to develop an alternative production system. 
Collectively, these efforts have resulted in C. roseus being one of today’s best studied 
medicinal plants. 
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1.1.5 Strictosidine biosynthesis in Catharanthus roseus 
More than 130 different MIAs have been reported to be produced by C. roseus 19. All MIAs are 
derived from the central precursor molecule strictosidine that is formed as a condensation 
product of the terpenoid moiety secologanin (Figure 5A) and the indole moiety tryptamine 
(Figure 5B), via a Pictet-Spengler condensation (Figure 5C) 18,24. Investigation into strictosidine 
biosynthesis in C. roseus over the past decades has led to the elucidation of all reactions, as 
well as establishing the order of all enzymatic steps involved in its production. This has 
consequently enabled the production of the early part of alkaloid biosynthesis, strictosidine 
biosynthesis, in S. cerevisiae (yeast) as an alternative host 25. 
 
Figure 5 Biosynthesis of strictosidine precursor secologanin and tryptamine in C. roseus 
A: The biosynthesis of secologanin in C. roseus proceeds from MEP pathway precursors IPP and DMAP 
that form GPP, with its first committed step being the formation of geraniol. The nine-step pathway 
comprises an oxidation by the enzymes geraniol 8 hydroxylase (G8H), an oxidation by 8-hydroxygeraniol 
oxidoreductase (GOR), cyclisation by iridoid synthase (ISY), another oxidation by iridoid oxidase (IO), a 
glycosylation by 7-deoxyloganetic acid glucosyltransferase (7DLGT), a hydroxylation by 7-deoxyloganic 
acid hydroxylase (7DLH) and subsequent methylation by loganic acid methyltransferase (LAMT) and a 
final oxidation by secologanin synthase (SLS). B: Tryptamine is produced via the decarboxylation of 
tryptophan by the enzyme tryptophan synthase (TDC). C: Strictosidine is formed by the action of 
strictosidine synthase (STR). 
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Secologanin production proceeds from the isoprenoids isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP), which form geranyl-pyrophosphate (GPP). IPP and DMAP 
can be produced by two pathways the cytosolic mevalonate (MVA) and the non-mevalonate or 
plastidic methyl-D-erythritol 4-phosphate (MEP) pathway. [1-13C]-glucose feeding of C. roseus 
cell suspension cultures has established that in C. roseus the MEP pathway is predominantly 
responsible for secologanin production 26. 
GPP is then converted to geraniol by geraniol synthase 27. Geraniol is hydroxylated by the 
cytochrome P450 geraniol-8 hydroxylase (G8H) to 8-hydroxygeraniol 28. In combination with 
the action of 8-hydroxygeraniol oxidoreductase (GOR) the linear dialdehyde 8-oxogeranial is 
formed 29. 8-oxogeranial is cyclised by iridoid synthase (ISY) 30. Iridoid oxidase (IO), a second 
cytochrome P450 involved in secologanin production, oxidises cis-trans-nepetalactol to 7-
deoxyloganetic acid 29,31. This product is subsequently glycosylated by 7-deoxyloganetic acid 
glucosyltransferase (7DLGT) 32 and further hydroxylated by a third cytochrome P450, 7-
deoxyloganic acid hydroxylase (7DLH) 32,33 and methylated by loganic acid methyltransferase 
(LAMT) to form loganin 34. In a final step performed by the fourth cytochrome P450 involved in 
this pathway loganin is oxidatively cleaved by secologanin synthase (SLS) to yield the 
monoterpene secologanin 35 (Figure 5A). 
In a parallel pathway tryptamine is produced. To yield tryptamine the amino acid tryptophan is 
decarboxylated by the pyridoxal phosphate dependent enzyme, tryptophan decarboxylase 
(TDC) 36 (Figure 5B). The condensation of secologanin and tryptamine to form the central 
metabolic intermediate, strictosidine is the first committed step in the formation of MIAs and 
represents a key branch point in this pathway 18. 
 
1.1.6 Fate of deglycosylated strictosidine  
The deglycosylation of strictosidine by strictosidine β-D-glycosidase (SGD) is the next step in 
alkaloid biosynthesis in C. roseus and other monoterpene indole alkaloid producing plants. 
Deglycosylated strictosidine rearranges to 4,21-dehydrogeissoschizine, which forms the 
structural basis for the diverse range of scaffolds occurring in this plant. In C. roseus the highly 
reactive intermediate is transformed by an unknown number of subsequent reactions that 
lead to the molecular rearrangements necessary for the formation of the three distinct 
molecular backbones or skeletons, representing the three different classes of C. roseus 
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alkaloids, namely the iboga, the corynanthe and the aspidosperma alkaloids (Figure 6). None of 
the biosynthetic genes responsible for the transformation of strictosidine aglycone to these 
scaffolds was known at the beginning of this work, though a biosynthetic gene responsible for 
the biosynthesis of the corynanthe skeleton has been identified in the last year 37. 
 
 
Figure 6 Examples of strictosidine derived scaffolds in C. roseus and related plants 
Secologanin and tryptamine are condensed by strictosidine synthase (STR) to form strictosidine. 
Strictosidine is deglycosylated by strictosidine -glucosidase (SGD) and rearranges to 4,21-
dehydrogeissoschizine which forms the structural basis for a different of alkaloid backbones in multiple 
plant species. Strictosidine derived MIA scaffolds in C. roseus are represented by serpentine (corynanthe 
scaffold), catharanthine (iboga scaffold) and vindoline (aspidosperma scaffold), while Rauwolfia 
serpentine contains for example the MIA yohimbine (also corynanthe scaffold) and ajmaline (ajmalan 
scaffold). Vinca minor, a close relative of C. roseus, contains the MIA vincamine an eburnamine scaffold. 
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1.1.7 Vindoline biosynthesis in Catharanthus roseus 
Vindoline is one of the precursors for vinblastine production, and is widely used in semi-
synthesis of vinblastine by chemical coupling with catharanthine. Vindoline is derived from the 
simpler precursor tabersonine, which is produced from strictosidine aglycone in a pathway 
uncharacterised to date. Tabersonine is then derivatised to vindoline through a series of 
tailoring reactions. During the course of this work a vindoline biosynthesis gene was 
discovered, so vindoline biosynthesis and the genes and enzymes involved will be introduced 
here in more detail, presenting the state of knowledge at the start of this work. 
The biogenic origin of the alkaloid vindoline from the precursor tabersonine and their shared 
terpenoid origin has been a focus of investigation since the 1960s, beginning with feeding 
studies using isotopically labeled substrates and the isolation and characterisation of 
intermediates and end products 38,39. Early research into the pathway leading from tabersonine 
to vindoline established a set of necessary reactions and a conclusive order of those steps 40. 
After initial hydroxylation of tabersonine by tabersonine-16-hydroxylase (T16H) 41,42 , the 
resulting 16-hydroxytabersonine is O-methylated by 16-hydroxytabersonine 16-O-
methyltransferase (16OMT) 34 to form 16-methoxytabersonine. The next reaction, which yields 
the product 16-methoxy-2-3-dihydro-3-hydroxytabersonine, is a formal hydration of 16-
methoxytabersonine. The gene or genes responsible for this transformation were unknown at 
the start of this thesis. Subsequently, an N-methyltransferase (NMT) 43 catalyses methylation 
of the indoline nitrogen. Desacetoxyvindoline, the NMT product is further hydroxylated by 
desacetoxyvindoline 4-hydroxylase (D4H) 44 to form deacetylvindoline and in a final step, 
deacetylvindoline is O-acetylated by deacetylvindoline acetyltransferase (DAT) 45 to yield 
vindoline (Figure 7). 
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Figure 7 Vindoline biosynthesis enzymes known at the start of this work 
Starting from the substrate tabersonine, the steps of vindoline biosynthesis known at the start of this 
work were the oxidation of tabersonine by tabersonine 16-hydroxylase (T16H) and methylation of the 
same position by 16-hydroxytabersonine O-methyltransferase (16OMT). After one or possibly two 
unknown steps the biosynthesis proceeds with the methylation by 16-hydroxy-2,3-dihydro-3-
hydroxytabersonine N methyltransferase (NMT), hydroxylation by desacetoxyvindoline 4-hydroxylase 
(D4H) and ends with a final acetylation by deacetylvindoline 4-O-acetyltransferase (DAT). 
 
1.1.8 Localisation of alkaloid biosynthesis in Catharanthus roseus 
The localisation of MIA biosynthesis has been studied in C. roseus with three cell types known 
to be involved in this pathway. The very early steps of seco-iridoid production are localised to 
the IPAP cells and most likely the intermediate loganic acid is imported into the epidermis 
(Figure 8) 29. In the epidermis, tabersonine, catharanthine and other alkaloids are produced. A 
large proportion of catharanthine is actively exported by an ABC transporter out of the 
epidermis to a waxy outer layer of the leaf 46. Other end products of the alkaloid biosynthesis 
of C. roseus such as serpentine and vindoline are stored in the vacuole of the mesophyll. The 
application of carborundum abrasion to C. roseus leaves, yielding leaf epidermis enriched 
extracts, demonstrated an accumulation of tabersonine and 16-methoxytabersonine in this 
26 
 
 
fraction suggesting an epidermal location of the two initial steps in vindoline biosynthesis 47. 
While transcripts of NMT are primarily found in the epidermis 48 the two last steps carried out 
by D4H and DAT are localised to the specialised mesophyll cells the idioblasts and the laticifer 
making desacetoxyvindoline the most likely transported intermediate 49 (Figure 8). 
Consequently, all current models of alkaloid biosynthesis in C. roseus involve a complex 
network of biosynthetic intermediate transport. This is true for the early part of the pathway, 
strictosidine production, as well as later parts like the vindoline biosynthesis. 
 
Figure 8 Localisation of alkaloid biosynthesis in C. roseus in three cell types 
Localisation of alkaloid biosynthesis in C. roseus leaf, modified after 48,50. Three cell types are involved in 
alkaloid biosynthesis. Early steps of iridoid biosynthesis are localised to the internal phloem associated 
parenchyma while later steps are localised to the epidermis. The epidermis is also the main site of 
tryptamine biosynthesis and the early steps of vindoline biosynthesis. Only the last two steps of 
vindoline biosynthesis are located at specialised cells at the leaf body mesophyll (laticifer and idioblast 
cells). Furthermore the medicinally important bisindole alkaloids vinblastine and vincristine are 
predominantly found in this cell type. Solid arrows represent single steps while dotted arrows indicate 
multiple enzymatic steps. 
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1.1.9 Function of alkaloids in Catharanthus roseus  
Studies into the native biological function of C. roseus alkaloids are hindered by the lack of its 
natural aggressors. Alkaloids such as catharanthine and vindoline, which account for the 
largest amount of total alkaloid content in C. roseus, are produced by the plant as part of 
normal development. Yet under certain stress conditions, mimicked by application of methyl 
jasmonate and other elicitors, production of these alkaloids increases up to 3 fold 51,52. This 
observation has led to different hypotheses regarding the function of alkaloids in C. roseus 
defence against pathogen and herbivore attack. It has been suggested that glucosyl 
intermediates of alkaloid biosynthesis, such as strictosidine, are inactive alkaloids that are 
stored in the vacuole to be reactivated by formation of the aglycone, which is a highly reactive 
and therefore toxic compound. Such storage of inactive compounds, that can be enzymatically 
activated by deglycosylation upon pathogen attack, are well known in plants for example from 
the glucosinolates of the Brassica species 53. In C. roseus the resulting aglycone is a highly 
reactive dialdehyde that causes protein crosslinking and precipitation. Therefore, it was 
suggested that it might serve as a defence system or may reduce the nutritional value of the 
plant for the attacking herbivore 54. In other studies, C. roseus extracts and their antimicrobial 
and antifeedant potential has been investigated 55 and it has been found that deglycosylated 
strictosidine was active against several microorganisms 56. Catharanthine, which accumulates 
at the C. roseus leaf surface in concentrations of 14 µg to 23 µg per cm², was able to inhibit in 
vitro the growth of fungal zoospores (Phytopthora parasitica) at comparable concentrations. 
However commercially available Phytopthora resistant and unresistant C. roseus varieties 
contain similar levels of catharanthine suggesting a more complex mechanism of in vivo 
disease resistance 57. 
1.1.10 Summary of MIA biosynthesis in Catharanthus roseus 
More than six decades of research into C. roseus have helped to draw a picture of alkaloid 
biosynthesis including many of the individual pathway enzymes and corresponding genes 
(Figure 9). 
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Figure 9 Characterised genes of alkaloid biosynthesis in C. roseus 
Genes of the monoterpene indole alkaloid pathway in C. roseus published as of May 2016. Missing 
genes are represented by question marks. Dashed arrows indicate unknown numbers of enzymatic 
steps. Black top row arrows represent methylerythritol phosphate (MEP) pathway, the upstream 
terpene biosynthesis genes: DXS, 1-deoxy-D-xylulose 5-phosphate synthase 2; DXR, 1-deoxy-D-xylulose-
5-phosphate reductoisomerase; CMS, 4-diphosphocytidyl-methylerythritol 2-phosphate synthase; CMK, 
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase; MCS, 2C-methyl-D-erythritol 2,4-cyclodiphosphate 
synthase; HDS, GCPE protein; HDR, 1-hydroxy-2-methyl-butenyl 4-diphosphate reductase; IPI, plastid 
isopentenyl pyrophosphate, dimethylallyl pyrophosphate isomerase; GPPS, geranyl pyrophosphate 
synthase and GES, plastid geraniol synthase. Bold arrows represent iridoid biosynthesis genes: G8H, 
geraniol 8-hydroxylase; GOR, 8-hydroxygeraniol oxidoreductase; ISY, iridoid synthase; IO, iridoid oxidase 
(CYP76A26); 7DLGT, UDP-glucose iridoid glucosyltransferase; 7DLH, 7-deoxyloganic acid 7-hydroxylase; 
LAMT, loganic acid methyltransferase and SLS, secologanin synthase. Red arrows represent downstream 
alkaloid biosynthesis genes: TDC, tryptophan decarboxylase; STR, strictosidine synthase; SGD, 
strictosidine -glucosidase; THAS, tetrahydroalstonine synthase; T19H, tabersonine/lochnericine 19-
hydroxylase (CYP71BJ1) and MAT, minovincinine 19-hydroxy-O-acetyltransferase. Blue arrow represent 
vindoline biosynthesis pathway: T16H1, tabersonine 16-hydroxylase 1 (CYP71D12); T16H2, tabersonine 
16-hydroxylase 2 (CYP71D351); 16OMT, 16-hydroxytabersonine O-methyltransferase; T3O 16-
methoxytabersone 3-oxigenase; T3R, 16-methoxytabersonine 3-reductase NMT, 16-methoxy-2,3-
dihydro-3-hydroxytabersonine N-methyltransferase; D4H, desacetoxyvindoline-4-hydroxylase and DAT, 
deacetylvindoline 4-O-acetyltransferase. 
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1.2 Available sequence resources for Catharanthus roseus 
The following section summarises the sequence resources available at the start of this work. 
Since the discovery of the medicinal value of C. roseus, interest in the elucidation of the MIA 
pathways has led to the application of available sequencing technologies to this model 
medicinal plant. The result has been insights not only into alkaloid biosynthesis but also into 
areas such as the transcriptional regulation and transport of secondary metabolism. 
 
1.2.1 Catharanthus roseus expressed sequence tags  
Expressed sequence tags (ESTs) are generated by sequencing randomly selected clones from a 
cDNA library. The resulting sequences are relatively short with only 500 to 800 bp 58. The NCBI 
EST database reports 20,168 ESTs for Catharanthus roseus. The first ever reported EST datasets 
for C. roseus, two cDNA libraries of leaf base and root tip tissue 59, did not succeed in capturing 
the majority of known genes of MIA production in C. roseus. However, in 2008 the 
identification of the gene encoding loganic acid methyl transferase (LAMT), a major pathway 
step in the MIA pathway of C. roseus, was reported. This discovery utilised an EST dataset 
generated using leaf epidermis tissue 50. Since many steps of MIA biosynthesis are known to be 
localised to this tissue, the epidermis of C. roseus has been of special interest for investigation 
into alkaloid biosynthesis. It was shown that it is indeed the preferred site for the production 
of precursors of vindoline biosynthesis 34,47 as well as the site of predominant expression of 
other MIA genes such as TDC, STR and SLS 35,60.  
The same EST set helped identify 16-hydroxytabersonine O-methyltransferase (16OMT), the 
second enzymatic step in vindoline biosynthesis in C. roseus 34 after several previous attempts 
to clone 16OMT from C. roseus using homology based methods or protein purification had 
failed 61,62. Ultimately the discovery of further pathway genes such as that of a transporter 
involved in catharanthine transport 46 and that of 7-deoxyloganic acid hydroxylase (7DLH) 33, a 
key step in the seco-iridoid pathway, were guided by the knowledge of the high expression in 
epidermis tissue. 
The results of the analysis of the same EST dataset also facilitated the cloning of a gene that, 
when functionally expressed in yeast, results in the preferential accumulation of α-amyrin over 
β-amyrin. Considering its predominant expression in the leaf epidermal cells, combined with 
the knowledge that the main triterpene from C. roseus, ursolic acid, is derived from amyrin and 
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is exclusively secreted to the cuticular wax layer, strongly suggests that this gene is amyrin 
synthase 63,64 . The first of the two publications additionally reports the discovery of amyrin 
oxidase (AO), a multifunctional C-28 oxidase that catalyses the subsequent successive 
oxidations leading to the production of ursolic acid from α-amyrin, again exploiting the 
mentioned EST data to search for candidate genes with high expression in leaf epidermis of 
C. roseus 63.  
 
1.2.2 Catharanthus roseus transcriptomic data 
All transcriptomic data available for C. roseus at the start of this work was de novo assembled, 
as no reference genome for C. roseus was available. The NCBI sequence read archive (SRA) 
contains 65 entries for C. roseus as of May 2016.  
The transcriptomic data set used in this thesis is a robust set of annotated transcript 
assemblies of C. roseus. It is publicly available at http://medicinalplantgenomics.msu.edu/. The 
development of this Medicinal Plant Genomics Resource (MPGR) was facilitated using isolated 
RNA from a broad range of cell types (Table 1), from which cDNA libraries were constructed 
and then sequenced using the Illumina sequencing platform with single end reads and a read 
length of 36 bp 65. 
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Table 1 Tissues and treatments contained in MPGR transcriptomic dataset  
This set is derived from 23 different C. roseus tissues and/ or treatments 65. Suspension cultures were 
treated with 0.3 mg/ml yeast extract (YE) for different amounts of time. Sterile seedlings and hairy roots 
were incubated with 100 µM methyl jasmonate (MeJA) for different amounts of time. The TDCi hairy 
roots are lines with silenced tryptophan decarboxylase expression 66. The RebH hairy root line expresses 
a bacterial halogenase 67. In bold are recalculated transcriptomes on the basis of the C. roseus 
genome 68. 
Number Tissue/ experimental condition 
1 Flowers 
2 Suspension culture YE 6 h 
3 Suspension culture YE 12 h 
4 Suspension culture YE 24 h 
5 Sterile seedlings MeJA 0 h 
6 Sterile seedlings MeJA 6 h 
7 Sterile seedlings MeJA 12 h 
8 Sterile seedlings MeJA 24 h 
9 Sterile seedlings MeJA 5 d 
10 Sterile seedlings MeJA 12 d 
11 Sterile seedlings (control) 
12 Suspension culture (control) 
13 Mature leaf 
14 Immature leaf 
15 Stem 
16 Root 
17 Wild type hairy roots 
18 Wild type hairy roots MeJA 0 h 
19 Wild type hairy roots MeJA 24 h 
20 TDCi hairy root 
21 TDCi hairy root MeJA 0 h 
22 TDCi hairy root MeJA 24 h 
23 RebH hairy root 
 
Two additional sources are also available. Firstly, CathaCyc (http://www.cathacyc.org/) 
provides a platform on which C. roseus transcriptomic data is linked to metabolic pathways 
and offers tools for their visualisation and analysis 69. It comprises two newly generated 
transcriptomic datasets as well as the complete C. roseus transcriptomic data from the MPGR 
consortium mentioned above. Recalculating the FPKM values, the obtained expression data is 
comparable between both applied datasets. This data is easily accessible for individual genes. 
Secondly, the Canadian based Phytometasyn (http://www.phytometasyn.org/) provides a 
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further source with 74 plant transcriptome assemblies of which 9 belong to Catharanthus 70. 
Here different members of the Catharanthus genus such as C. longifolius and C. ovalis are 
reported.  
After the C. roseus draft genome assembly became available raw data of 8 tissues of the 
original MPGR data set (Table 1) was aligned to the genome and used to recalculate expression 
(FPKM) for those 8 transcriptomes 68.  
1.2.3 Catharanthus roseus genomic data  
In 2014 the genome of coffee (Coffea canephora) was published 71. Belonging to the same 
plant order as C. roseus, the Gentianales, coffee also contains alkaloids. Yet the coffee alkaloids 
are produced by substantially different biosynthetic pathways and homologies to C. roseus are 
very unlikely. C. roseus belongs to the plant family Apocynaceae. Only one other genomic 
resource for plants of the Apocynaceae family is available, a 0.5 x genome of the common 
milkweed 72. Sequence data for the C. roseus plastid genome is available 73, but no nuclear 
genomic data for C. roseus was available at the start of this thesis. 
 
1.3 Co-expression analysis for gene discovery in plant secondary metabolism 
1.3.1 General aspects of co-expression 
Gene co-expression describes the similarity of gene expression patterns under various 
conditions. Functionally related genes, such as the genes belonging to a metabolic pathway, 
often display co-expression 74 making the “guilt by association” principle a powerful tool in 
gene discovery 75. Many examples for co-expression of specific pathways in primary  74,76 and 
especially in secondary metabolism exist such as anthocyanin biosynthesis in A. thaliana 76, or 
the production of monoterpenes in A. thaliana flowers 77.   
1.3.2 Aspects of co-expression analysis specific to Catharanthus roseus 
Global co-expression analyses are possible for model plants such as A. thaliana where 
hundreds 65 of datasets are available and can be computationally mined 78. For C. roseus far 
less resources are available. However, a dataset composed of 23 tissues and treatments was 
established in 2011 65 and careful analysis has led to a number of gene discoveries in alkaloid 
biosynthesis in C. roseus 30,79 as this pathway displays strong co-expression at least in its 
upstream region 49. 
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However, this dataset 65 has its limitations. Out of the 23 tissues of this set, 11 are obtained 
from tissue cultures such as hairy root cultures and suspension cultures. This is due to the fact 
that a lot of early research focused on C. roseus cell and tissue cultures for both practical and 
commercial reasons 3. Both systems are relatively easy to maintain and can be scaled up to 
demands. The biggest advantage is however the possibility to genetically modify these 
systems. Successful examples are the overexpression of transcription factor ORCA2 in cell 
suspension cultures to study its effect on alkaloid production 80 or the silencing of tryptamine 
biosynthesis in hairy roots, a tissue that is also included in the transcriptomic dataset 65, to 
explore the potential of producing non-natural alkaloids by feeding alternative substrates 66. 
Nevertheless, limitations of cell and tissue cultures are apparent. Apart from their instability 
and fluctuation in alkaloid quantity over time 81 most suspension cultures produce only the 
MIAs ajmalicine and serpentine. Hairy roots additionally produce tabersonine and 
catharanthine, but both systems lack the ability to generate the full spectrum of different 
alkaloids produced by whole plants. Most importantly the medicinally valuable alkaloids 
vinblastine and vincristine cannot be obtained from C. roseus cell cultures or hairy roots 
because of their lack of vindoline production. This has an important implication: co-expression 
analysis of transcriptome data obtained from tissues with inconsistent vindoline production 
are consequently an unreliable source for gene discovery in vindoline biosynthesis. 
 
1.4 Virus Induced Gene Silencing 
While techniques such as co-expression analysis provide candidates, further investigation of a 
possible involvement of these identified candidates in alkaloid biosynthesis requires additional 
experimental tools. Classical functional genomic studies for the rapid analysis of enzymes rely 
on loss of function techniques such as the generation of knockout mutants. For many non-
model organisms, such as C. roseus, a reliable protocol for stable genetic transformation is 
lacking. Alternatively Virus Induced Gene Silencing (VIGS), a transient posttranscriptional gene 
silencing technique, provides a system to asses gene function in planta. 
Virus induced gene silencing (VIGS) utilises the RNAi mechanism for the sequence specific 
down regulation of protein expression. Infection of plants with a viral vector, which 
additionally carries part of a host plant gene, results in sequence specific post transcriptional 
gene silencing (PTGS) 82. The technique exploits the fact that plants defend themselves against 
viral infection by targeting the viral-genome for sequence-specific degradation. Double-
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stranded RNA (dsRNA) is produced during viral replication by RNA-polymerase from the single 
stranded viral RNA. The dsRNA is recognised and cleaved by DICER, specific enzymes that are 
part of the plants defence response. These enzymes degrade the dsRNA to form 21 to 30 
nucleotide long small interference RNA (siRNA) 83. The siRNA is subsequently incorporated into 
the RNA-induced silencing complex (RISC) which uses them as template to recognise 
complementary messenger RNA (mRNA). Argonaute proteins, which form a part of the 
multiprotein RISC complex, cleave the identified specific mRNA 84. Both virus and plant mRNAs 
targeted in this manner are degraded, consequently leading to reduced accumulation of 
specific transcripts, reduced translation and ultimately to a knockdown phenotype of the 
targeted host gene 85. 
One of the most widely applied VIGS techniques employs Agrobacterium tumefaciens to infect 
the host plant with Tobacco Rattle Virus (TRV) 86. Main advantages of applying TRV, apart from 
its large host range, are its limited visual symptoms on the infected host plant and the ability of 
TRV to infect cells at an early time point in their development and differentiation and 
subsequently to start gene silencing before large amounts of the target protein are produced 
by the cell. Additionally, unlike most other plant viruses, TRV is able to penetrate growing 
points in plants and is therefore able to not only spread by transport but also by cell to cell 
distribution via cell division 87. 
TRV is a bipartite positive sense RNA virus that consists of RNA1 and RNA2. RNA1 encodes 
several genes including a replicase and proteins involved in viral movement that allow long-
distance movement of RNA1 in the plant and systemic infection without the requirement of 
RNA2 88. RNA2 includes a viral coat protein which can encapsulate both RNA1 and RNA2. Most 
importantly RNA2 was engineered to contain a multiple cloning site to allow insertion of target 
gene sequence from the host plant 89. The TRV RNA1 and RNA2 were each cloned between 
cauliflower mosaic virus (CaMV) 35S promoter and a nopaline synthase (NOS) terminator of a 
T-DNA vector. This binary shuttle vector is able to replicate in both E. coli and in A. tumefaciens 
89. The resulting plasmids pTRV1 and pTRV2 have been used for successful gene silencing in a 
diverse range of plants such as tomato 90, opium poppy 91 and barley 92. 
To infect plants, A. tumefaciens cultures carrying either pTRV1 or pTRV2 are mixed in equal 
amounts and used for infiltration of a host plant (Figure 10). Once the T-DNA has been 
integrated into the host plant genome and transcribed by the host plant’s RNA polymerase, 
formation of the systemic virus occurs and the antiviral RNAi silencing pathway is induced. 
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Figure 10 Schematic overview of agrobacterium mediated TRV gene silencing in plants 
Short segments (usually 200-400 bp) of candidate genes are cloned into the pTRV2 vector. Competent A. 
tumefaciens was transformed with the pTRV2 vector and mixed with a second A. tumefaciens containing 
the pTRV1 plasmid. Plants are infected with the mixed Agrobacterium cultures by pinching (forceps or 
syringe). Other methods include drenching 93 or biolistic methods 94. Figure modified after 95. 
 
1.5 Gene clustering in plant secondary metabolism 
The term “operon” 96 defines a group of genes that are functionally related, co-regulated and 
often transcribed as a single messenger RNA (mRNA). Operons were thought to be restricted 
to prokaryotic organisms with only a few exceptions, such as the biotin synthesis pathway of 
yeast 97 or the major histocompatibility complex in humans 98. However it was shown that for 
example filamentous fungi harbour a rich and diverse range of gene clusters that produce 
secondary metabolites, many of which have antimicrobial and antibiotic function 99. 
The recent discovery of a relatively modest number of secondary metabolite gene clusters in 
plants has stirred great attention and has been discussed 100,101 and reviewed 7,102–104 to a great 
extent. Plant metabolic gene clusters are now known for various plants and a variety of 
different secondary metabolites, with terpenoid clusters being the most abundant (Table 2). 
Much of the excitement generated by the discovery of plant gene clusters is due to the 
36 
 
 
consideration that the discovery of such gene clustering in plants could enable efficient 
elucidation of complex specialised biosynthetic pathways and circumvent the current laborious 
process of plant gene discovery. 
Table 2 Examples of known plant secondary metabolite cluster 
Table modified after 105,106. 
plant class/ secondary metabolite reported 
maize (Zea mays ssp.) benzoxazinones (bx cluster, DIBOA, DIMBOA) 1997 
cassava (Manihot escolenta) cyanogenic glucosides/ linamarin and lotaustralin 2011 
sorghum (Sorghum bicolor) cyanogenic glucosides/ dhurrin 2011 
lotus (Lotus japonicus) cyanogenic glucosides/ linamarin and lotaustralin 2011 
poppy (Papaver somniferum) alkaloid/ noscapine 2012 
tomato (Solanum lycopersicum) alkaloid/ sterodial glycoalkaloids 2013 
potato (Solanum tuberosum) alkaloid/ sterodial glycoalkaloids 2013 
various Solanum ssp. monoterpene 2013 
rice (Oryza sativa) diterpene/ phytocassane (chromosome 2) 2009 
rice (Oryza sativa) diterpene/ momilactone (chromosome 4) 2004 
oat (Avena ssp) triterpene/avenacin 2004 
lotus (Lotus japonicus) triterpene/ lupeol 2013 
thale cress (Arabidopsis thaliana) triterpene/thalianol 2008 
thale cress (Arabidopsis thaliana) triterpene/marneral 2011 
various Euphorbiaceae ssp. diterpenoid 2014 
ricinus (Ricinus communis) diterpenoid 2014 
barley (Hordeum vulgare) 107 beta-diketone 2016 
 
1.5.1 A definition of plant specialised metabolism gene cluster 
According to a recent review, a gene cluster is defined as: “a set of two or more non-
homologous genes encoding enzymes from the same pathway (to be distinguished from the 
gene clusters resulting from tandem duplication and those consisting of homologous genes)” 
105. A more detailed definition cannot be made as the plant gene clusters identified to date 
vary greatly in many aspects such as cluster size, the actual number of genes, the number of 
genes unrelated to the pathway contained within the cluster, the co-regulation of the genes, 
and the order of genes in respect to the order in the pathway for which they are responsible. A 
brief overview over a few selected gene clusters in secondary metabolism discovered to date is 
given in the following section.  
One of the two known rice gene clusters, the chromosome 2 cluster, includes genes that are 
involved in the production of not one but two different phytoalexins, phytocassanes and 
oryzalides/ oryzadiones 108. These genes are differently regulated, an exception to the typically 
co-regulated genes of plant gene cluster. The rice chromosome 2 cluster contains four closely 
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related members of the cytochrome P450 CYP76M subfamily (CYP76M5-8). These four 
homologous P450s have a similar but not identical substrate scope 109 providing a metabolic 
plasticity that might enable positive selection pressure and play a role in the further evolution 
of this cluster. The second rice specialised metabolite cluster is involved in the production of 
momilactone and is located on chromosome 4. It contains a putative dehydrogenase gene 
(AK103462) and two functionally unknown P450 genes (CYP99A2 and CYP99A3) together with 
OsKS4 and OsCyc1, both diterpene cyclase genes. Together these genes form a chitin 
oligosaccharide elicitor- and UV-inducible gene cluster involved in momilactone biosynthesis 
that spans a distance of 168 kb 110. 
The first ever secondary metabolite cluster to be discovered in plants is much larger. It 
encodes the 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) biosynthesis in maize 
111. While six of the steps of this pathway (Bx1 to 5 and Bx8) are located within less than 300 kb 
on maize chromosome 4, the sixth step in DIMBOA biosynthesis, Bx6 is located in 2 Mb 
distance while the seventh step Bx7 is located in as far as 15 Mb distance and further genes 
identified to be belonging to the same pathway are not even on the same chromosome 105.    
The 10-gene cluster for the production of noscapine, identified in Papaver somniferum (opium 
poppy) 112 is one of the few so far identified clusters implicated in the biosynthesis of alkaloids. 
Containing three O-methyltransferases, four cytochrome P450 enzymes, one 
acetyltransferase, one carboxylesterase and a short-chain dehydrogenase/reductase it 
comprises five different enzyme classes on a genomic region spanning only 221 kb.  
1.5.2 Origin of plant specialised metabolite clusters 
The known cluster can give insight into evolution of plant secondary metabolism. For example, 
the biosynthesis of several terpenes in Solanum lycopersicum, a gene cluster on chromosome 8 
is responsible. Notably, similar clusters could be detected at the same position on 
chromosome 8 in several closely related members of the Solanum plant family. This syntheny 
thus provides insight into the possible evolution of this conserved cluster by duplication and 
divergence from an original set of genes 113. Another particularity can be seen in the DIMBOA 
cluster of maize. It originates most likely from an ancestral monocot as wheat and rye for 
example are able to synthesis DIMBOA yet the gene cluster responsible is split in two parts in 
the genome, most likely due to a genomic translocation events 7. 
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Convergent or “repeated” evolution is a frequent phenomenon in plant secondary metabolism 
114 and can for example be observed in the biosynthesis of cyanogenic glucosides in Lotus 
japonicus, the Poaceae sorghum (Sorghum bicolor) and in the Euphorbiaceae cassava  
(Manihot esculenta). In all three plants, which are only distantly related, cyanogenic glucoside 
biosynthesis has evolved and the responsible genes are clustered.  While in L. japonicus and M. 
esculenta the cyanogenic glucosides linamarin and lotaustralin are biosynthesised from L-
valine and L-isoleucine, in S. bicolor biosynthesis of a different class of cyanogenic glucoside 
starts with the precursor L-tyrosine. Although the biosynthesis in all three cases requires three 
steps and in all three plants species the first and third step is carried out by a similar enzyme (a 
Cyp79 and a UGT85), two facts suggest a convergent evolution. First, the gene responsible for 
the second step in the biosynthesis has been recruited from two different P450 families (CYP71 
and CYP736) and second, the order of the genes in the individual cluster is very different and 
does not suggest a common inheritance but rather an independent occurrence 115. 
1.5.3 Gene clustering supports pathway elucidation 
The important crop plant oat (Avena ssp.) produces the defence compound avenacin, a 
saponin triterpene. Originally a mutant population was screened for saponin deficient (SAD) 
plants and it was shown that nine out of ten SAD mutants co-segregate, suggesting a close 
physical location of the responsible genes in the genome 116. Over the following years much 
could be revealed regarding the location, but also identity and function, of genes involved in 
avenacin biosynthesis. Oat β-amyrin synthase (AsbAS1) encodes for the first committed step in 
this biosynthetic pathway. Genetic and biochemical analysis indicated that AsbAS1 is located in 
the linkage group D of the diploid oat genome together with at least three other genes 
required for distinct biochemical processes in avenacin synthesis, forming a gene cluster that 
had not arisen from simple gene duplication of a common ancestor 117. More precise 
information on the exact location of the genes involved in this cluster gene could be obtained 
by the addition of BAC data revealing that the first two steps of avenacin biosynthesis, the 2,3-
oxidosqualene cyclisation by β-amyrin synthase and the β-amyrin oxidase, are located within 
70 kb on the oat genome 118 119. A further methyltransferase gene, responsible for the SAD 9 
mutant could also be linked to this cluster 120 and ultimately the cluster known to date 
comprises five genes, representing five of the original ten sad mutants (SAD 1, 2, 7, 9 and 10) 
whose identity and function in avenacin biosynthesis could be uncovered. These discoveries 
highlight how gene clusters streamline the functional characterisation of plant metabolic 
genes. 
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1.6 Aim of the work presented in this thesis 
The highly complex secondary metabolite pathway of C. roseus, leading to the production of 
valuable anti-cancer compounds, has been the focus of research for decades. Nevertheless, 
not all enzymatic steps involved in the biosynthesis of the complex alkaloids have been 
discovered. Full understanding of the entire pathway would enable the production of these 
compounds in alternative hosts as well as the targeted enzymatic modification of individual 
compounds, allowing for the rapid expansion of the existing plethora of natural products from 
C. roseus. 
The recent acceleration of sequencing approaches to obtain plant genomic data has driven the 
discovery of a number of metabolic gene clusters involved in a variety of secondary metabolite 
pathways in a range of plants. In parallel, the availability of transcriptomic datasets has 
allowed the application of co-expression analyses to identify new genes. 
This thesis aims at combining co-expression analysis, which has aided discovery of genes 
involved in plant secondary metabolism in many plant species, with the investigation of 
potential gene clustering of the C. roseus MIA pathway. The objective is to discover and 
characterise in vitro missing steps in the alkaloid biosynthesis in C. roseus as well as to 
functionally validate the involvement of genes in planta in this secondary metabolic pathway. 
Co-expression analysis has been used to successfully identify a missing step in vindoline 
biosynthesis using existing transcriptomic resources 65.  The second part of this thesis describes 
the generation of newly established genomic resources, selected BACs and the first draft 
genome, for C. roseus. It describes the bioinformatics analysis of the obtained data and 
subsequent confirmation using PCR from genomic DNA. 
Chapter II validates the in planta role of two functionally identical alkaloid pathway genes in 
C. roseus leaves applying VIGS. It presents and discusses the results of experimental data 
obtained from determination of silencing success applying qRT PCR on VIGS tissue, as well as 
comparing LC-MS measurements of leaf extracts of silenced and unsilenced control tissues. 
Chapter III reports the discovery and characterisation of a missing step in vindoline 
biosynthesis. Coexpression analysis results in gene candidates and VIGS is applied to establish 
their involvement in vindoline biosynthesis. A positive candidate is identified and characterised 
using a yeast expression system. The chapter discusses the implications of an observed in-vivo 
rearrangement of the product of this step.  
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Chapter IV reports the newly establishment and analysis of genomic resources including 
genomic data and BAC data. The genomic context of alkaloid biosynthesis is investigated and 
further research is presented. The extent of observed gene clustering in MIA biosynthesis in 
C. roseus considering the quality and quantity of the available data is discussed. 
Chapter V presents an overview of all VIGS experiments that were discovered by either co-
expression analyses or genome mining and highlights some of the most promising outcomes. It 
also presents an approach to improve the existing VIGS protocol. 
The overarching theme of this research is to utilise existing transcriptomic and newly 
developed genomic resources in the task of gene discovery in secondary metabolism in the 
medicinal model plant C. roseus. 
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2 Investigating the in planta role of two C. roseus enzymes 
with identical in vitro function 
Part of this work was initiated as a collaboration with the group of Vincent Courdavault, 
University of Tours, France. VIGS constructs were designed, VIGS experiments and 
metabolite analysis as well as qRT PCR of the target gene and pathway related genes were 
performed by Franziska Kellner. The results of this work have been published in 42. The full 
publication can be found at the end of this thesis. 
 
2.1 Introduction 
The medicinal plant C. roseus, known for its production of the two valuable anti-cancer 
compounds vinblastine and vincristine, has one of the most extensively studied secondary 
metabolite pathways. More than 130 different monoterpene indole alkaloids (MIAs) have been 
reported for C. roseus 19. Despite decades of research that have shed light on the complex 
biosynthesis of MIAs, not all enzymatic steps are known.  
For many non-model organisms, such as C. roseus, a reliable protocol for stable genetic 
transformation is lacking. Therefore to validate or functionally characterise steps of alkaloid 
biosynthesis alternative tools have been developed such as Virus Induced Gene Silencing 
(VIGS). VIGS is a transient posttranscriptional gene silencing technique that provides a system 
to assess gene function in planta. 
 
 
2.1.1 Virus Induced Gene Silencing in Catharanthus roseus 
VIGS in C. roseus was first established by Dr. Dave Liscombe in the O’Connor group by adapting 
the gene silencing technique that had been shown to be functional in various plants 121 . 
Tobacco rattle virus (TRV) was chosen, as it was known that C. roseus is susceptible to infection 
with this virus. To assay successful silencing in C. roseus, young plants were pinched with A. 
tumefaciens transformed with a plasmid harbouring a segment of the C. roseus photoporphyrin 
IX magnesium chelatase subunit H (ChlH) (Figure 11).  
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Silencing of this chlorophyll biosynthetic gene should result in a lack of chlorophyll production, 
and consequently a yellowing of the leaf. Silencing of ChlH had previously been used in 
Nicotiana benthamiana as visual marker 122. As seen in Figure 11, the yellowing, which 
indicates successful gene silencing, is not restricted to the leaf tissue. Although not reported 
for C. roseus, specific gene silencing for flower or pericarp is possible. 
 
Figure 11 C. roseus photoporphyrin IX magnesium chelatase subunit H (ChIH) silencing 
An 11-week old C. roseus plant three weeks after inoculation with A. tumefaciens harbouring the VIGS 
vector for silencing C. roseus ChlH. The visible yellowing affects the leaves above the pinching site as 
well as stem, sepals and pericarp. However, the silencing effect does not spread into tissue beneath the 
pinching site. 
2.1.2 Optimisation of VIGS in Catharanthus roseus 
Virus induced gene silencing in C. roseus has been streamlined by the introduction of the uracil 
excision-based cloning (USER cloning) method 123 to the established VIGS pTRV2 vector. This 
ligation-independent cloning technique utilises PCR primers that contain a single deoxyuridine 
residue near the 5’ end. The subsequent treatment of the PCR product with Uracil-Specific 
Excision Reagent (USER) enzyme leads to the generation of 8 nucleotide 3’ overhangs. These 
overhangs complement the ends of a USER compatible linearised vector allowing for 
transformation of E. coli without prior ligation. For this purpose a new cassette had been 
introduced into the pTRV2 vector that facilitates rapid cloning with the newly created pTRV2u 
vector 30. 
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2.2 Results and Discussion  
The enzyme tabersonine 16-hydroxylase (T16H), a cytochrome P450, synthesises the first 
committed step of vindoline biosynthesis in C. roseus, hydroxylating the biosynthetic 
intermediate tabersonine at the 16 position of the indole ring (Figure 12).  
 
Figure 12 Tabersonine 16-hydroxylase reaction catalysed by T16H 
Given the importance of vindoline in the production of the anti-cancer agent vinblastine, there 
has been great interest in elucidating all of the biosynthetic enzymes that convert tabersonine 
to vindoline. In 1999 a gene encoding T16H was successfully cloned from a light and nutritional 
downshift induced C. roseus suspension culture line CP3a by the group of Schroeder 41. It was 
discovered after previous sucrose density gradient centrifugation revealed a subcellular 
localisation at the endoplasmic reticulum suggesting it to be a cytochrome P450 124. 
Tabersonine 16-hydroxylase (T16H) was able to catalyse the conversion of tabersonine to 16-
methoxytabersonine when co-expressed with the partner P450 reductase (P450red) as a 
translational fusion in E. coli. 
This gene was shown to be expressed in the epidermis of C. roseus leaves using RT PCR of 
isolated epidermal cells 47. The presence of T16H in an epidermis enriched EST data set 50 was 
consistent with these results. However, when the group of Vincent Courdavault (University of 
Tours, France) attempted to demonstrate the localisation of T16H in C. roseus leaves using 
RNA in situ hybridisation, the gene could not be detected. More careful analysis led instead to 
the discovery of a T16H like gene (T16H2) in C. roseus leaves with high sequence similarity. The 
two T16H genes, T16H1 (the gene identified in 1999) and T16H2, share 86.5% nucleotide 
identity. A C. roseus expression data set available at the time 65 is not precise enough to 
distinguish between both isoforms. Therefore, the expression profiles of T16H1 and T16H2 are 
not accurately represented in this dataset, making it challenging to understand the function of 
these two isoforms (Figure 13). 
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Figure 13 Expression of T16H and other vindoline biosynthesis genes 
Expression values (log₂FPKM) for the contig that represents both T16H versions and all other at the time 
known vindoline biosynthesis genes in the tissues: A (flower), B, C and D (sterile seedlings treated with 
MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root) according to the data obtained 
from (http://medicinalplantgenomics.msu.edu/). 
2.2.1 Mapping transcriptomic raw data to both T16H individual ORFs 
Read mapping is a method used in bioinformatics by which short raw reads from 
transcriptome sequencing are aligned to a reference sequence such as the open reading frame 
(ORF) of a gene. The different amount of matching reads for each reference sequence 
represents their individual abundance and can be used to calculate gene expression values. 
As mentioned above the expression of T16H1 and T16H2 was not individually represented in 
the transcriptomic data set available at the time 65. In order to investigate the individual 
expression of each of the highly similar versions of T16H mapping of raw reads of three 
transcriptomic raw data sets was performed. According to data obtained from mapping the 
raw reads, the expression of T16H2 and T16H1 differs quite significantly in different tissues. 
For the mapping two sources were used. The raw data of two tissues of the C. roseus 
transcriptomic data set made available by the Medicinal Plant Genomics Resource (MPGR) 65 
and one tissue (leaf) from a second study 70 (Phytometasyn, http://www.phytometasyn.ca/). 
 
0
2
4
6
8
10
T16H
16OMT
NMT
DAT
D4H
A B C D E F G He
x
p
re
s
s
io
n
 v
a
lu
e
 (
lo
g
2
 F
P
K
M
)
tissue/ experimental condition
45 
 
 
The quality and amount of raw data is different for both studies with the first one being 
composed of only single reads with 35 bp read length and considerably less coverage. However 
the data conclusively supports that T16H1 is expressed at negligible levels in leaf tissues of 
C. roseus while T16H1 is clearly the predominantly expressed version in flowers and 
suspension culture (Table 3). 
 
Table 3 Distribution of mapped reads for T16H1 and T16H2 in different C. roseus tissues 
Tissue Source 
Number of raw 
reads 
Reads mapped to 
T16H1 
Reads mapped to 
T16H2 
Flower SRX047002 31,645,190 15259 6333 
Suspension Culture SRX047006 26,234,705 725 198 
Leaf SRX096098 292,873,732 337 65339 
 
To investigate the function of the newly found T16H gene in C. roseus leaf tissue, VIGS 
experiments were conducted as described in the following section. Along with the enzymology 
work performed in the Courdavault Group, these data demonstrate that both genes are 
functional tabersonine 16-hydorxylases, yet that they have undergone sub-functionalisation, 
leading to differential spatial localisation of vindoline biosynthesis 42. 
 
2.2.2 T16H2 VIGS construct 
To investigate the function of the newly found T16H gene in C. roseus leaves, VIGS 
experiments were conducted as described in the following sections. Even though all evidence 
suggested that the previously reported T16H1 41 was not present in leaves the VIGS plasmid for 
T16H2 silencing was constructed to minimize potential cross silencing. Due to the high 
sequence similarity it was impossible to choose a region that did not contain any identical 
regions between the two T16H genes. Ultimately, the final VIGS construct contains a gene 
fragment that incorporates part of the untranslated region (UTR) to maximise sequence 
differences and has only a single 23 bp long region that is identical between T16H2 and T16H1 
(Figure 14). 
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T16H2           1 ------------------------TG--ATTGG--AAACTTG----CCAG--TGAT---G   23  
                                          TG  ATT G   AACTT     CCA   TGAT           
T16H1        1321 CATTTGCTTTGGCTAATATAGAATTGCCATTAGCACAACTTTTGTTCCATTTTGATTGGC 1380  
 
T16H2          24 AAACAAATATTGATAAATTAGACATGACGGAGAGTAGAGGGGTAACAGTTAGAAGAGAAG   83  
                  AA CAAATA TGA AAATTA A ATGA  GAGAGTAGAGGGGTAACAGTTAG  GAGAAG       
T16H1        1381 AATCAAATACTGAGAAATTAAATATGAAAGAGAGTAGAGGGGTAACAGTTAGGCGAGAAG 1440  
 
T16H2          84 ATGATTTGTGTCTGATTCCATTTCCTTATTCTGCTTCTTCTCTCAAAGGTAAATATTAGA  143  
                  ATGATTTGT T TGA TCCA TT  TT TTCT C TCTTCTC      G AAAT TT  A       
T16H1        1441 ATGATTTGTATTTGACTCCAGTTAATTTTTCTTCCTCTTCTCCTGCTTGAAAATCTT-TA 1499  
 
T16H2         144 TGGAGACAACATCACCAAATAATTGAAGACCAAGA----------TTGTAGGTCATGAAT  193  
                    GA ACAA      CAA   AT G AG CCA GA          TT T   TC T   T       
T16H1        1500 CCGAAACAA----TTCAAGACATGGTAGTCCATGAAGGATTTTTTTTTTTTTTCTTTCTT 1555  
 
T16H2         194 AG-TTGTCGGTCAAGAA----ATGGTGGCAAAAATTGCTACGGAAGATTTCGTTGCTAAT  248  
                     TT TC   C AGAA    ATG  GG   AA TT  T  GGA    TT GTT  T          
T16H1        1556 CCTTTTTCTTACGAGAAGTCCATGAAGGATTAAGTT--TGTGGA----TTTGTTAGTTTG 1609  
 
T16H2         249 CCAT--------------------------------------------------------  252  
                  CC T                                                               
T16H1        1610 CCTTTGGTAACAAGTTTGTGGATTTGTTTGTATCTAAATGAATAAAGCAATGATTGCCTC 1669  
 
 
 
Figure 14 Sequence identity between T16H2_VIGS construct and T16H1 gene 
The nucleic acid sequence alignment of T16H1 and T16H2 show the single 23 bp long section 
(highlighted in grey) that is identical between the gene segment used for silencing T16H2 and the 
corresponding T16H1 gene segment. The forward and reverse primer for cloning the VIGS construct are 
in bold. 
 
The designed VIGS construct was used in silencing experiments on 8 week old C. roseus 
seedlings. As a control, tissue harvested from plants infected with an empty vector (EV) 
silencing construct was used. Silenced tissue was harvested three weeks after infection, milled 
and each sample divided into two fractions, one for RNA extraction and subsequent qRT PCR 
and the second fraction to be prepared for metabolite analysis with LC-MS. 
 
2.2.3 T16H2 silencing success determined by qRT PCR 
RNA was extracted from 6 samples of T16H2_VIGS tissue and an equal amount of RNA from EV 
control tissues was converted to cDNA and T16H2 gene expression was measured. An 
approximately 80% decrease of transcripts in the T16H2 silenced tissues relative to the EV 
controls confirmed the efficient knockdown of the T16H2 gene by VIGS (Figure 15). 
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Figure 15 Silencing effect on gene expression of T16H2 
Relative expression of T16H2 gene in T16H2 silenced tissues compared to EV tissue (n=6). Expression 
was normalised to expression of CrRPS9. Data presented is the mean + SEM. 
 
Repeated efforts to detect the presence of T16H1 in the silenced or empty vector control 
tissues gave only negative results. If any T16H1 expression is present in leaves of C. roseus it is 
below the detection limit of the qRT PCR protocol. 
 
2.2.4 T16H2 silencing influences leaf alkaloid content 
The alkaloid content of C. roseus has been investigated and reported several times over the 
past years 19,125. One study examines the leaves of 64 modern commercial C. roseus varieties 
126, reporting a large spectrum of total alkaloid concentration ranging from approximately 5 mg 
to 0.5 mg per g dry weight 126. Although over 130 different MIAs are reported for C. roseus only 
a few accumulate to significant levels in C. roseus tissues 19. “SunStorm Apricot” (Figure 4), the 
variety used predominantly for this thesis, accumulates 1.9 mg of catharanthine per g dry leaf 
tissue and 0.8 mg per g dry leaf tissue of vindoline and reaches an average total alkaloid 
content of 3 mg per g leaf tissue 126. 
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Liquid Chromatography Mass Spectrometry (LC-MS) measurements of leaf tissue methanol 
extracts are used to examine the effect of silencing a specific gene on leaf alkaloid content. As 
a first analysis of the obtained data, the peak area of the known metabolites secologanin, 
strictosidine, serpentine, catharanthine, tabersonine, vindoline and vindorosine (Figure 16) are 
investigated.  
 
 
 
Figure 16 Chemical structures of metabolites investigated in silenced leaf tissue 
 
Generally samples of between six and eight individually silenced plants are measured per 
treatment. LC-MS analysis of all VIGS experiments used either a Surveyor high performance 
liquid chromatography (HPLC) system attached to a DecaXPplus ion trap MS (Thermo-Finnigan) 
or a Nexera/Prominence UHPLC IT-ToF (Shimadzu). All compounds of interest ionise 
comparably on both machines (Dr. Lionel Hill, Dr. Richard Payne, personal communication).  
LC-MS data was obtained as total ion chromatogram (TIC) (Figure 17 A). Peak area was 
calculated from the extracted ion chromatogram (EIC) for each of the metabolites of interest 
(Figure 17 B) using the appropriate software for each instrument.  
 
 
 
 
 
 
 
49 
 
 
Figure 17 Representative chromatogram of young leaf tissue of C. roseus methanol extract 
A: Representative total ion chromatogram (TIC) of a C. roseus “SunStorm Apricot” methanol extract of 
young leaf tissue obtained on the IT-TOF mass analyser (Shimadzu). B: Red: Extracted ion chromatogram 
(EIC) for m/z 337 representing catharanthine and tabersonine at time 3.9 and 4.3 respectively, blue and 
black: EIC for vindoline and vindorosine with m/z 457 and m/z 427 respectively. C: Red: Extracted ion 
chromatogram (EIC) for strictosidine with m/z 531, blue: EIC for secologanin (Na+ adduct) with m/z 411 
and black: EIC for serpentine with m/z 349. 
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For the Thermo-Finnigan ion-trap instrument peak areas were calculated using the Thermo, 
Xcalibur Roadmap 2.2 SP1.48 software. For the IT-ToF mass spectrometer (Shimadzu) peak 
areas were calculated using the Shimadzu LC-MS solution software version 3.80.409. 
The extracted peak areas are normalised by sample tissue weight and caffeine as internal 
standard. Subsequently statistical analyses was used to compare the average normalised peak 
areas of metabolites in silenced to those of empty vector control tissues to detect significantly 
changes in alkaloid accumulation. 
2.2.4.1 T16H2 silencing alters vindoline and vindorosine accumulation significantly 
The hydroxylation of tabersonine at the C16 position by T16H is the first enzymatic step in the 
multiple step biosynthesis of vindoline from tabersonine in C. roseus leaves (Chapter 1, Figure 
7).  
The silenced tissues of two independent VIGS experiments were analysed by LC-MS using the 
Thermo-Finnigan ion-trap instrument. Already during initial inspection of the data it became 
strikingly apparent that the vindoline peak in T16H2 silenced plants was reduced while at the 
same time the peak for a closely related alkaloid, vindorosine was increased in comparison to 
EV control samples. Vindorosine is a naturally occurring vindoline derivative that lacks the 
hydroxyl moiety at carbon 16. In EV control tissues vindorosine is consistently found at lower 
levels than vindoline, but in TH162 silenced tissues, this ratio is reversed (Figure 18). 
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Figure 18 Comparison of extracted ion chromatograms of T16H2 and EV silenced tissues 
Extracted ion chromatograms obtained from LC-MS data generated on the Thermo-Finnigan ion-trap 
instrument for vindorosine (m/z 427) and vindoline (m/z 457) A: Representative example of an EV 
silenced plant. The vindoline peak, usually the largest peak in the chromatogram, exceeds the 
vindorosine peak. B: Representative example of a T16H2 silenced plant. The area of the vindorosine 
peak exceeds the vindoline peak. 
 
Peak areas were calculated from vindoline and vindorosine EIC using the Xcalibur software. 
Obtained data was normalised by internal standard and sample fresh weight. Statistical 
analysis was performed and confirmed the observed change in vindoline and vindorosine 
accumulation (Figure 19). Although a strong decrease of vindoline was observed, levels of 
tabersonine, the substrate of T16H, were not significantly altered. 
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Figure 19 T16H2 silencing effect on leaf vindoline, vindorosine and tabersonine content 
Relative MIA content as mean peak area normalised by tissue weight and internal standard for 
vindoline, vindorosine and tabersonine in T16H2 silenced plants in comparison to EV control plants 
(n=8). Error bars represent + SEM. P-value was calculated using Student’s t test (**p<0.01, ***p<0.001). 
 
2.2.4.2 T16H2 silencing causes changes in accumulation of possible intermediates of 
vindoline and vindorosine biosynthesis   
The data obtained from statistical analysis of extracted peak areas of the major metabolite 
clearly showed a significant decrease in the level of accumulating vindoline in favour of an 
equally strong increase of a new mass thought to be vindorosine, the de-methoxylated 
analogue of vindoline. The levels of other known alkaloids that can be identified using 
available standards such as secologanin, strictosidine and catharanthine, were unaffected by 
silencing as no significant changes could be detected. 
The order of reactions in vindoline biosynthesis is well established. First the C16 position is 
hydroxylated by T16H and the same position is subsequently methoxylated. Although the next 
step (or steps) were unknown at the time, it had been shown that the known downstream 
enzymes of vindoline biosynthesis NMT, D4H and DAT were able to accept the 16-
methoxylated and the demethoxylated tabersonine derivatives 121, suggesting the observed 
change in vindoline and vindorosine levels are due to a shift in metabolic flux caused by the 
silencing of T16H2 (Figure 20). 
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Figure 20 Vindoline and proposed vindorosine biosynthesis in C. roseus 
Vindoline and vindorosine biosynthesis in C. roseus proceed from the joint substrate tabersonine. 
Enzymatic steps in brackets and the respective intermediates were not known at the time. At the time 
known genes NMT, D4H and DAT had been shown to accept the 16-methoxy and the unmethoxylated 
tabersonine derivatives 121,127. 
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To investigate in more detail the metabolic changes caused by silencing T16H2, automated 
peak extracted was performed on silenced and unsilenced samples (n=8) using the software 
XCMS on all obtained metabolite data raw files. All extracted peak areas were normalised by 
sample fresh weight. Interestingly, comparing the peak mean for each treatment, out of 616 
extracted peaks the highest increase was that of the vindoline peak and the largest decrease of 
a extracted peak was for that of vindorosine, confirming the previous observations. 
Vindoline and vindorosine biosynthesis proceed via several intermediate steps. None of the 
intermediates accumulates in C. roseus leaves at high levels and for none of them standards 
were available at the time. Two of the possible intermediates share the same calculated 
monoisotopic mass (Table 4). 
Table 4 Intermediates of vindoline and vindorosine biosynthesis 
Intermediates of vindoline and vindorosine biosynthesis with exact masses. Masses in bold occur in the 
vindoline as well as in the vindorosine biosynthesis. 
vindoline biosynthesis intermediates 
monoisotopic 
mass 
16-hydroxytabersonine 352.1860 
16-methoxytabersonine 366.1943 
16-methoxy-2,3-dihydro-3-hydroxytabersonine 384. 2122 
desacetoxyvindoline 398. 2278 
deacetylvindoline 414. 2227 
vindoline 456. 2227 
vindorosine biosynthesis intermediates   
2,3-dihydro-3 hydroxytabersonine 354.1943 
desacetoxyvindorosine 368. 2173 
deacetylvindorosine 384. 2122 
vindorosine 426. 2227 
 
The dataset generated by applying the automated peak extraction was mined for peaks of 
masses corresponding to the intermediates in vindoline and vindorosine biosynthesis (Figure 
20, Table 4). For all intermediates at least one corresponding peak could be identified (Table 
5). 
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Table 5 Peaks corresponding to vindoline and vindorosine biosynthesis intermediates 
Peaks extracted automatically using the XCMS software out of a LC-MS total ion chromatogram data set 
of EV and T16H silenced leaf tissue extracts, were investigated for the increase or decrease of peaks of 
masses that correspond to intermediates in the biosynthesis of vindoline and vindorosine. Data 
presented includes the m/z, Student’s ttest (p-value), mean of corresponding peak area for T16H2 
silenced and EV silenced plants (n=8) and the calculated increase or decrease of the mean peak area. 
Grey underlined are peaks with significant changes (p-value <0.05). Bold is vindoline identified according 
to an available standard. 
 
 
 
To further investigate this two samples of silenced and control tissue extracts were subjected 
to an accurate mass analysis using a Surveyor LC system attached to an LTQ Orbitrap (Thermo). 
For the calculated exact masses of six of the ten possible intermediates, peaks were detected, 
with corresponding masses within a range of 3 ppm (Table 6). Four of those peaks correspond 
to intermediates significantly decreased in vindoline biosynthesis or significantly increased in 
vindorosine suggesting a redirection of flux from vindoline to vindorosine production in 
silenced leaves. 
 
 
353.2108 0.01510 0.056 0.164 -0.108 355.2383 0.01334 0.059 0.031 0.0278
353.2233 0.16093 0.376 0.290 0.0864 355.0168 0.71545 0.113 0.106 0.0068
353.2476 0.08736 0.216 0.333 -0.117 355.2612 0.23687 0.045 0.059 -0.014
353.2497 0.26053 0.116 0.094 0.0211 355.3352 0.01750 0.010 0.021 -0.011
367.3066 0.77367 0.436 0.414 0.0222 369.1218 0.61415 0.025 0.023 0.0018
367.219 0.87304 0.060 0.058 0.002 369.3115 0.58344 0.167 0.143 0.0237
385.2615 0.02374 0.077 0.046 0.0311 385.2615 0.02374 0.077 0.046 0.0311
399.3247 0.03159 0.026 0.083 -0.057 427.2513 0.01513 4.932 2.791 2.1409
415.2446 0.00012 0.013 0.030 -0.017
457.218 0.00001 1.275 3.025 -1.749
ttest
mean 
T16H2 
mean EV
increase/ 
decrease
masses corresponding to vindoline biosynthesis masses corresponding to vindorosine biosynthesis
m/z ttest
mean 
T16H2 
mean EV
increase/ 
decrease
m/z
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Table 6 Accurate mass analysis with Surveyor LC system attached to an LTQ Orbitrap 
Accurate mass was determined of methanol extracts of T16H silenced and not silenced EV control 
tissues using a Surveyor LC system attached to an LTQ Orbitrap (Thermo). For all possible intermediates 
of vindoline and vindorosine biosynthesis exact masses were calculated and compared to peaks of 
accurate mass measured samples. For six masses a single corresponding peak could be detected. 
 
  
Formula 
Calculated 
(m/z, 
[M+H]) 
Found 
(m/z, 
[M+H]) 
Error 
(ppm) 
16-hydroxytabersonine C21H24N2O3 353.1860 353.1850 2.74 
desacetoxyvindorosine C22H28N2O3 369.2173 369.2176 0.90 
deacetylvindorosine C22H28N2O4 385.2122 385.2120 0.48 
vindorosine C24H30N2O5 427.2227 427.2227 0.11 
desacetoxyvindoline C23H30N2O4 399.2278 399.2280 0.42 
deacetylvindoline C23H30N2O5 415.2227 415.2229 0.36 
 
 
2.2.5 Effect of T16H2 silencing on other alkaloid biosynthesis genes 
The silencing of T16H2 gene expression was successful and led to a significant change in 
metabolite profile, clearly identifying its role in vindoline biosynthesis in leaves of C. roseus. 
Repeated attempts to quantify T16H1 expression failed. If it is expressed at all, expression of 
this gene remained below the qRT PCR detection limit in both empty vector and T16H2 
silenced tissues. 
The changes observed in metabolic phenotype of T16H silenced tissues can be explained by 
T16H silencing alone and do not suggests significant reduction in expression of other MIA 
pathway genes. Therefore it can be assumed that the redirection of flux does not lead to a 
possible feedback inhibition of the pathway. Instead expression of three exemplary chosen 
alkaloid biosynthesis genes both upstream (G8H) and downstream (D4H and DAT) of T16H2 is 
increased in T16H2 silenced tissues (Figure 21) as if to compensate for the reduced vindoline 
accumulation. 
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Figure 21 Gene expression of alkaloid biosynthesis genes in T16H2 silenced tissues 
Relative expression of alkaloid biosynthesis genes G8H D4H and DAT in T16H2 silenced tissues compared 
to EV tissue (n=4). Expression was normalised to expression of CrRPS9. Data presented is the mean 
+ SEM. 
2.3 Conclusion 
A protein was discovered in C. roseus leaves with 82% identity in the deduced amino acid 
sequence to the known vindoline biosynthesis gene tabersonine 16-hydroxylase (T16H). The 
original C. roseus T16H (T16H1) gene was discovered in 1999. It had been cloned from a 
C. roseus suspension culture 41. Rigorous in vivo characterisation identified the newly found 
gene to be a second gene encoding a functional T16H (T16H2). 
In the scope of this thesis the in planta function and relevance of the T16H2 gene in C. roseus 
leaves was investigated. It could be confirmed that indeed this new T16H is responsible for 
vindoline biosynthesis in C. roseus leaves, the primary site of vindoline and subsequently 
dimeric MIA production in C. roseus 42. 
Successful silencing of the expression of the newly identified T16H2 to approximately 20% of 
the level in empty vector control tissue, led to significant changes in metabolite profile. Most 
strikingly the level of vindoline is reduced by almost 60% as a result of silencing and instead, 
levels of the des-methoxy vindoline analogue, vindorosine are increased by a similar amount 
suggesting a redirection of metabolic flux. Vindorosine had been isolated in trace amounts 
from C. roseus for the first time in the early 1960s 128 and later research into vindoline/ 
vindorosine production in C. roseus linked the biosynthesis of both alkaloids.  
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It had been established that the downstream vindoline biosynthesis genes NMT, D4H and DAT 
are able to accept both the methoxylated and the unmethoxylated precursor as substrate 
121,127 (Figure 23). The significant reduction of vindoline biosynthetic intermediates and 
increase of vindorosine intermediates support this hypotheis, but since authentic standards 
remain unavailable these results have to be interpreted not without caution. Despite this, the 
combined evidence of our results strongly suggest that T16H2 and not T16H1 is indeed the 
hydroxylase responsible for the first step in vindoline biosynthesis in leaves and represents a 
crucial control point determining the composition of accumulating alkaloids in C. roseus leaves 
and the fate of tabersonine. 
An individual expression profile for the two T16H versions was not visible in the original MPRG 
expression data set 65. Data resulting from the mapping of raw reads of two different publicly 
available transcriptomic studies 65,70 strongly suggests a preferential expression of T16H2 in 
leaves, while T16H1 is the predominantly expressed version in tissues like flower. The mapping 
confirms that T16H1 is the dominating version expressed in suspension cultures (Table 3). This 
tissue specific expression of both T16H versions is in accordance with our own qRT PCR results 
and the qRT PCR results obtained by our collaborators both T16H genes in different tissues 42. 
In retrospect, it is interesting to note, that in the publication that first reports the discovery of 
the T16H1 gene 41, the possible existence of a second closely related gene is mentioned. 
Performing a genomic DNA Southern blot in this study showed hybridisation bands that led to 
the hypothesis of possibly at least two closely related genes existing. Yet given the much 
stronger expression of T16H1 over T16H2 in the cell suspension culture tissue, it is not 
surprising that T16H1 rather than T16H2 was cloned.  
After the C. roseus genome was sequenced, as described in Chapter 4 we discovered that 
T16H1 and T16H2 are part of a gene pair located in close proximity next to each other 68. This 
suggests a recent duplication event and will be discussed further at the corresponding chapter 
of this thesis. 
The biosynthesis of vindoline and vindoline-related alkaloids such as vindorosine in C. roseus is 
highly complex with over 20 enzymatic steps, involving at least three different cell types, as 
well as several different subcellular localisations. The discovery of T16H2, a second functional 
tabersonine 16-hydroxylase, adds a novel dimension of complexity to the already complicated 
network of alkaloid production in C. roseus. It is the first example of two genes in C. roseus 
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that, despite catalysing the same enzymatic reaction, are transcriptionally regulated in a way 
that determines their individually different tissue dependent relevance and function. A clear 
distinction has to be made to genes with a simple redundant function. The herein presented 
evidence clearly shows how C. roseus uses sub-functionalisation of secondary metabolic genes. 
Unfortunately there is no literature available that would investigate if vindorosine and 
vindoline have different functions in for example protection of the plant from different types 
of herbivores. Therefore, it can only be speculated if the differing ratios of vindoline or 
vindorosine production holds any evolutionary advantage.  
The deconvolution of the two T16H genes has implications for example for co-expression 
analysis. A set of genes co-expressed with either one of the two T16H versions is clearly going 
to be very different from a set of genes co-regulated with the combined expression of the two 
T16H genes. It raises the question if there are more genes in C. roseus alkaloid biosynthesis for 
which close paralogues with district tissue dependent expression exist. 
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3 Discovery of an enzymatic step in vindoline biosynthesis 
Some aspects of this work were conducted in close collaboration with members of the 
O’Connor Lab Dr. Nat Sherden and Dr. Stephanie Brown. Results are published in (146). The 
publication can be found at the end of this document. 
Shotgun sequencing of the transcriptome (RNA-seq) allows the detailed study of gene 
expression within a certain tissue and/ or under a certain experimental condition. It allows us 
to observe and compare the individual expression profiles of genes in co-expression analyses 
129. Functionally related genes, such as the genes belonging to a certain metabolic pathway, 
often display a similar expression pattern in both primary 74,130 and secondary 76,131 
metabolism, making co-expression analysis a powerful tool for gene discovery 75. 
The search for a missing enzymatic step in vindoline biosynthesis that is presented in this 
chapter utilises co-expression analyses of a large C. roseus transcriptomic data set 65 to identify 
genes that are co-ordinately regulated with known genes of vindoline biosynthesis. The 
physiological function of the identified candidate genes was tested in planta utilising VIGS, a 
reverse genetics method for targeted transient gene silencing and resulted in identification of 
a promising gene candidate for the missing 16-methoxytabersonine 3-oxygenase step in 
vindoline biosynthesis. Subsequently 16-methoxytabersonine 3-oxygenase (T3O) was 
characterised in vitro and in a yeast expression system in collaboration with Dr. Nat Sherden 
and Dr. Stephanie Brown. 
 
3.1 Introduction 
Vindoline is one of the two necessary precursors for the formation of the valuable anti-cancer 
compounds vinblastine and vindorosine, uniquely produced by and laboriously extracted from 
C. roseus. Vindoline biosynthesis in C. roseus has been studied extensively, with the discovery 
of enzymatic activity for one of the pathway steps first reported almost 30 years ago 127.  
Despite these efforts the full elucidation of vindoline biosynthesis was still lacking one crucial 
step at the start of this work. The order of reactions that leads to vindoline production has long 
been established 43,132 and the known enzymes of the vindoline pathway at the start of this 
work, the genes encoding those enzymes and the localisation of the enzyme within the leaf of 
C. roseus will be introduced briefly (Figure 22): Vindoline biosynthesis is initiated by two 
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enzymes predominantly expressed in the epidermis of leaves 47. Tabersonine 16-hydroxylase 
(T16H) 41 and 16-hydroxytabersonine O-methyltransferase (16OMT) 34 hydroxylate and 
subsequently methylate the C16 position of tabersonine to yield 16-methoxytabersonine. The 
gene or genes responsible for the subsequent hydration reaction were unknown at the start of 
this work. After hydration, the next enzymatic step is the methylation of the indoline nitrogen 
catalysed by 16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase (NMT) 127. 
The gene encoding NMT was discovered in 2010 43. All literature reporting the localisation of 
NMT in C. roseus predates this publication and therefore these localisation experiments relied 
on detecting protein activity by assaying the substrate with different cellular fractions 
obtained by ultracentrifugation. These studies report a mesophyll and not epidermis location 
for NMT 34,47 suggesting that either the epidermis or the mesophyll could be the location of the 
unknown hydration enzymatic step(s). However later studies confirmed a predominant 
expression of NMT in the epidermis using qRT PCR 48, which suggests that the hydration 
reaction also takes place in the epidermis. Finally the last two steps of vindoline biosynthesis, 
the hydroxylation of desacetoxyvindoline by desacetoxyvindoline 4-hydroxylase (D4H) 44 to 
form deacetylvindoline followed by O-acetylation by deacetylvindoline acetyltransferase (DAT) 
45 to yield vindoline, are located in specialised mesophyll cells, the idioblasts and laticifers 60. 
The subcellular localisation of vindoline/vindorosine biosynthesis has also been assessed. 
Utilising a combination of GFP imaging, bimolecular fluorescence complementation assays and 
yeast two-hybrid analysis showed that T16H, a cytochrome P450 enzyme, is localised to the 
endoplasmic reticulum (ER), while 16OMT homodimerises in the cytoplasm 132. D4H and DAT 
are as well cytosolic 133 while NMT is associated with peroxisome membrane (Dave Liscombe 
and Vincent Courdavault, personal communication) (Figure 22). 
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Figure 22 Known steps in vindoline biosynthesis with cellular and subcellular location 
At the start of this thesis known vindoline biosynthesis genes had been identified as: T16H; tabersonine 
16-hydroxylase, 16OMT; 16-hydroxytabersonine O-methyltransferase, NMT; 16-methoxy-2,3-dihydro-3-
hydroxytabersonine N-methyltransferase, D4H; desacetoxyvindoline-4-hydroxylase and DAT; 
deacetylvindoline 4-O-acetyltransferase. For genes in red enzyme location is the ER, in blue enzyme 
location is cytosolic and black depicts a localisation of the enzyme with the peroxisome membrane. 
 
Catharanthine and vindoline are the two most abundant alkaloids in C. roseus 126. The work 
reported in Chapter 2 conclusively describes that the C. roseus variety “SunStorm Apricot”, 
predominantly employed in this thesis, contains a significant amount of an additional alkaloid, 
vindorosine. Vindorosine is a des-methoxy vindoline analogue and was first isolated in trace 
amounts from C. roseus in 1963 128. The biosynthesis of both compounds is closely linked. 
Silencing the first step in vindoline biosynthesis redirects the flux from vindoline towards the 
production of vindorosine in C. roseus “SunStorm Apricot” 42. These observations are in 
accordance with previous publications where it had been demonstrated that the downstream 
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vindoline biosynthesis enzymes NMT, D4H and DAT are able to accept both the methoxylated 
and the unmethoxylated precursor as substrate 121,127 leading ultimately to the production of 
either vindoline or vindorosine (Figure 23). 
 
Figure 23 Vindoline/ vindorosine biosynthesis 
At the start of this thesis known genes in the synthesis of vindoline and vindorosine in C. roseus. Arrows 
represent single enzymatic steps. Dashed arrows represent unknown number of enzymatic steps. 
Question marks represent unknown enzymatic steps. Blue (top row) arrows represent iridoid 
biosynthesis genes. Grey arrows represent downstream alkaloid biosynthesis genes. Black arrows 
represent then known vindoline/ vindorosine biosynthesis pathway genes. Genes in black are exclusive 
in vindoline biosynthesis: T16H, tabersonine 16-hydroxylase 1 (CYP71D12) and 16OMT, 16-
hydroxytabersonine O-methyltransferase. Genes in red are active in both vindoline and vindorosine 
pathway: NMT, 16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase; D4H, 
desacetoxyvindoline-4-hydroxylase and DAT, deacetylvindoline 4-O-acetyltransferas. 
 
3.1.1 Proposed reaction for the missing step in vindoline biosynthesis 
The product of the enzymatic reaction carried out by the enzyme 16OMT– and the substrate 
for the missing step in vindoline biosynthesis– is 16-methoxy tabersonine. NMT, carrying out 
the next known enzymatic step after this missing step, accepts only the 2,3-dihydration 
product 16-methoxy-2,3-dihydro-3-hydroxytabersonine and not tabersonine 43. However, the 
exact reaction mechanism yielding 16-methoxy-2,3-dihydro-3-hydroxytabersonine remained 
speculative. 
Chemical studies investigating the total synthesis of vindoline all report the occurrence of an 
intermediate between 16-methoxy tabersonine and 16-methoxy-2,3-dihydro-3-
hydroxytabersonine 134–137 although no such intermediate has been identified in plants. This 
intermediate suggests that the net hydration reaction most likely proceeds stepwise via two 
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reactions. As shown in Figure 24, it can be hypothesised that first an epoxide is formed from 
the C2, C3 alkene of 16-methoxy tabersonine. This epoxide spontaneously opens to the imine 
alcohol and a reduction of the imine leads to the formation of the final product, 16-methoxy-
2,3-dihydro-3-hydroxytabersonine. 
 
 
Figure 24 Proposed reaction for missing step in vindoline biosynthesis 
The proposed two step reaction from 16-methoxy tabersonine to 16-methoxy-2,3-dihydro-3-
hydroxytabersonine. 
 
On the basis of these chemical studies, it was assumed that the biosynthetic process of the 
hydration likely requires an oxidising enzyme to first catalyse the formation of the 
epoxide/imine alcohol. For the following necessary reduction of the resulting imine alcohol, a 
second enzyme was proposed to be involved. To start our search, an oxidising enzyme, in 
particular an epoxidase, became the focus of the search for suitable gene candidates for the 
missing step in vindoline biosynthesis. Since epoxidation reactions can be catalysed by 
cytochrome P450s 138, special attention was paid to candidates annotated as a P450. 
 
3.1.2 Strategies for identifying candidates for missing step in vindoline biosynthesis 
Extensive research over the past decades had focused on finding the remaining unknown steps 
in C. roseus alkaloid biosynthesis. Co-expression analysis has proven to be a powerful gene 
discovery tool in plant systems. Based on the observation that genes belonging to a single 
specialised metabolic pathway are often expressed in a similar pattern 74, co-expression 
analysis is employed to identify gene candidates for unknown enzymatic steps in this pathway, 
in an approach sometimes called “guilt-by-association” 75.  
In C. roseus the expression of MIA pathway genes strongly responds to MeJA elicitation 60 and 
the approach of “guilt-by-association” has been employed successfully by comparing elicited 
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and non-elicited tissues. For example the close co-regulation of a majority of the alkaloid 
biosynthesis genes in C. roseus 49 had previously enabled the discovery of genes such as iridoid 
synthase 30 and tabersonine 19-hydroxylase 79. 
The strategy for the search of the missing steps in vindoline biosynthesis was led by two major 
hypotheses. First, the missing gene/s in vindoline biosynthesis would be co-regulated with the 
already known vindoline biosynthesis genes. Second, it is most likely that an oxidising enzyme, 
such as a cytochrome P450, is responsible for this undiscovered enzymatic step and that a 
subsequent reduction or reducing enzyme might also be required. 
In consequence the candidate selection combined both hypotheses. Co-expression analysis of 
the available C. roseus gene expression data for various physiological and experimental 
conditions would provide a candidate list with genes whose expression profile is similar to that 
of known vindoline biosynthetic genes. Functional characterisation focused on candidates that 
belong to the cytochrome P450 enzyme class, proposed to be the most likely enzyme class to 
catalyse formation of an epoxide (Figure 24). 
3.2 Results and Discussion  
3.2.1 Transcriptomic data for co-expression analysis 
For the co-expression analysis a dataset comprising expression values (log₂FPKM) of 33,287 
contigs over 23 different C. roseus tissues and/ or treatments was employed 65. This dataset is 
available at (http://medicinalplantgenomics.msu.edu/). 
Since vindoline/vindorosine are not reproducibly produced in either suspension cultures or 
hairy roots 81, those tissues were excluded from further analysis. Consequently all co-
expression analysis used up to eight C. roseus tissues and experimental conditions. For most 
analyses six tissues were employed: flower, mature leaf, young leaf, non-elicited seedling, 
seedling elicited with methyl jasmonate for 5 days and seedling elicited with methyl jasmonate 
for 12 days.  
3.2.2 Initial data examination 
The upstream region of alkaloid biosynthesis, the seco-iridoid pathway (Chapter 1, Figure 5), 
has been shown to be tightly co-regulated 49, which has facilitated the discovery of genes such 
as iridoid synthase 30 . An initial examination of the expression of known vindoline biosynthetic 
genes revealed that the very close co-expression is not fully maintained (Figure 25 A) in 
comparison to genes involved in the upstream seco-iridoid production (Figure 25 B). 
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Figure 25 Expression of vindoline biosynthesis genes and seco-iridoid biosynthesis genes 
Expression values (as log₂FPKM) of C. roseus genes. Gene expression is displayed for the tissues: A 
(flower), B, C and D (sterile seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf) and F (young 
leaf). A: A selection of seco-iridoid pathway genes are displayed. B: A selection of vindoline biosynthesis 
genes are displayed. 
 
3.2.3 Co-expression analysis of vindoline biosynthesis 
Numerous software tools for gene expression analysis are available. Data in this work were 
primarily analysed using the MultiExperiment Viewer (MeV v.4.8) software. Co-expression 
analysis employs different clustering methods with a broad range of clustering algorithms 
being available. They apply either similarity or distance measure and can be further combined 
with additional parameters 139. For this work several clustering methods were tested. 
Generally, the most productive method was hierarchical clustering (average linkage distance) 
applying different distance metrics such as Pearson correlation similar to the co-expression 
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experiments described in 140. Known genes involved in the vindoline biosynthesis pathway 
were marked and it was observed to what extent different distance metrics and different 
tissue combinations produced a cluster of those genes. The goal was to identify a cluster that 
would contain all or most known vindoline biosynthesis genes and a minimal number of other 
uncharacterised co-regulated genes. However the outcome of these analyses were of limited 
success as vindoline biosynthesis itself is not very tightly coregulated (Figure 25). Candidates 
identified from those experiments and resulting VIGS experiments are reported in Chapter 5.  
The set of VIGS candidates that ultimately led to the discovery of the missing step in vindoline 
biosynthesis originates from filtering the original large dataset to reduce the number of 
contigs.  Filtering was performed by applying different thresholds for minimum expression 
value in certain tissues as well as minimum induction values by methyl jasmonate. Ultimately 
those contigs with an expression value (log₂FPKM) lower than 1.0 in flower, mature leaf, young 
leaf, and three seedling tissues were eliminated, since vindoline is predicted to be synthesised 
in these tissues. Since methyl jasmonate is a known elicitor of MIA biosynthesis 141, expression 
values of contigs in non-elicited seedlings were compared to the corresponding expression 
value in seedlings after 12 days of elicitation with methyl jasmonate. Only contigs with a ratio 
greater than 1.0 (elicited/non-elicited) were retained. Together, these steps reduced the total 
number of contigs from 33,248 to 6538. All previously identified vindoline biosynthesis 
pathway genes (T16H, 16OMT, NMT, D4H and DAT) were still included in this data set. These 
6538 contigs were named Subset_A, and screened for contigs annotated as cytochrome P450. 
This search resulted in 38 cytochrome P450 candidates (Figure 7). 
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Transcript ID 
log₂FPKM 
young 
leaf tissue 
non 
elicitated/ 
elicitated 
seedling 
VIGS 
candidate 
name 
revised gene 
annotation 
cra_locus_7369_iso_2_len_1702_ver_3 2.09 2.38     
cra_locus_1753_iso_2_len_2512_ver_3 4.75 1.84 C44   
cra_locus_24716_iso_1_len_1549_ver_3 2.82 1.69     
cra_locus_4293_iso_2_len_2076_ver_3 5.69 1.63 C47   
cra_locus_5338_iso_3_len_1820_ver_3 3.22 1.52     
cra_locus_15539_iso_2_len_1747_ver_3 4.06 1.46     
cra_locus_9393_iso_1_len_941_ver_3 4.79 1.33   SLS (KF309242.1) 
cra_locus_3243_iso_4_len_2217_ver_3 5.49 1.32   7DLH (KF415115.1) 
cra_locus_5201_iso_5_len_1638_ver_3 4.16 1.3     
cra_locus_589_iso_4_len_2044_ver_3 4.34 1.28     
cra_locus_605_iso_4_len_1576_ver_3 6.51 1.26   IO (KF302066.1) 
cra_locus_15915_iso_3_len_2758_ver_3 1.43 1.24     
cra_locus_7549_iso_4_len_1960_ver_3 4.18 1.23 C20   
cra_locus_11931_iso_1_len_427_ver_3 6.77 1.22   SLS like 
cra_locus_1071_iso_4_len_2072_ver_3 5.97 1.18     
cra_locus_2442_iso_7_len_1193_ver_3 7.19 1.18 C30   
cra_locus_18082_iso_1_len_750_ver_3 1.51 1.14     
cra_locus_9461_iso_1_len_2170_ver_3 5.33 1.13     
cra_locus_671_iso_4_len_1679_ver_3 6.04 1.13     
cra_locus_1656_iso_6_len_2093_ver_3 3.45 1.13     
cra_locus_4585_iso_4_len_2055_ver_3 4.44 1.12     
cra_locus_3614_iso_5_len_2267_ver_3 4.66 1.11     
cra_locus_1227_iso_6_len_1706_ver_3 5 1.1 C48   
cra_locus_17827_iso_1_len_1524_ver_3 3.63 1.1     
cra_locus_3274_iso_2_len_1806_ver_3 2.3 1.1     
cra_locus_6313_iso_4_len_2019_ver_3 1.38 1.09     
cra_locus_4244_iso_1_len_2009_ver_3 3.77 1.08     
cra_locus_11820_iso_4_len_2037_ver_3 2.95 1.05     
cra_locus_6425_iso_2_len_1992_ver_3 2.74 1.05     
cra_locus_12789_iso_2_len_1965_ver_3 5.18 1.05     
cra_locus_47945_iso_1_len_897_ver_3 5.06 1.04     
cra_locus_14905_iso_1_len_1191_ver_3 4.04 1.04     
cra_locus_828_iso_9_len_1821_ver_3 6.35 1.03     
cra_locus_2317_iso_3_len_1999_ver_3 4.82 1.02     
cra_locus_1131_iso_1_len_1777_ver_3 5.12 1.02     
cra_locus_17344_iso_1_len_1088_ver_3 5.5 1.01     
cra_locus_11715_iso_1_len_2413_ver_3 4.08 1.01     
cra_locus_14103_iso_6_len_1909_ver_3 3.54 1     
 
Table 7 Transcripts annotated as cytochrome P450 contained in Subset_A 
Filtering expression data of C. roseus as described in the text above yielded a subset of 6538 contigs that 
contained 38 contigs annotated as cytochrome P450. These cytochrome P450 genes were sorted by 
their individual response to elicitation by methyl jasmonate calculated as the ratio of expression in 
sterile seedlings against sterile seedling treated with methyl jasmonate for 12 days. A BLASTn search of 
the nucleotide sequence of each of the individual 38 contigs revealed that contigs cra_locus_9393, 
cra_locus_11931, cra_locus_3243, cra_locus_605 correspond to the known pathway genes SLS, 7DLH 
and IO, which are involved in secologanin biosynthesis. 
69 
 
 
 
The nucleotide sequences of all 38 contigs were inspected manually and it was revealed that 
they contained four already known pathway genes: 7DLH, IO and two partial fragments of SLS. 
This is unsurprising, considering the criteria that led to the selection of this set. As the genes 
encoding 7DLH 33 and IO 29were discovered after the publication of the transcriptomic data set 
65 those genes were still only annotated as cytochrome P450. The known pathway gene T16H 
is also a cytochrome P450 and had been manually removed prior to the extraction of the 
cytochrome P450 candidate genes. Of the remaining 34 contigs, five candidates (C30 
(cra_locus_2442), C44 (cra_locus_1753), C47 (cra_locus_4293), C48 (cra_locus_1227) and C20 
(in bold in Table 7) corresponds to T3O) (cra_locus_7549)) were chosen for immediate further 
analysis based on their high response to methyl jasmonate or tight co-expression with various 
MIA biosynthetic genes, with the expectation that if no positive results were obtained, 
additional candidates from the list would be tested.  
 
3.2.4 Virus induced gene silencing of selected cytochrome P450 candidates 
To determine whether any of the candidates, (C30 (cra_locus_2442), C44 (cra_locus_1753), 
C47 (cra_locus_4293), C48 (cra_locus_1227) and C20 (cra_locus_7549), were involved in 
vindoline biosynthesis, we used VIGS to assess the metabolic phenotype that results from 
silencing of these genes. The expected outcome of successful silencing of an enzyme directly 
involved in a secondary metabolite pathway is the accumulation of precursors and/or direct 
substrate to this enzymatic step as well as the reduction of products of this reaction. The 
intermediates in vindoline biosynthesis are known to accumulate only in very small amounts in 
C. roseus leaf tissue 42,121 making their detection difficult, however both vindoline and the 
upstream precursor tabersonine are clear peaks that can easily be identified using available 
standards. 
VIGS experiments were conducted as described in Chapter 2. Briefly, competent 
Agrobacterium was transformed with a plasmid harbouring a 300-400 bp long section of the 
gene of interest.  Agrobacterium was then used to infect young C. roseus plants. Leaf tissue of 
plants silenced with this construct were harvested and prepared for metabolic analysis. 
Of the five tested candidates, one (candidate C20) gave the desired metabolic phenotype, 
implicating this gene in vindoline biosynthesis. Consequently, C20 was named 16-
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methoxytabersonine 3-oxygenase (T3O). The results of silencing of the remaining four 
candidates suggested that they played no role in MIA biosynthesis and are discussed in 
Chapter 5. 
3.2.4.1 Initial inspection of silencing results for C20, C30, C44, C47 and C48  
Initial inspection of the total ion chromatograms (TIC) of LC-MS traces of tissue extracts from 
C30, C44, C47 and C48 showed no major changes in metabolite composition or content. 
However a first inspection of the total ion chromatograms (TIC) of LC-MS traces of C20/ T3O 
tissue extracts showed the clear emergence of a significantly increased peak compared to 
traces of EV control tissue (Figure 26). 
 
 
Figure 26 Comparison of TIC of an EV silenced and a T3O silenced leaf extract 
The comparison of total ion chromatograms of two samples. A: Representative total ion chromatogram 
of an EV silenced leaf extract. B: Representative total ion chromatogram of a T3O silenced leaf extract 
with a strong increase of a peak with a mass of m/z 367, which corresponds to predicted substrate of 
T3O, 16-methoxytabersonine. 
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3.2.4.2 Metabolite analysis of silencing results for C20, C30, C44, C47 and C48  
Analyses of six major accumulating alkaloids by manual extraction of peak area and 
normalisation of data by weight and internal standard revealed that silencing of the candidates 
C30, C44, C47 and C48 caused no major changes in metabolites (Chapter 5, Table 28). 
However the peak that increases in intensity upon T3O silencing has a mass of m/z 367, which 
corresponds to the mass of the predicted substrate of T3O, 16-methoxytabersonine, 
suggesting that this gene likely encodes the missing step in vindoline biosynthesis (Figure 27). 
 
Figure 27 T3O silencing effect on leaf m/z 367 and tabersonine content 
Relative MIA content as mean peak area for m/z 367 and tabersonine in T3O silenced plants in 
comparison to EV control plants (n=8). Error bars represent mean + SEM. P-value was calculated using 
Student’s t test (*p<0.05, **p<0.005). 
 
Further strong evidence for the involvement of T3O in vindoline biosynthesis was provided by 
the significant decrease of vindoline (Figure 28). Additionally vindorosine, the des-
methoxylated analog of vindoline, was also significantly reduced supporting the assumption 
that T3O is involved in both pathways (Figure 23). Three independent VIGS experiments were 
conducted for this candidate, with all resulting in similar significant metabolite changes. 
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Figure 28 T3O silencing effect on leaf vindoline and vindorosine content 
Relative MIA content as mean peak area for vindoline and vindorosine in T3O silenced plants in 
comparison to EV control plants (n=8). Error bars represent mean + SEM. P-value was calculated using 
Student’s t test (**p<0.005, ***p<0.00005). 
 
3.2.5 Transcriptional down-regulation of candidate C20/ T3O 
To confirm that the observed strong metabolic phenotype is in fact caused by successful T3O 
gene silencing, the expression of T3O was measured with qRT PCR in silenced tissues. In 
comparison to EV control tissues, T3O silencing led to a significant change in T3O gene 
expression (Figure 29). The transcripts of T3O were 70% decreased compared to EV control 
silenced tissues. 
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Figure 29 Gene expression of T3O in silenced tissue 
Relative expression of T3O in tissue silenced for candidate T3O in comparison to tissue silenced with EV 
control (n=6). Expression was normalised to CrRPS9 expression. Data presented is the mean + SEM. 
3.2.6 In vitro assays confirm T3O role in vindoline biosynthesis 
The successful significant downregulation of T3O expression and the resulting strong changes 
in vindoline concentration suggest an involvement of T3O in alkaloid biosynthesis in C. roseus. 
To further investigate the function of this candidate we proceeded to characterise this enzyme 
in a yeast expression system. 
Numerous expression systems such as insect cells 142 and E. coli 108 have been reported for 
successful plant P450 expression. However, previous research in P450 enzymes conducted by 
the O’Connor lab 79 and other labs working on C. roseus P450 characterisation 29,42 has most 
successfully used the Saccharomyces cerevisiae strain WAT11, a yeast strain harbouring the A. 
thaliana P450 reductase 143, as expression system for plant P450 enzymes. Therefore, the 
heterologous expression of T3O was performed in this system. 
T3O was cloned into the yeast expression plasmid pXP218 144 and competent WAT11 yeast 
cells were transformed with this pXP218 plasmid. WAT11 transformed with an empty plasmid 
pXP218 served as empty vector control. The yeast culture was grown as 100 ml liquid culture 
in selective media. Protein expression was induced and yeast microsomes harbouring the P450 
were isolated as described previously 145. This was done for the yeast strain WAT11 with the 
T3O harbouring plasmid (WAT11+pT3O), as well as a yeast strain containing the EV plasmid 
(WAT11+pEV) that served as a negative control. 
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Both microsomal fractions were assayed in the presence of NADPH and the crude, aqueous 
fraction of a leaf extract of a T3O silenced tissue as substrate. After one hour of incubation, all 
of the accumulated mass of m/z 367 observed in the silenced tissues was consumed by the 
WAT11+pT3O microsomes, and a new peak with an m/z of 383 appeared as the product 
(Figure 30A). The mass of this product corresponds to the mass of the proposed epoxide/imine 
alcohol intermediate in vindoline biosynthesis (Figure 24). It was therefore concluded that the 
newly identified gene T3O does catalyse only the first step of the two step reaction from 16-
methoxytabersonine to 16-methoxy-2,3-dihydro-3-hydroxytabersonine. No conversion of m/z 
367 into m/z 383 by the WAT11+pEV microsomes even after 12 hours was observed (Figure 
30B). 
 
Figure 30 Microsomal assays using T3O silenced tissue extracts as substrate 
Assays using T3O silenced leaf extract and yeast microsomal fractions in presence of NADPH. A: The 
peak of mass m/z 367 is consumed in the WAT11+pT3O microsomes containing assays. Instead a new 
peak appears with a mass m/z of 383. B: No conversion of m/z 367 by the WAT11+pEV microsomes 
containing assay into m/z 383 even after 12 hours was observed. 
 
It had been speculated that the missing step in vindoline biosynthesis would be able to accept 
both tabersonine and 16-methoxytabersonine, as all subsequent genes in vindoline/ 
vindorosine biosynthesis are able to accept methoxylated and unmethoxylated 
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substrates 121,127 (Figure 23). Since tabersonine is not present in high quantities in the VIGS 
extracts, commercially available tabersonine was used in microsomal assays at 5 µM final 
concentration, an amount sufficient for LC-MS measurements. Theses assays confirmed that 
tabersonine is also an accepted substrate of T3O (Figure 31). 
 
Figure 31 Microsomal assays using tabersonine as substrate 
Assays using tabersonine and yeast microsomal fractions in presence of NADPH. A: The peak of 
tabersonine disappears in assays with WAT11+pT3O microsomes. Instead a new peak appears with an 
m/z of 353. B: No conversion of tabersonine by the WAT11+pEV even after 12 hours was observed. 
3.2.7 Characterisation of substrate and product of T3O reaction 
The combined results of the gene silencing experiments and the microsomal assays clearly 
suggested that T3O is involved in vindoline biosynthesis in C. roseus. We wanted to further 
confirm the reaction carried out by T3O by characterising the structure of the enzymatic 
product. Therefore, sufficient amounts of both substrate 16-methoxytabersonine and product 
needed to be available for subsequent structural investigations such as nuclear magnetic 
resonance (NMR). 
Neither the T3O natural substrate in vindoline biosynthesis, 16-methoxytabersonine, nor the 
product of the T3O reaction were commercially available. In experiments performed in parallel 
with this work, a yeast strain (Strain A) containing all previously identified vindoline 
76 
 
 
biosynthesis genes (T16H, 16OMT, NMT, D4H, DAT) (Figure 23) integrated into its genome 
including CPR, the P450 reductase from C. roseus 146 was engineered by Stephanie Brown 
(O’Connor lab). 
Strain A was used to produce 16-methoxytabersonine from tabersonine by the action of T16H 
and 16OMT. Feeding of tabersonine to a liquid culture of Strain A had shown that this results 
in m/z 367 accumulation, corresponding to the product of T16H and 16OMT 16-
methoxytabersonine. No further downstream vindoline biosynthesis intermediates 
accumulate in the culture, since the enzyme that acts after 16OMT is absent. 
To produce 16-methoxytabersonine on a milligram scale, a liquid culture of Strain A was 
supplemented with 120 µM tabersonine and the formation of the 16-methoxytabersonine 
production was monitored over time by LC-MS. After all tabersonine was consumed, the 
product was extracted from the supernatant of the culture with ethyl acetate and analysed by 
NMR to confirm its structure by comparing it to reported literature values 147. 
Strain A was also used to produce the T3O product. The T3O gene was introduced into Strain A 
by transforming competent cells of Strain A with the previously constructed T30 containing 
pXP218 plasmid to create strain_A+pT3O. A corresponding negative control was created by 
transforming in the respective empty plasmid into strain A to create strain_A+pEV. Strain A 
with the empty vector control plasmid displayed predictably the same product as Strain A 
without any plasmid forming only 16-methoxytabersonine as identified by co-elution with the 
now available standard (Figure 32B and C). However, strain_A+pT3O led to the production of 
both T3O products 16-methoxy-2,3-dihydro-3-hydroxytabersonine and 2,3-dihydro-3-
hydroxytabersonine (Figure 32A). Under these conditions, the ratio of products favoured the 
des-methoxy product derived directly from tabersonine (m/z 353) as opposed to the product 
derived from 16-methoxytabersonine (m/z 383), which is on pathway to vindoline. 
77 
 
 
 
Figure 32 Products of yeast strain A, with and without T3O 
Yeast strain A transformed with a plasmid containing T3O or an EV plasmid was supplemented with 
tabersonine and extracted ion chromatograms of expected products were monitored after 24 hours. Of 
the extracted ion chromatograms three are co-eluting with known standards, these are m/z 337 for 
tabersonine, m/z 367 for 16-methoxytabersonine and m/z 383 for the subsequently characterised T3O 
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product. A: Extracted ion chromatograms of the tabersonine supplemented strain_A+pT3O reveals that 
after 24 hours the substrate tabersonine (m/z 337) is almost fully consumed. Three new peaks emerge: 
m/z 367, which corresponds to the 16-methoxylated substrate of T3O as well as m/z 383 and m/z 353, 
likely representing the methoxylated and non-methoxylated products of T3O. B: Extracted ion 
chromatograms of the tabersonine supplemented strain_A+pEV show that after 24 hours culture the 
substrate tabersonine (m/z 337) has been completely consumed and instead 16-methoxylated 
tabersonine (m/z 367) is accumulating. No m/z 383 and m/z 353 are produced in a strain lacking the T3O 
gene. C: Extracted ion chromatograms of standards for m/z 337 (tabersonine), m/z 367 (16-
methoxytabersonine) and m/z 383 for the later characterised T3O product. 
 
To improve the yield of the vindoline pathway T3O product 16-methoxy-2,3-dihydro-3-
hydroxytabersonine for structural characterisation, an alternative production method was 
used. A large scale liquid culture of the previously employed yeast WAT11 transformed with 
the T3O harbouring plasmid (WAT11+pT3O) was used to convert 16-methoxytabersonine via a 
single step reaction into the T3O product. As with 16-methoxytabersonine, the product was 
extracted from the media, purified and characterised as described below. 
3.2.8 Structural characterisation of the T3O product in vindoline biosynthesis 
The obtained T3O enzymatic product was analysed and characterised by IR, HRMS and 
¹H/¹³C¹⁵N NMR by Nathaniel Sherden (O’Connor lab). It had been anticipated that either the 
epoxide or, if the epoxide spontaneously opens, the imine alcohol, would be observed. 
However, the NMR data did not correspond to either of these products. After an extensive 
review of the literature, Dr. Sherden recognised that 2-imine,3-alcohols on the tabersonine 
framework are able to undergo an acid catalysed rearrangement 148–151. Gratifyingly the NMR 
resonances corresponded to literature reports of this rearranged product. This implies that, 
although not observable, the epoxide and imine alcohol forms initially but in absence of the 
subsequent enzyme that reduces the imine alcohol, the product rearranges to this new 
scaffold (Figure 33). 
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Figure 33 T3O reaction and observed rearrangement of reaction product 
Acid catalysed rearrangements of the 2-imine 3-alkohol, in absence of the subsequent reductase, turn 
the initially by the action of T3O formed epoxide and into the eburnamine-vincamine skeleton. Proposal 
by Dr. Nat Sherden according to previously reported data 150. 
 
 
This rearrangement had first been proposed for the biosynthesis of the pharmaceutically 
important vincamine from the tabersonine/ aspidosperma skeleton 150. Vincamine, an alkaloid 
from the C. roseus close relative Vinca minor, is used to synthesise vinpocetine (Figure 34) first 
in the early 1960s. Vinpocetine, available under the trade name Cavinton since 1978, is a drug 
used for treatment of conditions such as cerebrovascular disorders, chronic stroke and 
degenerative senile cerebral dysfunction (Alzheimers) 152. 
 
 
 
80 
 
 
 
 
Figure 34 Chemical structures of vincamine and vinpocetine 
The structural similarity between the rearranged intermediate and vincamine suggest that 
perhaps in V. major the reductase is missing completely and a homolog of T3O is involved in 
vincamine biosynthesis. These results also experimentally establish a long standing hypothesis, 
namely the biosynthetic relationship of the aspidosperma (tabersonine, vindoline)- and 
eburnamine (vincamine, vincopetine)-type alkaloids. 
 
3.3 Conclusion 
Vindoline is a C. roseus-derived natural product that is used in the semi-synthesis of valuable 
anti-cancer drugs 153. The order of steps in vindoline biosynthesis from the precursor 
tabersonine is not arbitrary but follows a strict sequence of reactions. This sequence is largely 
dictated by the substrate specificity of the enzymes involved. At the start of this thesis five 
34,41,43–45 out of the proposed seven 134–137 enzymes as well as the encoding genes were known 
(Figure 22, Figure 23). 
In this work, a cytochrome P450 was discovered amongst a number of candidate genes that is 
required in the biosynthesis of vindoline and also the alternative shunt product vindorosine. It 
oxidises 16-methoxy tabersonine and tabersonine and was named 16-methoxytabersonine 3-
oxidase or T3O. 
The successful candidate was selected following two major leads: 
 Firstly we hypothesised that it was a  cytochrome P450 enzyme, as most chemical studies 
suggested the missing step to involve an epoxidation 134–137, a reaction often carried out by 
P450 enzymes 138.  
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Secondly special attention was paid to the gene expression of the candidates in different C. 
roseus tissues and experimental conditions. Candidates were selected that showed a strong 
resemblance to the expression profile of known alkaloid biosynthesis genes in C. roseus as the 
alkaloid biosynthesis genes of C. roseus are known to be co-regulated 49. 
VIGS experiments of five selected P450 candidates revealed that significantly reduced gene 
expression of cra_locus_7549 (candidate C20) by successful transient gene downregulation, 
leads to the significant decrease in levels of vindoline in leaf tissue of C. roseus. This decrease is 
accompanied by a significant increase in a compound with a mass and retention time identical 
to 16-methoxytabersonine, the expected substrate of the silenced T3O gene. The shunt 
product 16-des-methoxy-vindoline (vindorosine) is also significantly reduced while tabersonine 
is increased, suggesting that the candidate gene is involved in both the vindoline and 
vindorosine pathways. 
Enzymatic assays with the successful candidate showed that T3O is able to enzymatically 
convert both tabersonine and 16-methoxytabersonie to their respective oxidised products as 
evidenced by the appearance of a compound with the expected mass on an LC-MS assay. 
Several yeast strains were employed to produce milligram quantities of the substrate and 
product of T3O in vindoline biosynthesis for structural elucidation. Structural studies of the 
product, however, revealed that in the absence of the subsequent reduction, the reaction 
product undergoes rearrangement. This rearrangement leads to formation of a product 
structurally similar to the alkaloid vincamine from the plant V. major, a close C. roseus relative. 
Based on extensive work reported in the literature, we can infer that the expected 
epoxide/imine alcohol was formed by T3O, but rearranged to the new product during 
purification. This discovery also opens up opportunities of gene discovery in vincamine 
biosynthesis following hypothesis that a T3O homolog in absence of a subsequent reductase 
could be involved in vincamine biosynthesis. 
The discovery of T3O closes the gap in vindoline biosynthesis and will ultimately aid the 
understanding and possible reconstitution of the complete vindoline pathway. It furthermore 
provides evidence for a long-standing hypothesis about the biosynthetic relationship of the 
aspidosperma- and eburnamine-type alkaloids and might aid the discovery of vincamine 
biosynthesis in V. major. 
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The function of the remaining cytochrome P450 candidates (Table 7) still remains to be 
determined. Obviously the expression pattern of the four candidates that had been subjected 
to VIGS, especially their strong increase in expression after induction with methyl jasmonate 
suggests a potentially involved in stress response and/or plant defence. As it has recently been 
shown that beginning an investigation with as little as a single pathogen induced upregulated 
P450 in combination with metabolomics and co-expression analysis can lead to exciting 
discovery like that of the previously unknown 4-hydroxyindole-3-carbonyl nitrile pathway even 
in a well-studied organism such as Arabidopsis thaliana 154. 
After it had become apparent that a second enzymatic step would be needed to complete the 
vindoline biosynthesis pathway, the same Subset_A from which the T3O gene had been 
successfully identified, was mined for contigs with a reductase annotation. They were tested 
using VIGS experiments and the results are presented in Chapter 5. 
In parallel to this work and the resulting publication 146 a second publication reported the 
discovery of not only T3O but also of the subsequent enzymatic step carried out by T3R the 
tabersonine 3-reductase 48. This discovery completed the search for missing genes and 
consequently for the first time reports the complete reconstitution of the tabersonine to 
vindoline pathway in the alternative host Sacchomyces cerevisiae 48. 
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4 Gene clustering in alkaloid biosynthesis in C. roseus 
The major findings of analysing the C. roseus draft genome and the individual BAC 
assemblies for gene clustering in alkaloid biosynthesis have been published 68. 
Biosynthesis of the valuable anti-cancer compounds vinblastine and vincristine by the plant C. 
roseus has been under investigation ever since the discovery of their chemical structure and 
anti-cancer activity in the mid twentieth century 19. Precursors of vinblastine and vincristine, 
which are classified as bisindole alkaloids, are vindoline and catharanthine, produced primarily 
in above ground tissues. The approximately 30 step biosynthetic pathway, although studied for 
decades, is still not fully resolved 18, despite the many efforts to discover the enzymes 
responsible for alkaloid biosynthesis that have been made over the years. These efforts have 
included exploitation of major sequencing technique developments such as obtaining C. roseus 
EST data 59 and RNA seq data 65. Recent discoveries, such as the 10 gene cluster in alkaloid 
noscapine synthesis in opium poppy 112, gave evidence that the genes of some plant secondary 
metabolic pathways are located in close proximity to each other on the genome. This raised 
the question whether such gene clustering could also be observed in C. roseus, a discovery that 
would greatly progress the elucidation of alkaloid biosynthesis in this model medicinal plant. 
To answer this question a draft genome for C. roseus in combination with sequence of BAC 
constructs was obtained, and the organisation of the monoterpene indole alkaloid biosynthetic 
genes was analysed. 
 
4.1 Introduction 
4.1.1 Bacterial artificial chromosomes 
The ability to clone sections of eukaryotic DNA larger than 100 kb is crucial for many biological 
applications. With the introduction of the yeast artificial chromosomes (YACs) in the late 
1980s, cloning and maintenance of DNA fragments of up to 1000 kb became feasible 155. 
Apparent disadvantages of this system, such as high level of chimerism, insert instability and 
contamination of cloned insert DNA with yeast DNA 156, led to research into alternative 
systems and the development of a bacterial (E. coli) based system 157. The low copy fertility (F-
factor) plasmid of E. coli was modified by the addition of a multiple cloning site and universal 
promoters together with the addition of a chloramphenicol resistance gene to facilitate 
negative selection of non-transformed bacteria, resulting in the original bacterial artificial 
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chromosome (BAC) plasmid pBAC108L 158. Since then, the original plasmid pBAC108L has been 
modified and optimised to suit different purposes, leading to the development of alternative 
plasmids such as the commercial pIndigo-BAC5-HindIII vector (Epicentre, USA) used in this 
study. This vector is strictly regulated to a single copy per cell and has been widely used for 
construction of plant BAC libraries.  
 
A BAC genomic library combines a set of recombinant clones that contain all of the DNA 
sequence present in an individual organism. To construct such a library, high molecular weight 
DNA is digested with the appropriate restriction nuclease, in this case HindIII, and the resulting 
DNA fragments are cloned into the linearised pIndigo-BAC5-HindIII vector. Competent E. coli     
was transformed with the resulting plasmids (Figure 35).  
 
 
Figure 35 Schematic overview of BAC library construction 
DNA is extracted from the cells and digested with HindIII, a restriction enzyme. DNA fragments are 
cloned into a vector and E. coli transformed with this vector. 
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The resulting library can either be sequenced fully and used to facilitate genomic analysis such 
as large-scale physical mapping 159 and genomic sequencing 160. Alternatively, the clones can be 
sequenced sequentially using the known sequence of one BAC to screen the library for the 
overlapping/adjacent BAC in a technique called chromosome walking that can be exploited to 
sequence entire chromosomes or a specific genomic region of interest 161. 
 
4.1.2 Plant whole genome sequencing 
The number of available plant genomes has been growing steadily since the first successful 
plant genome project, the Arabidopsis thaliana genome, was completed in 2001 160. In 2012 
alone, 13 new plant genomes were published, by the end of 2013 more than 50 different plant 
genomes were available, and with this trajectory likely to continue, many more are expected 
to be published over the coming years 162. Plant genome size is variable with C. roseus having a 
moderate size genome in comparison with other plants (Figure 36). 
 
Figure 36 Genome size of different plants 
Genome size for Genlisea aurea 163, Picea abies 164, Zea mayes 165, Solanum lycopersicum 166, Hordeum 
vulgare 167, Carica papaya 168 and Arabidopsis thaliana 160 in comparison to C. roseus 68,169.  
 
86 
 
 
Over the past decade sequencing costs have steadily declined while the speed in which data is 
generated has increased massively due to the development of high throughput sequencing 8. 
Most of the recently published plant genomes have been sequenced using the Illumina 
technique that increasingly replaces the previously applied Sanger sequencing. Illumina paired-
end sequencing, which was used to generate the genomic sequence for C. roseus, creates a 
read-pair for every sequenced DNA template. Although the full sequence of the DNA fragment 
is not known, the distance between the two ends is known (Figure 37). Sequencing is followed 
by assembly, the computational reconstruction of an original long sequence from short 
sequenced reads. First, individual short reads are assembled into longer continuous sections, 
so called contigs. With paired-end sequencing data this process is continued using the 
additional position information to join contigs into even longer scaffolds (Figure 37). Without 
an existing reference genome this process is called de-novo assembly. 
 
Figure 37 Paired-end sequencing and Mate-pairs 
Paired-end sequencing results in both ends of a DNA fragment being sequenced creating two individual 
reads for each piece of DNA. Although the full sequence of the DNA fragment is not known the distance 
between the two ends is known and can be used to increase the assembly quality especially across 
repetitive regions that are generally difficult to sequence and assemble. Mate pair sequencing provides 
information for even longer DNA fragments improving assembly scaffold length strongly. 
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The quality of an assembly depends on many factors comprising, for example, the quality of 
the original template DNA, the quality, length and amount of created reads as well as the 
assembly process and the software used. It is difficult to define the success of a sequencing 
project or the quality of an assembly without a relevant standard for comparison 170. However 
commonly used metrics are physical coverage which refers to how often the sum of all reads 
or read-pairs could cover the whole genome. This is different from the sequencing coverage or 
sequencing depth which refers to the average number of reads for a specific locus. As the most 
common way to describe the quality of an assembly the N50 value for contigs or scaffolds is 
used 162. The N50 value refers to the size (in kb) above which half of the total length of the 
sequence set can be found. A higher N50 therefore is indicative of a higher percentage of 
longer contigs which ultimately determines the explanatory capacity of the assembly with 
respect to gaining insight into the genomic organisation of the organism sequenced. A low N50 
can be caused by highly repetitive sequences, polymorphisms or simply low quality or missing 
sequencing data 170. 
A typical N50 value for a de novo Illumina sequencing and assembly project, according to 
similar studies, was expected to be close to the value of 12.5 kb, reported for Cucumis sativus 
171. Other comparable genome sequencing projects, such as the sequencing of Cannabis sativa, 
relied on including further data obtained from, for example, mate-pair libraries to increase the 
N50 from 2 kb (only Illumina data) to 12 kb and reach an even higher N50 of 16 kb after further 
addition of large-insert 454 data 172. It has to be noted that the N50 can be significantly higher 
for scaffolds containing genes, as the higher complexity of theses sequences enables better 
assembly and therefore for example in the Cannabis sativa study the N50 is 24.9 kb for gene 
containing scaffolds 172. 
Apart from Sanger sequencing and Illumina, other sequencing platforms have been developed 
such as the commercial Affimetrix, the SoLiD and the Roche 454 platform as well as the 
relatively recently established PacBio sequencing. Since each sequencing technique has 
limitations, indeed most plant genome projects have used hybrid approaches creating an 
assembly by combining data from more than one of the available platforms 173. 
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4.1.3 Discovery of gene clusters in plant secondary metabolism 
The possible clustering of genes involved in a specific biosynthetic pathway in plant secondary 
metabolism is a relatively recent observation. Today clustering has only been shown for a small 
number of plant secondary metabolic pathways. On the other hand the actual number of fully 
elucidated plant secondary metabolite pathways is, with less than 50, relatively small and 
therefore a prediction as to whether to expect more clustered pathways, or whether clustering 
remains the exception to the rule, is speculative 174. 
Even in the absence of a genome sequence, trait guided discoveries of plant secondary 
metabolite cluster have been reported. It was for example possible to link a clear phenotypic 
trait, such as the accumulation of noscapine in Papaver somniferum 112 or the resistance to a 
herbivore in Zea mays 111, to a certain region of the genome by mapping and to consequently 
determine the multi-genic region responsible for the trait as a cluster of biosynthesis pathway 
genes. In both cases BACs of the trait identified regions were obtained and facilitated the 
discovery of the cluster of secondary metabolite pathway genes. 
The availability of a genome sequence enables the targeted and detailed analyses of 
neighbouring regions of known pathways genes and has led to for example the discovery of 
gene clustering in triterpene biosynthesis in Lotus japonicus 175. Triterpene biosynthesis had 
previously been shown to cluster for example from the work with Avena strigose (oat) 116–118. 
The strategy for identification of triterpene gene clustering in Lotus japonicus was to search for 
“signature” enzymes 103, oxidosqualene cyclase (OSC) enzymes that form the skeleton 
structure of triterpenes, in the available genomic data. Consequently the genomic areas 
containing the OSCs was mined for potential gene clustering, resulting in the identification and 
characterisation of a triterpene gene cluster 175. The mining of publicly available sequencing 
data for combinations of certain genes in close proximity has led for example to the discovery 
of the triterpene thalianol 176 and marneral 177 cluster in Arabidopsis thaliana. In conclusion the 
discovery of gene secondary metabolite clusters in plant genome data strongly depends on the 
amount and quality of the genomic data available, most importantly on the length of 
contiguous sequences available in the assembly. 
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4.1.4 Aim of the project 
The goal of this sequencing project was to gain insight into the genomic organisation of 
alkaloid biosynthesis in C. roseus and to investigate possible gene clustering of the 
monoterpene indole alkaloid secondary metabolite pathway. Despite recent advancements in 
gene discovery in alkaloid biosynthesis in C. roseus, that have for example enabled the 
reconstitution of the seco-iridoid part of the pathway in yeast 25 and Nicotiana benthamiana 29, 
crucial steps that lead to the C. roseus typical alkaloid classes, and therefore to the precursors 
of valuable anti-cancer compounds vinblastine and vincristine, still remain unknown. 
Reported plant gene clusters vary in size between 35 and several hundred kb 174. The expected 
N50 scaffold size of an assembly based on Illumina HiSeq sequencing raw data of a single 
TruSeq genomic DNA library (as used in this case) is in the lower part of this range. Therefore 
to increase the chances of observing gene clustering in alkaloid biosynthesis it was decided to 
additionally obtain BACs, which cover a region of up to 150 kb surrounding a target gene, for 
selected alkaloid pathway genes. A BAC library was created and then screened for BACs 
containing the desired pathway genes. The sequence information obtained would also serve as 
a confirmation of the results of the assembly of the draft genome as the coverage of the BAC 
sequencing is much higher and a better assembly of this data is expected. It would most 
importantly enable us to investigate a relatively large neighbouring genomic regions of the 
chosen alkaloid pathway gene. 
Ample transcriptomic data is available for C. roseus and mining this data, especially using co-
expression analysis, has led to a great number of discoveries of so far unknown pathway 
components, regulators and transporters. The data is however limited in precision and 
completeness for example by not being precise enough to distinguish between the individual 
expression of close homologs. With the availability of a reference genome all existing 
transcriptomic data could be re-evaluated increasing the precision and explanatory power of 
co-expression analysis.  
C. roseus is self-pollinating and diploid (2n = 16). The genome size was determined by flow 
cytometry and revealed a C-value of 1C = 0.76 pg, corresponding to 738 Mbp 169. Overall, this 
inbred plant, with a moderate sized genome, is an excellent candidate for whole genome 
sequencing. In summary, obtaining one of the first medicinal plant genomes would not only 
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provide a valuable source for further pathway discovery in C. roseus, but provides a valuable 
resource for comparative plant genomics especially in the light of highly specialised and 
complex secondary metabolism. 
 
4.2 Results and Discussion 
C. roseus genomic DNA was extracted and sent to The Genome Analysis Centre (TGAC, 
Norwich, UK) were it was sequenced and assembled. In parallel C. roseus plant material was 
sent to Bio S&T Inc. (Montreal, Canada) where DNA was extracted and the BAC library was 
constructed and later the screening of the BAC library for specific targets was conducted. 
4.2.1 Catharanthus roseus whole genome sequencing and assembly statistics 
Genomic DNA of C. roseus “SunStorm Apricot” was extracted yielding 10.8 µg high molecular 
weight DNA. From this material a single TruSeq library was constructed with a 398 bp fragment 
size and sequenced on one lane Illumina HiSeq at The Genome Analysis Centre (TGAC, 
Norwich, UK), yielding 33 Gb of data that was subsequently assembled using ABySS 178 and 
applying a k-mer size of 71. This assembly consisted of 78 766 scaffolds larger than 200 bp and 
half of the assembly is covered by scaffolds larger than 26,256 bp (N50). The sum of all 
scaffolds larger than 200 bp is 5235 Gb. The longest scaffold in the assembly is 250 200 bp. The 
raw reads of the draft genome are available at NCBI SRA BioProject number PRJNA252611. The 
assembly (C. roseus SunStorm Apricot v.1.0) has been deposited under the accession 
JQHZ00000000 at the NCBI Whole-Genome Shotgun Sequence database. A database that is 
publicly available and searchable of the assembly (C. roseus SunStorm Apricot v.1.0) is located 
at The Medicinal Plant Genomics Resource (http://medicinalplantgenomics.msu.edu/). 
4.2.2 Catharanthus roseus BAC library construction, candidates and screening 
4.2.2.1 Construction of BAC library 
The BAC library was constructed from plant material of the same C. roseus “SunStorm Apricot” 
plants used to obtain the material for genome sequencing to ensure maximal comparability. At 
Bio S&T Inc. (Montreal, Canada) the pINDIGOBAC-5 vector in E. coli strain DH10B was used to 
create the BAC library. The obtained library was pooled in a 96 well plate. Each of the wells 
contained approximately 500 clones. The BAC library had an approximately 10 fold coverage 
and an average insert size of 155 kb (Areti Karadimos, personal communication). 
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4.2.2.2 Candidate genes for BAC library screening 
The obtained BAC library was to be screened for individual BACs that contain known genes of 
C. roseus alkaloid biosynthesis to increase the chance of discovery of possible gene clustering. 
Initially three genes, ISY, T16H2 and SGD, were chosen as targets for screening the BAC library 
(Figure 38). Each of these candidates represent a key step in alkaloid biosynthesis: ISY for the 
monoterpene seco-iridoid pathway, T16H as the first committed enzyme of the vindoline 
pathway, and SGD which is the origin of the complex and poorly understood scaffold formation 
that results in the three classes of alkaloids, the iboga, the corynanthe and the aspidosperma, 
found in C. roseus. The reaction product of the deglycosylation reaction catalysed by SGD 
formulates an even greater diversity, as this intermediate enters multiple pathways to both 
indole and quinoline alkaloid types in the three plant families Apocynaceae, Rubiaceae, and 
Loganiaceae, though still none of the genes responsible for the formation of those diverse 
alkaloid types is known today 18. In summary this makes SGD the most interesting gene for 
which clustering could potentially lead to discoveries that are applicable to not only C. roseus 
but other strictosidine derivative producing plants. 
 
Figure 38 Genes of alkaloid biosynthesis including candidate genes for BAC library screening 
Monoterpene indole alkaloid pathway in C. roseus. Missing genes are represented by question marks. 
Dashed arrows indicate unknown numbers of enzymatic steps. Genes for which a BAC was obtained in 
the initial screen are in red bold. Genes for which a BAC was obtained in the second screen are in blue 
bold. Black (top row) arrows represent iridoid biosynthesis genes: G8H, geraniol 8-hydroxylase; GOR, 8-
hydroxygeraniol oxidoreductase; ISY, iridoid synthase; IO, iridoid oxidase (CYP76A26); 7DLGT, UDP-
glucose iridoid glucosyltransferase; 7DLH, 7-deoxyloganic acid 7-hydroxylase; LAMT, loganic acid 
methyltransferase and SLS, secologanin synthase. Grey arrows represent downstream alkaloid 
biosynthesis genes: TDC, tryptophan decarboxylase; STR, strictosidine synthase; SGD, strictosidine -
glucosidase; THAS, tetrahydroalstonine synthase; T19H, tabersonine/lochnericine 19-hydroxylase 
(CYP71BJ1) and MAT, minovincinine 19-hydroxy-O-acetyltransferase. Black arrows (middle row) 
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represent vindoline biosynthesis pathway: T16H1, tabersonine 16-hydroxylase 1 (CYP71D12); T16H2, 
tabersonine 16-hydroxylase 2 (CYP71D351); 16OMT, 16-hydroxytabersonine O-methyltransferase; T3O 
16-methoxytabersone 3-oxigenase; T3R, 16-methoxytabersonine 3-reductase NMT, 16-methoxy-2,3-
dihydro-3-hydroxytabersonine N-methyltransferase; D4H, desacetoxyvindoline-4-hydroxylase and DAT, 
deacetylvindoline 4-O-acetyltransferase. 
 
Suitable primers were designed and tested for each candidate gene, with the aim to obtain a 
gene specific band of 200 to 500 bp when amplifying from genomic DNA. The suitable primers 
were send to Bio S&T Inc. (Montreal, Canada) to screen the C. roseus BAC library. For each 
candidate gene a BAC was identified and extracted from the library. Both an individual culture, 
as LB stab, and a small amount of extracted plasmid were received for each extracted BAC. 
The initial set of candidates ISY, T16H2 and SGD were chosen without any prior knowledge of 
the genomic context of alkaloid biosynthesis in C. roseus. Analysis of the draft C. roseus 
genome, as described below, revealed that the two pathway genes TDC and STR are located in 
close proximity on the same scaffold (Figure 46). This scaffold has a size of only 29 490 bp and 
it was decided that a BAC of this region would not only strengthen the evidence pointing to the 
existence of this cluster but, with an expected size of up to 150 kb, a BAC could additionally 
reveal possible more genes involved in this cluster. Only one further gene, MATE, a transport 
protein, is found on the STR/TDC genome scaffold as shown in (Figure 46). The genes are 
located on the scaffold in the following order: MATE, TDC and STR. To maximise the extension 
of the known region into the direction of the MATE gene, Bio S&T Inc. (Montreal, Canada) first 
screened the BAC library for positive clones of the gene MATE. Then, all positive identified 
BACs for MATE would, in a second round, be screened for the existence of the gene STR and a 
single BAC that contained MATE but not STR would be chosen to obtain a BAC with maximum 
extension into the genomic region beyond the MATE gene. For this purpose two further primer 
pairs specific for the genes MATE and STR were designed and sent to Bio S&T Inc. from which 
positive identified clones were sent back. 
The results of the sequencing of the first SGD BAC and the subsequent assembly suggested 
that SGD was not located on this BAC, so it was decided to repeat this screen with an 
optimised primer pair. As at this time point the C. roseus draft genome was available, a second 
improved SGD specific primer pair was designed and the BAC library screened again for SGD 
and sequenced. 
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4.2.2.3 BAC extraction, sequencing and assembly 
DNA was extracted for all candidates in house, except for the second SGD_BAC that was sent 
directly to Robin Buell’s lab (MSU, East Lansing, USA). All BAC DNA was individually sequenced 
on a MiSeq with a 150 bp or 250 bp fragment size, after construction of a single TruSeq DNA 
library at Robin Buell’s lab (MSU, East Lansing, USA). 
Sequencing data was assembled after reducing the raw read number to only the first 50000 
reads using the MIRA179 assembler. The assembly was analysed regarding scaffold number, 
scaffold size and the combined length of unique scaffolds in comparison to expected insert size 
of the individual BAC (Table 8). 
 
Table 8 BAC assembly results 
Assembly of BAC sequencing data including number of scaffolds (cut-off value for scaffolds is 1 kb), 
number of scaffolds larger or smaller 2000 bp, sum of all scaffolds larger 2000 bp and largest scaffold of 
the assembly in comparison to experimentally determined expected insert size of individual BAC. 
 
Target 
No. of 
scaffolds  
No. scaffolds 
> 2000 bp 
No. scaffolds 
< 2000 bp 
Largest 
scaffold 
Sum of all 
scaffolds  > 
2000 bp 
Size of BAC 
insert 
SGD 2 2 0 93 247 bp 105 551 bp 105 000 bp 
T16H2 6 4 2 59 670 bp 113 751 bp 125 000 bp 
ISY 17 7 10 29 781 bp 79 090 bp 125 000 bp 
STR 18 18 0 15 240 bp 78 250 bp 97 000 bp 
MATE 22 13 9 16 340 bp 85 000 bp 90 000 bp 
SGD 44 24 20 19 891 bp 99 178 bp 100 00 bp 
 
 
4.2.3 Representation of alkaloid genes in draft genome and BAC assemblies 
No nuclear genomic sequence for C. roseus or any other alkaloid producing plant was available 
at the beginning of this thesis. The analysis described below was aimed to determine the 
genomic organisation of the known MIA biosynthetic genes. 
Encouraged by the high number of large scaffolds present in the genome, we investigated the 
completeness of the assembly by searching for all known MIA biosynthesis pathway genes 
(Figure 38). All published sequences of genes involved in the production of alkaloids in C. 
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roseus were searched manually and could be identified in the draft unannotated genome 
(Table 9). Manual inspection revealed that for 7DLH the exons are distributed on two rather 
than one scaffold but those two scaffolds overlap and can be joined to form one continuous 
sequence. With the exception of SGD and T3O all pathway genes could be unambiguously 
assigned to a single scaffold revealing the individual exon intron structure for each known 
pathway gene and making the investigation of co-localised genes, at least to some extent, 
possible. 
 
 
Table 9 C. roseus scaffolds of all alkaloid pathway genes known today 
For all 25 known (to date) alkaloid pathway genes of C. roseus the gene abbreviation, full gene name, 
scaffold number and size, as well as the identifier (ID) of gene locus on individual contig are given. The 
genes SGD and T3O are not available (n.a.) in full length in the assembly. 
Gene Full Gene Name Locus ID 
Scaffold 
No. 
Scaffold 
size (bp) 
G8H geraniol 8-hydroxylase CRO_015220 3061275 29,875 
GOR 8-hydroxygeraniol oxidoreductase CRO_033830 3068899 39,235 
ISY    iridoid synthase CRO_033829 3047130 46,594 
IO iridoid oxidase (CYP76A26) CRO_006321 3064716 28,101 
7DLGT UDP-glucose iridoid glucosyltransferase CRO_027006 3050165 46,244 
7DLH 7-deoxyloganic acid 7-hydroxylase 
CRO_014616 & 
CRO_005949 
2952847 & 
3058188 
5,196 & 
40,675 
LAMT loganic acid methyltransferase CRO_028497 3052816 52,328 
SLS_1 secologanin synthase-like protein 1 CRO_009297 3045390 49,729 
SLS_2 secologanin synthase/ cytochrome P-450 CRO_032842 3047714 65,404 
SLS_3 secologanin synthase-like protein 2 CRO_012140 3071001 48,935 
SLS_4 secologanin synthase-like protein 3 CRO_024556 3063455 76,903 
TDC tryptophan decarboxylase CRO_006098 3045674 29,490 
STR strictosidine synthase CRO_006099 3045674 29,490 
SGD strictosidine -glucosidase n.a. n.a. n.a. 
T16H1 tabersonine 16-hydroxylase CYP71D12  CRO_017448 3064268 32,093 
T16H2 T16H-like protein CRO_017447 3064268 32,093 
16OMT 16-hydroxytabersonine O-methyltransferase CRO_004356 3051716 19,234 
T3O tabersonine 3-hydroxylase n.a. n.a. n.a. 
T3R tabersonine 3-reductase CRO_021541 3066548 34,599 
NMT 
16-hydroxy-2,3-dihydro-3-hydroxytabersonine N-
methyltransferase  
CRO_033266 3065019 10,334 
D4H desacetoxyvindoline-4-hydroxylase CRO_012504 2969470 16,035 
DAT deacetylvindoline 4-O-acetyltransferase CRO_020280 3060125 26,177 
THAS tetrahydroalstonine synthase CRO_024553 3063455 76,903 
T19H tabersonine/lochnericine 19-hydroxylase  CRO_021082 2964965 34,685 
MAT minovincinine 19-hydroxy-O-acetyltransferase CRO_005213 3067490 69,370 
 
95 
 
 
 
4.2.4 Gene content of pathway gene genomic scaffolds and BAC assemblies 
For initial analysis, the unannotated draft genome was examined. Scaffolds identified to 
contain known pathway genes were examined for further gene content using BLASTn search 
against the C. roseus transcriptome available at the time 65 to mine for the presence and 
identity of neighbouring genes. From those transcripts, candidates that could potentially be 
missing steps in C. roseus alkaloid biosynthesis have been chosen and investigated either in the 
scope of this thesis or by other members of the O’Connor group. For example, a gene 
annotated as an alcohol dehydrogenase that is located in proximity to SLS was functionally 
characterised as an MIA enzyme involved in heteroyohimbine biosynthesis 37. 
After this first extended analysis of the assembly and in preparation of the publication of this 
data 68 the genome was annotated and the raw reads of 8 out of the 23 tissues contained in 
the original transcriptomic dataset 65 were used to calculate FPKM values for this revised 
transcriptomic dataset by Dr. Jeongwoon Kim (Robin Buell’s Lab, MSU, East Lansing, USA).  
Recently, in preparation of this thesis, the original analysis was repeated using the newly 
obtained annotation of the genome and the recalculated transcriptomic data as it is of much 
higher quality. In the original transcriptomic data, individual transcripts were often not full 
length and required individual manual inspection. In general, the obtained results of both 
analyses are the same. Furthermore the original mining was extended to pathway genes that 
had been discovered after the initial analysis, such as the vindoline pathway genes T3O 48,146 
and T3R 48. 
In total, 25 known pathway genes were employed in this analysis. The detailed investigation of 
their genomic context in combination with the BAC assembly data yielded 96 individual 
transcripts that are located in close proximity to the previously identified 25 C. roseus alkaloid 
pathway genes. Individual results are presented below with the results of the parallel analysis 
of the content of the BAC assemblies. If possible, the order of BAC scaffolds was manually 
determined using the BAC ends, overlapping regions of individual scaffolds, transcripts 
spanning more than one scaffold, and by BLASTn search against the draft genome scaffolds. To 
confirm individual findings, PCR from genomic DNA was conducted. The analysis presented 
below begins with the seco-iridoid pathway genes and follows the natural order of enzymatic 
steps in C. roseus alkaloid biosynthesis. 
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4.2.5 Geraniol-8 hydroxylase and 8-hydroxygeraniol oxidoreductase 
The hydroxylation of geraniol by geraniol-8 hydroxylase (G8H) 28 represents the first 
committed step of the seco-iridoid pathway. This cytochrome P450 enzyme belongs to the 
CYP76 family and geraniol hydroxylation activity has been shown for several members of this 
family, for example, from Arabidopsis thaliana 180. The product of G8H, 8-oxogeraniol, is 
converted by 8-hydroxygeraniol oxidoreductase (GOR) 29, which is a medium chain alcohol 
dehydrogenase, to the linear dialdehyde 8-oxogeranial (Figure 39). 
 
 
Figure 39 Monoterpene indole alkaloid pathway in C. roseus (Part I) 
Seco-iridoid section of MIA pathway from geraniol to loganin: G8H, geraniol 8-hydroxylase; GOR, 8-
hydroxygeraniol oxidoreductase; ISY, iridoid synthase; IO, iridoid oxidase; 7DLGT, UDP-glucose iridoid 
glucosyltransferase; 7DLH, 7-deoxyloganic acid 7-hydroxylase. 
 
The G8H scaffold contains only one further transcript, not a known alkaloid pathway gene and 
the GOR scaffold contains six further transcripts none of which is a known alkaloid pathway 
gene (Table 10). Based on the annotation, it seems unlikely that any of these genes adjacent to 
G8H and GOR play a role in the MIA pathway.  
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Table 10 Scaffold containing alkaloid biosynthesis gene geraniol 8-hydroxylase 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold.  
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
G8H 3061275 29,875 CRO_015221 DUF1649 domain containing protein 
      CRO_015220 geraniol 8-hydroxylase 
GOR 3068899 39,235 CRO_033830 8-hydroxygeraniol oxidoreductase 
   
CRO_004421 aspartate aminotransferase 
   
CRO_004419 Glycosyl hydrolase family protein 
   
CRO_004420 Glycosyl hydrolase family protein 
   
CRO_004422 hypothetical protein 
   
CRO_004424 RNA polymerase I-associated factor PAF67 
   
CRO_004423 Tetraspanin family protein 
 
 
4.2.6 Iridoid synthase 
The product of GOR, 8-oxogeranial, is converted by iridoid synthase (ISY) to a mixture of cis-
trans-iridodial and cis-trans-nepetalactol 30 (Figure 39). For the ISY gene, the draft genome 
data as well as the corresponding BAC (ISY_BAC) were analysed. The genome scaffold 
containing ISY contains six further transcripts (Table 11). 
 
Table 11 Genome scaffold containing alkaloid biosynthesis gene iridoid synthase 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold. 
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
ISY 3047130 46,594 CRO_025458 alpha/beta-Hydrolase protein 
   
CRO_025459 cytochrome B5 isoform B 
   
CRO_025460 glycine-rich protein 
   
CRO_033829 iridoid synthase 
   
CRO_025461 iridoid synthase paralog 
   
CRO_025462 Protein of unknown function (DUF620) 
   
CRO_025463 RNA binding (pumilio) 
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The combined ISY_BAC assembly was only approximately 79,000 bp, smaller than the 
previously experimentally predicted insert size of 125,000 bp for this BAC (Table 8). However 
in combination with the draft genome scaffolds, the size of the covered region could be 
increased by manual curation of the assembly to about 160,000 bp (Table 12). Importantly the 
draft genome scaffold for ISY and the ISY_BAC scaffolds are close to identical. This accordance 
was observed for all BAC data and strengthens the validity of both assemblies. A number of 
interesting observations were made from the annotations of the genes on these scaffolds, and 
are discussed further below. 
Table 12 ISY_BAC assembly scaffolds 
Size of ISY_BAC scaffolds larger 2000 bp, corresponding scaffolds with size in bp, transcripts contained 
and transcripts functional annotation. In bold is the known pathway gene ISY (CRO_025460/ 
JX974564.1). Its neighbouring gene CRO_025461 represents a duplication of the former. 
BAC 
Scaffold/size 
in bp 
Corresponding 
Scaffold/size in bp 
Transcripts 
contained 
Functional annotation 
c3/29781 3070152/ 76482 CRO_015511 adenine phosphoribosyl transferase 
    CRO_015512 Family of unknown function (DUF566)  
    CRO_015513 Glycosyl hydrolase family 35 protein 
    CRO_015508 LOB domain-containing protein 
    CRO_015509 nucleic acid binding 
    CRO_015510 ROOT HAIR DEFECTIVE 6-LIKE 
    CRO_015507 salt tolerance zinc finger 
c1/27294 3068236/ 44765 CRO_029922 ankyrin repeat family protein 
    CRO_029919 casein kinase alpha 
    CRO_029921 Peroxisomal membrane 22 kDa (Mpv17/PMP22) 
    CRO_029920 Syntaxin/t-SNARE family protein 
    CRO_029918 TBP-associated factor 
c2/22015 3047130/ 46594 CRO_025458 alpha/beta-Hydrolases superfamily 
    CRO_025459 cytochrome B5 isoform B 
    CRO_025460 iridoid synthase 
    CRO_025461 iridoid synthase paralog 
    CRO_025462 Protein of unknown function (DUF620) 
    CRO_025463 RNA binding (pumilio) 
c5/7939 3068236/ 44765 already contained in c1 
c6/6467 3068236/ 44765 already contained in c1 
c7/4986 3047130/ 46594 already contained in c2 
c4/4041 3068236/ 44765 already contained in c1 
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According to the analysis of the genomic data, ISY is accompanied by a second gene 
CRO_025461, an iridoid synthase paralog. The C. roseus genome contains six members of the 
progesterone 5 β-reductase (P5βR) family homologous to the actual iridoid synthase gene 
(Table 13). Four out of the six members of this family have been shown to accept 8-
oxogeranial as substrate in vitro, though their function in planta remains unclear 181. 
 
Table 13 Sequence similarity of C. roseus progesterone 5 β-reductase enzymes 
Sequence similarity in % based on nucleotide alignment of six C. roseus P5βR gene family members. 
CRO_025460, the actual ISY gene, corresponds to KJ873886.1 and is highlighted in red. CRO_025461 
corresponds to KJ873885.1. In bold are the genes that have been shown to be able to in vitro convert 8-
oxogeranial, the original ISY substrate 181. 
  KJ873884.1 KJ873885.1 KJ873883.1 KJ873886.1 KJ873882.1 KJ873887.1 
KJ873884.1   69.3 81.3 64 83.6 56.9 
KJ873885.1 69.3   68 65.6 70.6 58.2 
KJ873883.1 81.3 68   62.7 86.5 54.6 
KJ873886.1 64 65.6 62.7   64.5 59.4 
KJ873882.1 83.6 70.6 86.5 64.5   56.8 
KJ873887.1 56.9 58.2 54.6 59.4 56.8   
 
 
The two co-localised and functionally identical genes iridoid synthase and CRO_025461 are 
additionally very tightly co-ex pressed (Figure 40). The physiological function and involvement 
of iridoid synthase in C. roseus alkaloid biosynthesis had been confirmed previously with 
targeted virus induced gene silencing (VIGS) 30. However VIGS experiments silencing the gene 
corresponding to contig CRO_025461 cannot support an involvement of CRO_025461 in 
alkaloid biosynthesis 181. 
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Figure 40 Gene expression of iridoid synthase and iridoid synthase paralog  
Expression values (as log₂FPKM) of ISY (CRO_025460) and the ISY paralogue (CRO_02461). Gene 
expression is displayed for the tissues: A (flower), B, C and D (sterile seedlings treated with MeJA 0, 6 
and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
 
Contig CRO_025459, a second gene localised in close proximity to the iridoid synthase gene, is 
annotated as cytochrome B5. The alkaloid biosynthetic pathway in C. roseus includes seven 
enzymatic steps that are catalysed by cytochrome P450 enzymes (G8H, IO, 7-DLH, SLS, T16H, 
T19H and T3O). The catalysis of these P450s relies on electron shuttling from cytochrome P450 
reductase (CPR). It has been shown that this can be aided by additional action from 
cytochrome B5 182. However, the involvement of this enzyme in the alkaloid biosynthetic 
pathway has not been experimentally investigated. 
It is not clear is any of the other genes located in the ISY_BAC covered region are used in the 
MIA pathway, though these genes are under consideration for future experimental analyses. 
 
4.2.7 Iridoid oxidase, 7-deoxyloganetic acid glucosyltransferase, 7-deoxyloganic 
acid hydroxylase and loganic acid methyltransferase 
A second cytochrome P450 in the seco-iridoid pathway in C. roseus, iridoid oxidase (IO) 31, 
oxidises cis-trans-nepetalactol to 7-deoxyloganetic acid. The 7-deoxyloganetic acid is 
subsequently glycosylated by 7-deoxyloganetic acid glucosyltransferase (7DLGT), 47. The 
reaction product is hydroxylated by the third cytochrome P450 of the seco-iridoid pathway in 
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C. roseus, 7-deoxyloganic acid hydroxylase (7DLH) 33 and methylated by loganic acid 
methyltransferase (LAMT) to form loganin 34 (Figure 39). 
The IO scaffold contains only one further transcript. The scaffold containing 7DLGT contains 
five further transcripts. Two overlapping scaffolds each contain a part of 7DLH. No further 
transcript is located on the first of the two scaffolds, while five further transcripts are located 
on the second scaffold. Finally the LAMT scaffold contains only one further transcript (Table 
14). None of these transcripts is a known alkaloid pathway gene. 
Table 14 Scaffold containing alkaloid biosynthesis gene IO, 7DLGT, 7DLH and LAMT 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold. 
Gene Scaffold 
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
IO 3064716 28,101 CRO_006322 AGAMOUS-like 
      CRO_006321 iridoid oxidase (CYP76A26) 
7DLGT 3050165 46,244 CRO_027003 UDP-glucosyl transferase 
   
CRO_027004 UDP-glucosyl transferase 
   
CRO_027001 UDP-glucosyl transferase 
   
CRO_027005 UDP-glucosyl transferase 
   
CRO_027006 UDP-glucose iridoid glucosyltransferase 
      CRO_027002 heat shock protein 18.2 
7DLH 2952847 5,196 CRO_014616 7-deoxyloganic acid 7-hydroxylase 
7DLH 3058188 40,675 CRO_005949 7-deoxyloganic acid 7-hydroxylase 
   
CRO_005951 glyoxalase II  
   
CRO_005950 Ribosomal protein L18ae family 
   
CRO_029081 hypothetical protein 
   
CRO_029082 hypothetical protein 
      CRO_029080 Plasma-membrane choline transporter 
LAMT 3052816 52,328 CRO_028498 hypothetical protein 
   
CRO_028497 loganic acid methyltransferase 
 
Four of the transcripts located close to the pathway gene 7DLGT are as well annotated as UDP-
glucosyl transferases (UGT). These proteins belong to the large and diverse family of glucosyl 
transferases. Many (155) C. roseus transcripts are annotated as UGT, a value that corresponds 
to that of approximately 120 UGTs found in Arabidopsis thaliana 183 and 137 UGTs in flax 184. 
There is no evidence that suggests that those UGTs of close physical proximity are involved in 
alkaloid biosynthesis in C. roseus. 
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4.2.8 Secologanin synthase and tetrahydroalstonine synthase 
In the final step of the seco-iridoid section of MIA biosynthesis in C. roseus loganin is 
oxidatively cleaved by the fourth cytochrome P450 of this pathway, secologanin synthase 35 to 
yield the iridoid terpene secologanin. 
 
 
Figure 41 Monoterpene indole alkaloid pathway in C. roseus (Part II) 
Section of the MIA pathway in C. roseus: SLS, secologanin synthase; TDC, tryptophan decarboxylase; 
STR, strictosidine synthase; SGD, strictosidine -glucosidase and THAS, tetrahydroalstonine synthase. 
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The initial analysis of the draft genome identified four paralogs of this gene. Each could be 
linked to an individual scaffold, placing each gene in a district genomic context (Table 15). 
 
Table 15 Scaffolds containing alkaloid biosynthesis gene secologanin synthase 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold. 
Gene Scaffold 
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
SLS_1 3045390 49,729 CRO_009299 hypothetical protein 
   
CRO_009298 hypothetical protein 
      CRO_009297 secologanin synthase-like protein  
SLS_2 3047714 65,404 CRO_032843 hypothetical protein 
   
CRO_032844 hypothetical protein 
   
CRO_032845 hypothetical protein 
      CRO_032842 secologanin synthase/ cytochrome (CYP72) 
SLS_3 3071001 48,935 CRO_012141 hypothetical protein 
   
CRO_012139 MuDR family transposase 
   
CRO_012142 hypothetical protein 
      CRO_012140 secologanin synthase-like protein  
SLS_4 
/THAS 
3063455 76,903 CRO_024555 hypothetical protein 
   
CRO_024559 hypothetical protein 
   
CRO_024558 hypothetical protein 
   
CRO_024554 hypothetical protein 
   
CRO_024552 reticuline oxidase like-protein (RO) 
   
CRO_024557 hypothetical protein 
   
CRO_024556 secologanin synthase-like protein  
   
CRO_024553 tetrahydroalstonine synthase 
 
 
The exon intron structure of all four paralogs is identical but the size and sequence of the 
introns varies (Figure 42). To confirm this initial observation, primers were designed for the 
individual SLS versions for PCR from genomic DNA. Sequencing of the four PCR products 
confirmed the differences between the four SLS paralogs in the genic and the non-genic 
regions, strengthening the correctness of the genome assembly. 
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Figure 42 Exon intron structure of all four secologanin synthase paralog genes 
Schematic representation of exon intron structure of SLS paralog genes. Black sections represent exons. 
Gene open reading frame size is 1584 bp (SLS_1 and 4) or 1575 bp (SLS_2 and 3). 
 
 
 
 
Table 16 Nucleotide sequence similarity of the four secologanin synthase paralog genes 
Nucleotide alignment of all four SLS sequences cloned from C. roseus “SunStorm Apricot” display their 
sequence identity in %.  
 
  SLS_1 SLS_2 SLS_3 SLS_4 
SLS_1   94.2 94.2 93.9 
SLS_2 94.2   97.7 97.2 
SLS_3 94.2 97.7   96.6 
SLS_4 93.9 97.2 96.6   
 
 
All four SLS paralogs were cloned successfully from cDNA. The SLS paralogs are between 94 
and 98% identical in nucleotide sequence (Table 16). This high sequence similarity had made it 
impossible to assemble the four paralogs individually in the original transcriptomic data set 65 
leading to various partial SLS transcripts but no full SLS transcript 49. In the new improved 
transcriptomic dataset obtained using the genome assembly as reference 68 , the individual 
expression profiles of these genes can be resolved (Figure 43). An involvement of all four 
versions of SLS in C. roseus alkaloid biosynthesis is assumed based on their high sequence 
similarity and the fact that all four versions are expressed in the relevant tissues. 
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Figure 43 Gene expression of all four secologanin synthase paralog genes 
Expression values (as log₂FPKM) of all four SLS paralogs. Gene expression is displayed for the tissues: A 
(flower), B, C and D (sterile seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G 
(stem) and H (root). 
 
4.2.8.1 Further content of SLS_4 scaffold – tetrahydroalstonine synthase (THAS) 
After establishing the consistency of the assembly data, a closer inspection of all four SLS 
scaffold revealed that the SLS_4 scaffold contains two further transcripts of interest, the 
annotation of which suggests that they may have the potential to be involved in the unknown 
steps of alkaloid biosynthesis (Table 15). The contigs CRO_024553 (cra_locus_1974_iso_3 in 
the original transcriptomic dataset 65) was annotated as “sinapyl alcohol dehydrogenase”. 
Despite its relatively low expression in mature and young leaf it displays a strong upregulation 
after methyl jasmonate induction and was therefore suspected to be involved in alkaloid 
biosynthesis in C. roseus.  
After observing the evidence of gene clustering for this candidate, it was subsequently tested 
for its potential involvement in alkaloid biosynthesis. The activity of this enzyme was tested by 
Anna Stavrinides and Dr. Evangelos Tatsis, who were working on elucidation of enzymatic 
steps following the deglycosylation of strictosidine. Those experiments included targeted gene 
silencing as well as expression of this candidate in E. coli and testing it with the strictosidine 
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aglycone, the SGD reaction product. It was shown that this enzyme can accept the aglycone 
and convert it to the heteroyohimbine-type alkaloid tetrahydroalstonine (Figure 41). It was 
consequently named tetrahydroalstonine synthase. It represents the first ever report of 
cloning and characterisation of a gene involved at the crucial branch point in monoterpene 
alkaloid diversity not only in C. roseus but in all monoterpene alkaloid producing plants. THAS 
has been further characterised and the results have been published 37. 
The term collinearity in plant genomics describes the conserved order of genes that can be 
observed between different plant species 185. In plant gene clustering, collinearity refers to the 
order of genes belonging to a cluster representing the exact order of reactions in the pathway. 
It is however rather the exception then the rule that plant gene cluster display a strong 
collinearity 174. Therefore the fact that THAS is an enzyme not acting directly on the SLS 
product (Figure 41) is not unexpected. 
 
4.2.8.2 Further content of SLS_4 scaffold – reticuline oxidase (RO) 
The second contig of potential interest, CRO_024552, is annotated as a reticuline oxidase like-
protein. Reticuline oxidase, or (S)-reticuline oxygen oxidoreductase, is a methylene-bridge-
forming enzyme, also called berberine bridge enzyme, first characterised from Eschscholzia 
californica (california poppy) where it is essential to the formation of benzophenanthridine 
alkaloids that are involved in plant defence against pathogenic attacks 186. However RO is not 
expressed in leaves and therefore silencing of this gene using VIGS in C. roseus is not possible 
(Figure 44). Furthermore, it is only minimally induced by methyl jasmonate, a fact that makes 
its involvement in alkaloid biosynthesis less likely, as all so far reported genes are strongly 
methyl jasmonate induced. The function of RO remains unknown. 
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Figure 44 Gene expression of SLS, THAS and RO in C. roseus 
Expression values (as log₂FPKM) of SLS_4 paralogue as well as THAS (CRO_024553) and RO 
(CRO_024552). Gene expression is displayed for the tissues: A (flower), B, C and D (sterile seedlings 
treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
 
 
4.2.9 Tryptophan decarboxylase & strictosidine synthase 
In parallel to the reaction of loganin to secologanin catalysed by secologanin synthase (SLS), 
the amino acid tryptophan is decarboxylated by the pyridoxal phosphate dependent enzyme, 
tryptophan decarboxylase (TDC) to form tryptamine 187 (Figure 41). Both products, secologanin 
and tryptamine are enzymatically joined in a Pictet-Spengler condensation reaction catalysed 
by strictosidine synthase (STR), the first committed step in the creation of monoterpene indole 
alkaloids by formation of the central metabolic intermediate strictosidine (Figure 41) 188,189. 
 
4.2.9.1 Genome scaffold for tryptophan decarboxylase 
The TDC genome scaffold contains two further transcripts, one representing the pathway gene 
STR and one further transcript annotated as an efflux family protein of the Multi-antimicrobial 
extrusion protein type (MATE) (Table 17). 
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Table 17 Scaffold containing alkaloid biosynthesis gene tryptophan decarboxylase 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold.  
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
TDC / STR 3045674 29,490 CRO_006099 strictosidine synthase 
   
CRO_006098 tryptophan decarboxylase 
   
CRO_006097 MATE efflux family protein 
 
To ensure that this observation of pathway gene clustering is not an artefact of the assembly, 
PCR using genomic DNA as template was conducted. The forward primer for this PCR was 
located in the coding region of the TDC gene while the reverse primer was located in the 
coding region of the STR gene. Both primers amplified only one single target as was 
determined by BLAST search against the genome assembly. The expected band size was 6849 
bp. A band of approximately this size was amplified using PCR on C. roseus genomic DNA 
(Figure 45). 
 
Figure 45 Products obtained by amplifying TDC and STR from genomic DNA 
A band of approximately 7000 bp could be obtained using a TDC and STR specific primer pair on C. 
roseus genomic DNA, suggesting the close proximity of these genes in the C. roseus genome. 
 
Mapping the full open reading frames (ORFs) of all three genes to the genomic scaffold 
revealed their exact intron exon structure, direction of the ORFs and the distance between the 
individual genes. The genes TDC and STR are located only approximately 6000 bp apart with no 
other transcript mapping to this section (Figure 46). 
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Figure 46 Representation of scaffold 3045674 with genes MATE, TDC and STR 
Schematic representation of location of the three open reading frames for the gene MATE, TDC and STR. 
Black sections represent exons. 
 
The TDC/ STR genomic scaffold contains a third transcript. CRO_006097 is annotated as a Mate 
efflux family protein (MATE), a transport protein 190. Members of this family have been 
implicated in various transport processes in plants and interestingly also in the transport of 
secondary metabolites 191. The expression profile of these three co-localised genes displays 
remarkably strong co-regulation (Figure 47) making MATE an excellent candidate for further 
characterisation. This characterisation was done by Dr. Richard Payne from the O’Connor lab 
(John Innes Centre, Norwich, UK), with his work strongly suggesting that MATE is responsible 
for transporting secologanin, the co-substrate of STR, from the cytosol into the vacuole. 
 
Figure 47 Expression profile of TDC, STR and MATE 
Expression values (as log₂FPKM) of TDC, STR and MATE. Gene expression is displayed in the tissues: A 
(flower), B, C and D (sterile seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G 
(stem) and H (root). 
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4.2.9.2 STR_BAC and MATE_BAC 
Originally we instructed Bio S&T Inc. (Montreal, Canada) to extract a BAC that contained 
MATE, but not STR, to ensure that we could extend the BAC sequence data in the direction of 
MATE. This approach however failed and both BACs obtained still contained both STR and 
MATE (Table 18) The content of the STR_BAC and the MATE_BAC assemblies is almost 
identical. Only the overlap of a further genomic scaffold with one of the MATE_BAC scaffolds 
allows the extension of the sequence. MATE_BAC scaffold c3 overlaps with genomic scaffold 
3064339, a scaffold that is 57 729 bp long and allows to connect seven further transcripts to 
the existing gene cluster (Table 18). 
Table 18 STR_BAC and MATE_BAC assembly scaffolds 
Size of STR_BAC and MATE_BAC scaffolds larger 2000 bp, corresponding genomic scaffolds with size in 
bp, transcripts contained and transcript functional annotation. Bold are the known pathway genes 
strictosidine synthase and tryptophan decarboxylase. 
STR_BAC 
Scaffold/size 
in bp 
Corresponding 
genomic 
scaffold/size in 
bp 
Transcripts 
contained 
Functional annotation 
c1/15240 3045674/29490 CRO_006097 MATE efflux family protein 
    CRO_006098 tryptophan decarboxylase 
    CRO_006099 strictosidine synthase 
c2/5461   already contained in c1 
c3/3698   already contained in c1 
MATE_BAC 
Scaffold/size 
in bp 
Corresponding 
genomic 
scaffold/size in 
bp 
Transcripts 
contained 
Functional annotation 
c4/16340 3045674/29490 CRO_006097 MATE efflux family protein 
    CRO_006098 tryptophan decarboxylase 
    CRO_006099 strictosidine synthase 
c3/14187 3064339/57729 CRO_006603 cytochrome P450, family 71, subfamily B 
    CRO_006604 F-box family protein 
    CRO_006605 Galactosyltransferase family protein 
    CRO_006606 alpha carbonic anhydrase 
    CRO_006607 Ubiquitin-like superfamily protein 
    CRO_006608 aconitase 
    CRO_006609 Polynucleotidyl transferase 
c2/6507   already contained in c4 
c1/6003   already contained in c4 
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A surprisingly low number of transcripts that can be associated with both BACs is likely due to 
the large proportion of highly repetitive sequences. A dotplot graph 192 was used to investigate 
sequence similarity as similarity matrix. Horizontal and vertical edges representing the 
sequences to be compared with individual “dots” being coloured if they are identical in the 
two sequences. The structure and complexity of a sequence can be investigated by comparing 
it in a dotplot to itself. A dotplot then visualises regions of low complexity such as highly 
repetitive and low complexity sequences that are particularly challenging to assemble 193 as 
more or less fully coloured regions. The dotplot of the combined assembly of the MATE_BAC 
(85,000 bp, Table 8) displays a high proportion of highly repetitive sequences (Figure 48). 
However, the MATE_BAC contains a transcript annotated as a cytochrome P450 enzyme, 
transcript CRO_006603, which belongs to the CYP71 family. The expression values for this 
P450 is however very different from that of the pathway genes STR and TDC. This P450 is only 
expressed in seedling and stem tissue (Figure 49). Therefore, no VIGS experiment was 
conducted and the function of this gene remains unknown. 
 
        
Figure 48 Dotplot (self) of all scaffolds > 2000 bp of the STR_BAC 
The assembly of the STR_BAC results in a total number of 13 scaffolds with highly repetitive content. 
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Figure 49 Expression of transcripts of MATE_BAC scaffold 
Expression values (as log₂FPKM) of transcripts contained in scaffold 3064339 in comparison to TDC, STR 
and MATE. Gene expression is displayed for the tissues: A (flower), B, C and D (sterile seedlings treated 
with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
 
Other genes in close proximity include a contig annotated as aconitase. Aconitases are 
essential iron-sulphur proteins facilitating the isomerisation of isocitrate from citrate indicating 
their function in primary metabolism pathways. Additionally aconitase genes from Arabidopsis 
were shown to be involved in transcriptional regulating resistance to oxidative stress 194. 
Although aconitase (CRO_006608) is co-expressed with the alkaloid pathway genes TDC and 
STR (Figure 49) there is no other evidence suggesting an involvement of this gene in alkaloid 
biosynthesis in C. roseus. Given the known biochemistry of this alkaloid pathway, a role for 
aconitase activity does not seem likely. 
 
4.2.10 Strictosidine -glucosidase 
The deglycosylation of strictosidine by strictosidine -glucosidase (SGD) 195 results in formation 
of a reactive di-aldehyde species that subsequently rearranges to 4,21-dehydrogeissoschizine, 
an intermediate from which nearly all structural scaffolds of monoterpene indole alkaloids are 
derived 18 (Figure 41). 
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4.2.10.1 SGD scaffold 
Multiple scaffolds can be associated with the SGD gene sequence, none of which represent the 
full gene, which contains 13 exons (Table 19). 
 
Table 19 Scaffolds containing alkaloid biosynthesis gene strictosidine -glucosidase 
Scaffold number, size and contained transcripts ID and annotation. Neither any of the genomic nor the 
transcripts represent the full open reading frame of SGD. 
 
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
SGD  
2954985 834 
CRO_015796 
CRO_028721 
CRO_031126 
CRO_005478 
strictosidine -glucosidase 
3022133 734 
 
3042873 2880 
 
3043349 2919 
 
3042874 5337 
 
3038592 3868 
 
3038594 5212 
 
3062364 4,646 
 
 
Three contigs resembled the N-terminus of the gene, four the C-terminus of the gene, and one 
contig the middle region. The gene was manually reconstructed from these 8 scaffolds and 
consists of 13 exons and 12 introns. As in the case of the SLS genes, individual parts of the SGD 
gene were cloned from genomic DNA and sequenced to confirm the manual reconstruction. 
SGD spans more than 10 kb on the genome (Figure 50). The exon intron organisation is not 
unusual and can be found in other plant genomes such as rice where a comparison of all 
members of the glucosyl hydrolase family 1 -glucosidases revealed several types of gene 
structures with the most common gene pattern being the one in which there are 13 exons 
separated by 12 introns 196. Manual examination by Robin Buell and co-workers at Michigan 
State University (MSU, East Lansing, USA) had suggested that the misassembled SGD 
represented a collapsed genome assembly possibly representing a minimum of two close SGD 
paralogs. Later comparison with the Mate pair data confirmed the existence of two partial SGD 
genes surrounding the actual full length SGD gene in the C. roseus genome.  
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Figure 50 Reconstructed exon intron structure of the SGD gene 
The alkaloid biosynthesis gene SGD is represented partially by eight different scaffolds. Combined the 
exon/ intron structure becomes visible and reveals a total length of the gene in its genomic context of 
approximately 10000 bp. 
4.2.10.2 SGD_BAC 
The assembly of the first SGD_BAC resulted in only two scaffolds with a combined length of 
105000 bp, identical to the experimentally predicted insert size. Unfortunately the assembly of 
this SGD_BAC does not contain the actual SGD screening target sequence, in fact it contains 
almost no transcripts at all (Table 20). Attempts to map all obtained reads from the sequencing 
of the first SGD_BAC automatically onto the sequence of SGD did not result in any matches, 
suggesting that failure to detect SGD in the assembly was not due to a problem with the 
assembly. 
Table 20 First SGD_BAC assembly scaffolds 
Scaffolds resulting from the assembly of the SGD_BAC sequencing data, corresponding genomic scaffold 
and contained transcripts with functional annotation. 
BAC 
Scaffold/size 
in bp 
Corresponding 
genomic 
scaffold/size in bp 
Transcripts 
contained 
Functional annotation 
c1/93247 bp 3057594/43594 CRO_022807 hypothetical protein 
  2971237/8169  -   
  3062333/20761 CRO_013231 hypothetical protein 
  3051495/16542  -   
  2959308/6578  -   
c2/12304 2981604/43644 CRO_000238 MuDR family transposase 
 
As a consequence of the failure to locate SGD on the sequenced SGD_BAC, an improved primer 
pair was designed to screen the BAC library for a second time. The new knowledge of its exact 
genomic sequence helped identify an optimised primer pair for the second screening of the 
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BAC library. This time the SGD gene was part of the assembly and could, in full length, be 
localised on one scaffold of the SGD_BAC assembly (Table 21) confirming the previously 
manually reconstructed genomic structure (Figure 50). At this point, the genes surrounding 
SGD could be identified. 
Table 21 Second SGD_BAC assembly scaffolds 
Scaffolds larger 2000 bp, corresponding genomic scaffolds (in bp), transcripts contained and transcript 
functional annotation. 
BAC 
Scaffold/size 
in bp 
Corresponding 
genomic 
Scaffold/size in bp 
Transcripts 
contained 
Functional annotation 
c1/19897 2954369/20065 -    
c4/14177 3038756/4822 -   
c2/10658 
2954985/834, 
3022133/734, 
3042873/2880, 
3043349/2919, 
3042874/5337, 
3038592/3868, 
3038594/5212, 
3062364/4646  
CRO_015796, 
CRO_028721, 
CRO_031126, 
CRO_005478 
SGD/ strictosidine beta glucosidase 
c5/6829 3039922/3323 -   
  3110662/1692 -   
c7/6246 3067087/8810 -   
  3039593/6049 -   
c9/6202 3047206/8855 -   
c8/5969 contained in c7 
c3/5287 3041229/2400 -   
  3041230/2400 -   
c25/4071 3066832/2982 -   
  3066655/35788 CRO_011777 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase 
    CRO_011778 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase 
    CRO_011779 cytochrome P450, family 71, subfamily B, polypeptide 
    CRO_011781 hypothetical protein 
    CRO_011780 Peptidase C78, ubiquitin fold modifier-specific  
c6/3659 3038311/3332 -    
  3038311/3301 -    
  295449/1670 -   
c29/3566 contained in c25 
c11/3204 3059350/4493 CRO_026512 oligopeptide transporter 
c10/2930 3039593/6049 -   
c27/2271 contained in c11 
c14/2217 contained in c11 
c12/2063 contained in c25 
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The second SGD_BAC contains a transcript annotated as oligopeptide transporter. These 
transport family enzymes are implicated in various biological functions with demonstrated 
substrates in plants being metal-chelates, small peptides and glutathione 197. Transport of 
secondary metabolites is essential for complex pathways like the alkaloid pathway in C. roseus 
198 of which only two transporter have been characterised so far 46,199. However the contig 
CRO_026512 is only 600 bp long which is in stark contrast to the length described for the 
oligopeptide transporters from other plants such as A. thaliana 200 suggesting this is a partial 
gene/ pseudogene. Additionally CRO_026512 is not expressed in leaf tissues making it an 
unsuitable candidate for gene silencing (Figure 51). 
 
Figure 51 Expression profile of SGD and co-localised genes 
Expression values (as log₂FPKM) of SGD and co-localised transcripts CRO_026512 (partial transporter 
gene), CRO_011777 and CRO_011778 (2-oxoglutarate (2OG) and Fe (II)-dependent oxygenase) and 
CRO_011779 (P450 gene, VIGS candidate C18). Gene expression is displayed for the tissues: A (flower), 
B, C and D (sterile seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) 
and H (root). 
 
The low expression values are also the reason two further transcripts on the scaffold, 
CRO_011777 and CRO_011778, have not been subjected to further silencing experiments 
despite the fact that 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenases can be implicated 
in many examples of plant specialised metabolism 201. CRO_011779 is annotated as P450 
enzyme of the CYP71 family. Although again it displays low expression values, it was subjected 
to two VIGS experiments. The results of these experiments are detailed in Chapter 5. 
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4.2.11 Tabersonine 16-hydroxylase & 16-hydroxytabersonine O-methyl-transferase         
The first committed step of the seven enzymatic reactions comprising vindoline biosynthesis 
from the intermediate tabersonine in C. roseus is catalysed by the cytochrome P450 
tabersonine 16-hydroxylase (T16H). This enzyme hydroxylates tabersonine at the 16 position 
to 16-hydroxytabersonine 41 (Figure 52). It has been established as part of this thesis (Chapter 
2) that two T16H genes, T16H1 and T16H2, exist in C. roseus and that both are involved in 
vindoline biosynthesis in a tissue dependant manner 42. In the next enzymatic step the newly 
installed hydroxyl group of 16-hydroxytabersonine is methylated by 16-hydroxytabersonine O-
methyltransferase (16OMT) 34. 
 
Figure 52 Monoterpene indole alkaloid pathway in C. roseus (Part III) 
Downstream section of the MIA pathway in C. roseus: T16H2, tabersonine 16-hydroxylase 2 
(CYP71D351); 16OMT, 16-hydroxytabersonine O-methyltransferase; T3O 16-methoxytabersone 3-
oxigenase; T3R, 16-methoxytabersonine 3-reductase NMT, 16-methoxy-2,3-dihydro-3-
hydroxytabersonine N-methyltransferase; D4H, desacetoxyvindoline-4-hydroxylase; DAT, 
deacetylvindoline 4-O-acetyltransferase. 
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4.2.11.1 T16H and 16OMT scaffold 
The genomic scaffold for T16H contains both transcripts T16H1 and T16H2 along with two 
additional transcripts. The genomic scaffold for 16OMT contains one additional transcript 
(Table 22). 
 
 
Table 22 Scaffolds containing alkaloid biosynthesis genes T16H and 16OMT 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway genes in bold. 
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
T16H 3064268 32,093 CRO_017450 DUF4283 domain containing protein 
   
CRO_017447 T16H-like protein 
   
CRO_017449 cytochrome P450, family 71 B 
   
CRO_017448 tabersonine 16-hydroxylase CYP71D12 
16OMT 3051716 19,234 CRO_004355 cytochrome P450, family 71 B 
   
CRO_004356 16-hydroxytabersonine O-methyltransferase 
 
 
 
4.2.11.2 T16H2_BAC scaffolds 
As already discovered from the T16H scaffold, the alkaloid pathway genes T16H1 and T16H2 
represent a reversed tandem duplicated gene pair of a member of the CYP71 protein family. 
Both genes have been shown to carry out the same enzymatic reaction 42. The alkaloid 
pathway gene 16OMT acts immediately after the T16H reaction and is part of the T16H2_BAC 
assembly (Table 23). 
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Table 23 T16H2_BAC assembly scaffolds 
Size of T16H2_BAC scaffolds larger 1000 bp, corresponding genomic scaffolds with size in bp, transcripts 
contained and transcript functional annotation. In bold are the known pathway genes 16OMT 
(CRO_004356), T16H1 (CRO_ 017448) and T16H2 (CRO_017447). The transcript CRO_017449 is not 
contained on the BAC scaffold c3 but only on the genomic scaffold that overlaps partly with c3. 
 
BAC 
Scaffold/size 
in bp 
Corresponding 
genomic 
scaffold/size in bp 
Transcripts 
contained 
Functional annotation 
c1/59670 2997859/42721 CRO_025929 cell wall protein precursor, putative 
    CRO_025930 Protein phosphatase 2C family protein 
    CRO_025927 Putative uncharacterised protein ycf15 
    CRO_025928 photosystem II family protein 
    CRO_025931 cytochrome P450, family 71, subfamily B 
  3051716/19234 CRO_004356 16-hydroxytabersonine O-methyltransferase 
    CRO_004355 cytochrome P450, family 71, subfamily B 
c3/24101 3064268/32093 CRO_017449 cytochrome P450, family 71, subfamily B 
    CRO_017450 DUF4283 domain containing protein 
    CRO_017447 T16H-like protein 
    CRO_017448 tabersonine 16-hydroxylase CYP71D12 
c4/16202 3043234/7991 CRO_002269 Peroxisomal membrane 22 kDa family protein 
    CRO_002270 signal peptide peptidase 
  2999338/4703 CRO_017854 FAR1-related sequence 
c2/13778 3030070/17788 CRO_015028 Auxin-responsive GH3 family protein 
    CRO_015029 Pentatricopeptide repeat (PPR-like) superfamily 
c7/1969 3041661/3032 no transcripts contained 
c5/1235 3051716/19234 already contained in c1 
 
The assembly results reflect the previously experimentally predicted insert size of this BAC. 
The largest T16H2_BAC scaffold c1 contains the known pathway gene 16OMT, while the 
second largest T16H2_BAC scaffold c3 contains the known pathway genes T16H1 and T16H2 
(Figure 53). It was not possible to conclusively order the scaffolds of this BAC manually but 
given the fact that 16OMT is located on a 56 000 bp long scaffold and the given total length of 
the T16H2_BAC of 125 000 bp, we conclude that 16OMT and T16H1 and T16H2 cannot be 
more then approximately 60 000 bp distant. 
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Figure 53 T16H2_BAC scaffolds c1 and c3 
The T16H2_BAC scaffold c1 with the transcripts CRO_004356 (pathway gene 16OMT) and CRO_004355, 
a second CYP71 gene, and the T16H2_BAC scaffold c3 with the reversed tandem duplicated transcripts 
CRO_017447 (pathway gene T16H2) and CRO_017448 (pathway gene T16H1). Blue arrow indicate 
direction of gene ORF. The BAC scaffolds c1 contains one of the two BAC ends indicated by a black 
arrow. 
 
4.2.11.3 CYP71 from T16H2_BAC: CRO_025931, CRO_017449 and CRO_004355 
The gene content of the T16H2_BAC assembly was evaluated for possible candidates for 
unknown steps in alkaloid biosynthesis. Three transcripts are annotated as CYP71, the same 
cytochrome P450 family as T16H. Closer inspection of the CYP71 annotated transcripts, 
CRO_025931 and CRO_017449, revealed that they are only partial genes with CRO_025931 
containing only 612 bp and CRO_017449 containing only 441 bp. CRO_025931 represents most 
likely a partial duplication of T16H2 as they still share 93.3% identity and was therefore not 
included in any further investigations. For CRO_017449, the picture is less clear as the 441 bp 
can be found in at least four other transcripts of various length, all of which have very low 
expression values in the alkaloid producing relevant tissues such as flower, leaf, seedling, stem 
and root. This contig was therefore also not included in further investigations. The third CYP71, 
a full length P450 gene, found on the T16H2_BAC, is CRO_004355 (Figure 53). This gene 
however is negligibly expressed in the C. roseus tissues leaf, stem, flower, seedling or root, 
making it a very unlikely candidate for alkaloid biosynthesis.  
According to functional annotation, the CYP71 family is the largest family of cytochrome P450s 
in C. roseus accounting for more than 70 of the 255 as P450 enzyme annotated transcripts. 
This is in accordance with the numbers reported for other land plant genomes where CYP71 
also represents the largest P450 family 202. However, how many of the transcripts annotated as 
CYP71 in C. roseus are actually expressed, full length, functional genes and not partial 
duplications, pseudogenes or assembly fragments remains to be investigated. Additionally 
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CRO_017449 is not part of the actual T16H2_BAC but can only be found on the scaffold that 
exceeds the T16H2_BAC scaffold c3 (Table 23). CRO_017449 was used as template to design a 
VIGS construct and the construct was used to infiltrate young C. roseus plants in a VIGS 
experiment. However, this did not lead to any significant perturbations in metabolism (Chapter 
5, Table 28). 
 
4.2.12 Tabersonine 3-oxygenase, tabersonine 3-reductase, N-methyltransferase 
and desacetoxyvindoline 4-hydroxylase 
The 16-methoxytabersonine product of 16OMT is further hydroxylated and reduced by the 
concerted action of tabersonine 3-oxygenase (T3O) 146 and tabersonine 3-reductase (T3R)203. 
At the start of this thesis both genes were unknown. The reaction product of T3O and T3R, 16-
methoxy 2,3-dihydro-3-hydroxytabersonine, is the substrate for N-methylation by the N-
methyltransferase (NMT) 127 and further hydroxylation of the resulting desacetoxyvindoline by 
desacetoxyvindoline 4-hydroxylase (D4H) (Figure 52) 133. 
The T3O gene is, like SGD not represented by a single contig in the new transcriptome 68 but by 
five different partial transcripts. On genome level none of the scaffolds contains a full T3O 
gene and none of the scaffolds that contain part of T3O contain any other transcripts. 
The T3R gene is located on a single scaffold containing one further transcript. NMT is located 
on a single scaffold containing one further transcript. D4H is located on a single scaffold 
containing no further transcripts (Table 24). No other known or potential alkaloid biosynthesis 
gene is located on any of the scaffolds.  
 
Table 24 Scaffold containing alkaloid biosynthesis genes T3R, NMT and D4H 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold.  
Gene Scaffold  
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
T3R 
  
CRO_021542 hypothetical protein 
   
CRO_021541 tabersonine 3-reductase 
NMT 3065019 10,334 CRO_033267 hypothetical protein 
   
CRO_033266 
16-hydroxy-2,3-dihydro-3-hydroxytabersonine N-
methyltransferase 
D4H 2969470 16,035 CRO_012504 desacetoxyvindoline-4-hydroxylase 
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4.2.13 Minovincinine 19-hydroxy O-acetyltransferase, deacetylvindoline acetyl-
transferase and tabersonine 19-hydroxylase 
Tabersonine is a central intermediate in vindoline biosynthesis, which is derived in a seven 
step pathway in aerial tissues 48. In roots a different set of genes is responsible for the 
formation of several additional tabersonine derived alkaloids (Figure 54). 
 
Figure 54 Monoterpene indole alkaloid pathway in C. roseus (Part IV) 
Section of the MIA pathway in C. roseus DAT, deacetylvindoline 4-O-acetyltransferase; T19H, 
tabersonine/lochnericine 19-hydroxylase (CYP71BJ1) and MAT, minovincinine 19-hydroxy-O-
acetyltransferase 
In hairy root cultures of C. roseus, the alkaloids hörhammericine and lochnericine have been 
detected and as in vindoline biosynthesis, their production can be strongly increased by 
addition of elicitors such as jasmonic acid (JA) 204. Acting on tabersonine directly is tabersonine 
19-hydroxylase (T19H), a cytochrome P450 enzyme that hydroxylates tabersonine in the 19 
position yielding 19-hydroxytabersonine. Additionally, it was shown that T19H can convert 
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lochnericine into hörhammericine 79. While in the last step of vindoline biosynthesis 
deacetylvindoline is acetylated by deacetylvindoline acetyltransferase (DAT) 45 in the root 
specific alkaloid biosynthesis a highly similar gene encodes the enzyme minovincinine 19-
hydroxy-O-acetyltransferase (MAT) which conducts the reaction from minovincinine to 
echitovenine, similar to the one of DAT, in both cases transferring a acetyl group to a 
tabersonine derived scaffold. It was however shown that MAT was unable to accept either 
tabersonine directly or any other tabersonine-like substrates that were not hydroxylated at the 
19 position 205. Deacetylvindoline, the natural substrate of DAT and hörhammericine was 
converted by MAT albeit at a much lower turnover rates. In contrast DAT is specific to 
deacetylvindoline and accepts no other substrate 205. 
The scaffold for DAT contains two further O-acetyltransferase genes and the MAT scaffold 
contains three further O-acetyltransferase genes. T19H is located on a single scaffold that 
contains a second gene annotated as cytochrome P450 (Table 25). 
Table 25 Scaffold containing alkaloid biosynthesis genes MAT, DAT and T19H 
Scaffold number, size and contained transcripts ID and annotation. Alkaloid pathway gene in bold.  
Gene Scaffold 
Scaffold 
size (bp) 
Transcript ID Transcript annotation 
DAT 3060125 26,177 CRO_020282 HXXXD-type acyl-transferase family protein 
   
CRO_020283 hypothetical protein 
   
CRO_020281 HXXXD-type acyl-transferase family protein 
   
CRO_020280 deacetylvindoline 4-O-acetyltransferase 
      CRO_028722 RNA helicase family protein 
MAT 3067490 69,370 CRO_005217 beta-1,3-glucanase 
   
CRO_005218 Kunitz family trypsin and protease inhibitor 
   
CRO_005212 Kunitz family trypsin and protease inhibitor 
   
CRO_005211 HXXXD-type acyl-transferase family protein 
   
CRO_005216 Kunitz family trypsin and protease inhibitor 
   
CRO_005214 Kunitz family trypsin and protease inhibitor 
   
CRO_005210 HXXXD-type acyl-transferase family protein 
   
CRO_005215 HXXXD-type acyl-transferase family protein 
      CRO_005213 minovincinine 19-hydroxy-O-acetyltransferase 
T19H 2964965 34,685 CRO_021078 DEAD box RNA helicase (PRH75) 
   
CRO_021079 Peptidase family M48 family protein 
   
CRO_021080 Tetratricopeptide repeat (TPR 
   
CRO_021081 cytochrome P450, family 704 A 
   
CRO_021082 tabersonine/lochnericine 19-hydroxylase 
   
CRO_021083 hypothetical protein 
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4.2.13.1 Content of DAT and MAT scaffolds 
The C. roseus transcriptome contains 84 acetyl coenzyme A-dependent O-acetyltransferases 
(HXXXD acyl-transferase family proteins). Minovincinine 19-hydroxy-O-acetyltransferase 206 
and deacetylvindoline 4-O-acetyltransferase 45 share sequence identity on a nucleic acid level 
and no other C. roseus gene has a higher similarity to either gene, suggesting the evolution 
from a common ancestor. The only HXXXD acyl-transferase family protein on either of these 
scaffolds that is expressed in leaf is the DAT gene (Figure 55) (Figure 56). The function of the 
other acyl-transferases has not yet been elucidated. 
 
 
Figure 55 Expression of O-acetyltransferase genes located on the DAT scaffold 
Expression values (as log₂FPKM) of DAT and co-localised transcripts annotated as HXXXD acyl-
transferase family proteins. Gene expression is displayed for the tissues: A (flower), B, C and D (sterile 
seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
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Figure 56 Expression of O-acetyltransferase genes located on the MAT scaffold 
Expression values (as log₂FPKM) of MAT and co-localised transcripts annotated as HXXXD acyl-
transferase family proteins. Gene expression for displayed in the tissues: A (flower), B, C and D (sterile 
seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
 
4.2.13.2 Content of T19H scaffold  
The biosythesis of root specific tabersonine derived alkaloids is missing one enzymatic step 
(Figure 54) the epoxidation of tabersonine to yield lochnericine. Biochemical characterisation 
using labeled 14C-tabersonine had suggested a cytochrome P450 to be involved in this reaction 
205 making CRO_021081, a transcript located in close proximity to T19H a compelling candidate 
for this reaction despite its overall expression being relatively low Figure 57. 
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Figure 57 Expression of T19H and neighbouring P450 transcript 
Expression values (as log₂FPKM) of CRO_021082/T19H and co-localised P450 transcript CRO_021081. 
Gene expression is displayed for the tissues: A (flower), B, C and D (sterile seedlings treated with MeJA 
0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
4.2.13.3 Expression of candidate for epoxidation in root specific alkaloid biosythesis 
Testing of the physiological function of CRO_021081 in planta using silencing was omitted 
since this candidate was predicted to be involved in a pathway localised to roots which cannot 
be targeted by VIGS. Instead, the activity of this gene was assessed in vitro. Primers were 
designed and the full length gene encoded by CRO_021081 was cloned from C. roseus 
“Sunstorm Apricot” stem and root cDNA into the cloning vector pJET and subsequently into 
the yeast expression vector pXP218. Sequencing confirmed a 1527 bp ORF for this gene, 
referred to as candidate gene C72. The nucleotide sequence of C72 was aligned to the T19H 
nucleotide sequence. Interestingly both P450 genes share only 52.2% sequence identity on 
nucleotide level and therefore do not represent a recent gene duplication event. 
Competent cells of yeast strain WAT11, which harbours a P450 reductase 143, were 
transformed with pXP218 containing the candidate gene C72. WAT11 transformed to contain 
an empty plasmid served as empty vector control. Liquid cultures in appropriate selective 
media were induced for protein expression and supplemented with 5.5 µM tabersonine. The 
cultures were maintained for 48 hours and subsequently methanol extracts of culture samples 
measured by LC-MS (Xevo, Waters). No conversion of tabersonine in comparison to EV plasmid 
could be detected (Figure 58) 
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Figure 58 Yeast expressing C72 culture supplemented with tabersonine 
Extracted Ion chromatogram of LC-MS measurement (Xevo, Waters) for the masses m/z 337, 
corresponding to tabersonine and m/z 353, corresponding to the product of the oxidation/ epoxidation 
of tabersonine for yeast culture supplemented with tabersonine, with empty vector plasmid (top) or 
yeast culture supplemented with tabersonine, with plasmid containing C72 (bottom). 
 
It is possible that the missing epoxidation step is unable to accept tabersonine directly as a 
substrate. Instead the enzyme could require 19-hydroxytabersonine, the reaction product of 
the tabersonine hydroxylation by T19H 79. To investigate this possibility T19H was cloned from 
C. roseus stem and root cDNA and cloned into pXP218 plasmid. Competent WAT11 was 
transformed with the resulting plasmid. Mixed cultures of C72 plus T19H were tested. The 
cultures were maintained for 48 hours in the presence of tabersonine and subsequently 
measured by LC-MS. Previous intensive work with tabersonine derivatives in yeast cultures 
(Chapter 3) had shown that the products of the yeast cultures can be freely exchanged 
between yeast and media. 
The yeast culture expressing T19H shows a new peak of a mass corresponding to that of 19-
hydroxylated tabersonine (m/z 353). No such peak is detectable in the empty vector control 
culture (Figure 59). However the combination of C72 and T19H does not lead to the production 
of a further new peak suggesting no conversion of 19-hydroxytabersonine.  
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Figure 59 Extracted Ion chromatogram C72/ T19H cultures supplemented with tabersonine 
Extracted Ion chromatogram of LC-MS measurement (Xevo, Waters) for the masses m/z 337, 
corresponding to tabersonine and m/z 353, corresponding to the product of the oxidation/ epoxidation 
of tabersonine. A: Yeast culture supplemented with tabersonine, with empty vector plasmid. B: Yeast 
culture supplemented with tabersonine, with plasmid containing T19H. C: Yeast culture supplemented 
with tabersonine, with plasmid containing T19H and C72. 
In conclusion candidate C72 was tested with two out of three possible substrates and did not 
show any activity. The most likely explanation is that C72 is not a gene involved in this alkaloid 
pathway. 
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4.2.14 Clustering of other known secondary metabolite genes 
Clustering of pathway genes has been observed for a range of secondary metabolites. 
Clustering has been reported for monoterpene 113, diterpene 108,110 and triterpene 117,120,175–177 
biosynthesis genes. C. roseus contains the triterpenoid ursolic acid 207, which is synthesised 
from amyrin. Both amyrin synthase (AS) and amyrin oxidase (AO) from C. roseus have been 
characterised 63,64. However the two genes of C. roseus implemented in the biosynthetic 
pathway of the triterpenoid ursolic acid, AO and AS, are not located on the same scaffold 
(Table 26). 
Table 26 Scaffolds containing amyrin synthase and amyrin oxidase from C. roseus 
Scaffold name and size in bp as well as all contained transcripts and transcript annotation. Transcripts 
corresponding to AS and AO are in bold. 
Gene Scaffold  
Scaffold 
size (bp) 
Transcripts Transcript annotation 
AS 3068272 45,086 CRO_032476 Concanavalin A-like lectin protein kinase family protein 
      CRO_032479 Concanavalin A-like lectin protein kinase family protein 
      CRO_032478 hypothetical protein 
      CRO_032477 Human Cytomegalovirus UL139 protein domain containing 
      CRO_032475 camelliol C synthase 
AO 2996021 16,843 CRO_027941 cytochrome P450, family 716, subfamily A, polypeptide 
 
Triterpenoid biosynthesis has reported to be clustered in for example oat 117,118, lotus 175 and A. 
thaliana 176,177. The functional annotation of further genes located on those two scaffolds does 
not indicate that they belong any of the known typical tailoring enzymes of the triterpene 
backbone such as glycosyltransferases or cytochrome P450s. However the obtained scaffolds 
are relatively short and therefore no final conclusion can be drawn whether or not triterpene 
biosynthesis in C. roseus is clustered. 
Flavonoid biosynthesis has also been investigated in C. roseus. For example, chalcone synthase 
(CS) and flavonoid 3', 5'-hydroxylase (F3'5'H) from C. roseus have been characterised 208. 
Cinnamate 4-hydroxylase (C4H), the P450 enzyme that catalyses the second step of the 
phenylpropanoid pathway 209, tetrahydroxy chalcone 2’glycosyltransferase (THCGT) 210 and 4’-
O-methyltransferase (CrOMT) have also been shown to be involved in flavonoid biosynthesis in 
C. roseus 62. None of these genes are linked to the same scaffold (Table 27). 
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Table 27 Scaffolds containing known flavonoid biosynthesis genes from C. roseus 
Scaffold name and size in bp as well as all contained transcripts and transcript annotation. Transcripts 
corresponding to the genes CS, F3’5’H, C4H, THCGT and CrOMT are in bold. 
Gene Scaffold  
Scaffold 
size (bp) 
Transcripts Transcript annotation 
CS 2987430 18,619 CRO_014716 hypothetical protein 
      CRO_014717 Chalcone and stilbene synthase family 
F3'5'H 2965398 18,111 CRO_022260 Cytochrome P450 superfamily protein 
C4H 2986973 98,188 CRO_000895 hypothetical protein 
      CRO_000894 cinnamate-4-hydroxylase 
THCGT 3066087 75,392 CRO_029295 conserved hypothetical protein 
      CRO_029296 Got1/Sft2-like vescicle transport protein  
      CRO_029297 UDP-Glycosyltransferase superfamily  
CrOMT 3053220 69,879 CRO_022616 hypothetical protein 
      CRO_022617 O-methyltransferase family protein 
 
These results are not surprising; despite for example anthocyanin biosynthesis being 
transcriptionally very tightly clustered 76 there are no reports of gene clustering in flavonoid 
biosynthesis. In  A. thaliana it has been demonstrated that the genes are scattered across the 
whole genome 211, as has also been established for carotenoid biosynthesis and the 
biosynthesis of glucosinolates.  
4.3 Conclusion 
C. roseus produces a great variety of structurally complex secondary metabolites, some of 
which with high medicinal value, but not all steps of the biosynthesis have been elucidated. 
Investigating the biosynthetic pathway of a taxonomically restricted class of specialised 
metabolites such as the ones produced by C. roseus is challenging. Simple homology models to 
available genomic data is of limited applicability because genes of specialised metabolism may 
evolve more quickly than those of primary metabolism and may not exist in a common 
reference organism such as A. thaliana 212. 
The aim of the work presented in this chapter was to obtain the genome of a medicinal plant 
that produces a wide range of structurally diverse alkaloids. This would represent one of the 
first genomes of an alkaloid-producing plant. Of specific interest was to investigate if a draft 
genome sequence would be sufficient to detect any potential gene clustering in the C. roseus 
monoterpene alkaloid biosynthesis. In turn, the genome could serve as a source for future 
research by identifying candidates for still missing steps of the MIA pathway. 
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Whole genome sequencing of C. roseus genomic DNA on an Illumina HiSeq at The Genome 
Analysis Centre (Norwich, UK) and assembly using Abyss 178 yielded a draft genome for 
C. roseus. The sequencing output was 374,771,760,101 nucleotide paired-end reads to 
generate a 523 Mb assembly consisting of 79,302 scaffolds (> 200bp). This represents 71% of 
the previously determined genome size and is not unexpected, as the median value of 
coverage of predicted genome size, for all plant genomes published until 2013, has been 
reported to be 85%. This value is realistic due to areas in the genome that generally do not 
assemble such as repetitive structures, transposable elements but also functional elements of 
the genome such as telomeres and centromeres 162. The corresponding scaffold N50 of the C. 
roseus genome assembly is 26.2 kb, with the size of the scaffolds containing the C. roseus 
alkaloid pathway genes ranging from 10 to 76 kb. This value is again comparable to the median 
N50 of all plant genomes published till 2013, sequenced with comparable Illumina techniques, 
that was reported as 25.9 kb 162. The genome displayed excellent coverage, with 95.7% of all C. 
roseus ESTs mapping to the genome and 97.6% of the Core Eukaryotic Genes Mapping 
Approach (CEGMA) proteins mapping to the genome. All characterised MIA genes could be 
located in the genome as full length genes, with the exception of SGD and T3O, which had to 
be manually assembled. 
In summary the draft genome provides a comprehensive representation of the genic regions of 
C. roseus making it a valuable resource. In the course of publishing our results 68 the v1.0 
annotated draft genome was made available as a searchable database 
(http://medicinalplantgenomics.msu.edu/). 
In parallel with genome sequencing efforts, a BAC library was created and screened for three 
major branch points in the monoterpene indole alkaloid pathway to increase the chances of 
identifying possible gene clustering in this pathway. The BAC assemblies gave additional 
information on genomic context of known pathway genes. In total six BACs were sequenced 
and assembled and the results presented in this thesis. Two BACs are published and the 
corresponding datasets can be found under NCBI WGS accession number ERP006960 and 
PRJEB7256. 
 
A total of 25 alkaloid pathway genes were mined for their respective genomic context using 
the available draft genome and selected BAC assemblies. Following a minimum definition that 
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a gene cluster consists of two or more non-homologous genes that encode enzymes from the 
same pathway 105 our efforts have confirmed gene clustering in alkaloid biosynthesis in C. 
roseus in three cases (Figure 60). 
 
 
Figure 60 Detected gene clusters in monoterpene indole alkaloid biosynthesis in C. roseus 
First gene cluster (blue): TDC, tryptophan decarboxylase; STR, strictosidine synthase and MATE transport 
protein (not in figure). Second gene cluster (green): T16H, tabersonine 16-hydroxylase (both T16H1 and 
T16H2) and 16OMT, 16-hydroxytabersonine O-methyltransferase. Third gene cluster (red) SLS, 
secologanin synthase, THAS, tetrahydroalstonine synthase. SGD, strictosidine -glucosidase (not part of 
a detected gene cluster.) 
Three clusters were observed: 
1. The clustering of the pyridoxal dependent aromatic acid decarboxylase TDC that generates 
tryptamine from tryptophan and the ‘Pictet-Spenglerase’ STR that condenses the resulting 
133 
 
 
tryptamine with the iridoid secologanin to form strictosidine. The metabolic gene cluster is 
appears to be extended by a third gene. Silencing experiments performed by Dr. Richard Payne 
(manuscript submitted) strongly suggests the involvement of this MATE, a tightly co-expressed 
transport protein located in close physical proximity to STR and TDC, in transport of 
secologanin into the vacuole where STR is localised. 
2. The two paralogs of 16-tabersonine hydroxylase T16H1 and T16H, responsible for the 
hydroxylation of tabersonine at the 16 position 42, are located next to the 16-
hydroxytabersonine-16-O-methyltransferase 16OMT that installs a methyl group at the same 
position. 
3. Four paralogues for the pathway gene SLS could be identified in the genome assembly. One 
of the SLS paralogues is co-localised with a gene that has been identified by Anna Stavrinides 
as tetrahydroalstonine synthase, the first gene to be reported to accept strictosidine aglycone 
and therefore the first to be implicated at this critical branch point of alkaloid diversity37. 
Considering that the size of most pathway gene containing scaffolds of the current first and 
only available C. roseus draft whole genome assembly was below 50000 bp, while reported 
gene cluster for secondary metabolites range from 35 to several hundred kb 174 the amount of 
clustering detected is encouraging. The analysis of the genome focused on identifying 
candidate genes for unknown steps in this alkaloid pathway. A total of 25 alkaloid pathway 
genes were mined for their respective genomic context using the available draft genome and 
selected BAC assemblies. Collectively, this search resulted in 90 transcripts that can be 
physically linked to the known alkaloid pathway genes. Of those, 31 transcripts are annotated 
as gene of unknown function and likely play no catalytic role in this biosynthetic pathway. 
Resulting from this list a candidate linked to root specific alkaloid biosynthesis did not show 
activity when heterologously expressed in yeast and fed with tabersonine and 19-
hydroxytabersonine. A number of potentially promising biosynthetic gene candidates were 
targeted for further analysis by VIGS. The results of those experiments are provided in 
Chapter 5. 
The monoterpene indole alkaloid pathway of C. roseus shows the presence of small clusters of 
genes comprising alkaloid and/or iridoid biosynthetic genes. It further displays several cases of 
pathways gene that are located in close distance of functional related genes, like MAT and DAT 
that are co-localised with other acetyltransferase genes or the five as UGT-glycosyltransferase 
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annotated contigs on the 7DLGT genomic scaffold. For other pathway genes paralogs have 
been observed, some of which have identical in vitro function, as it has been reported for SLS 
213, ISY 181 or T16H 42. Duplication of a gene, were one gene retains the original function, while 
the other one undergoes mutations, can lead to novel functions. This neo-functionalisation 
provides a metabolic plasticity that might in turn provide positive selection pressure enabling 
facile metabolic evolution 214,215. Evolution of whole biosynthetic pathways depends strongly 
on the evolution of individual gene function. Noteworthy changes in gene regulation, as 
observed for the duplicated T16H1 T16H2 gene pair 42, and subsequently altered compound 
availability and spatial distribution can be linked to functional shifts 216. Gene duplication and 
neo functionalisation has also been implicated in the recruitment of enzymes into secondary 
metabolic pathways. For example the C. roseus vindoline biosynthesis gene NMT, is suggested 
to have evolved from ƴ-tocopherol C methyltransferases rather than other known N-methyl 
transferases, as phylogenetic analyses places C. roseus NMT clearly into a distinct clade with 
previously characterised ƴ-tocopherol C methyltransferases for example from Arabidopsis 
thaliana 43.  
Early research into a connection between co-expression of certain genes and their location in 
eukaryotic genomes gave statistical evidence that the frequency in which neighbouring are co-
expressed is too high to be by chance 217. In terpenoid biosynthesis, terpene synthases are 
responsible for the generation of scaffold diversity while P450s modify these scaffolds further, 
helping to create the largest class of plant-derived natural products. Available genomic and 
transcriptomic data for plants with specialised metabolism is still limited in comparison with 
for example A. thaliana. Here global analysis of 1469 publicly available expression profile 
datasets for Arabidopsis thaliana resulted in the prediction of around 100 gene clusters 78. 
The availability of further genomes of additional monoterpene indole alkaloid producing plant 
species will uncover the extent to which they are conserved or if there is evidence for 
converged evolution of these gene clusters helping to evaluated and better understand the 
biological role of these clusters in plant. 
Screening of BAC libraries 218 requires specialised equipment, such as a colony picking robot. 
Furthermore, BAC vectors are challenging to handle, and along with the size of the insert, 
additional care must be taken while handling the plasmid as BACs are known for their 
instability 219. Given the outstanding improvements that have been made with whole genome 
sequencing of plants, BAC screening is likely to become obsolete. 
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Research into C. roseus is driven by the strong interest in its secondary metabolism. However, 
the interest in C. roseus extends beyond alkaloid biosynthesis into many other fields. For 
example, C. roseus is being studied as a host for phytoplasma, insect transmitted bacterial 
pathogens that are able to live intracellularly in plants as well as insect hosts 220. Furthermore, 
research has focused on C. roseus for the investigation of signalling and transcriptional 
regulation especially of secondary metabolism 221–223 and a recent publication has specifically 
used the newly available genome data for the investigation of regulation of seco-iridoid 
biosynthesis in C. roseus 224.  
At the start of this work, no genome sequence was available for C. roseus or any plant of the 
Apocynaceae family, and this resource will undoubtedly enable progress in dissecting alkaloid 
biosynthesis as well as permit further research in related fields. 
Physical clustering of biosynthetic genes provides a powerful strategy to rapidly identify plant 
secondary metabolite pathways. Yet it is still unknown to what extent clustering occurs across 
the plant kingdom, and whether it is widespread or is limited to specific groups of metabolites. 
The phenomena of clusters of two or more paralogs is common in plants, while the occurrence 
of non-homologous clustering is a rather new observation. The clustering of genes in fungi and 
bacteria metabolic pathways greatly enables their discovery and characterisation 225. It has to 
be expected that a more detailed knowledge as to if and how certain plant secondary 
metabolic pathways are clustered would similarly enhance their detection and 
characterisation. 
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5 Gene function screening by targeted gene silencing 
 
5.1 Introduction 
Virus Induced Gene Silencing (VIGS) is a transient posttranscriptional gene silencing technique 
used throughout this thesis. It utilises RNA interference (RNAi), the sequence specific inhibition 
of protein expression and provides an alternative functional genomics tool in non-model 
organisms such as C. roseus for which no reliable protocols for the generation of knockout 
mutants exists. 
 
Monoterpene indole alkaloid biosynthesis in C. roseus requires the formation of secologanin 
via the monoterpene pathway and formation of tryptamine via the indole pathway. Both 
compounds together form strictosidine, the central intermediate from which all monoterpene 
indole alkaloids are derived. From strictosidine, after deglycosylation and a series of unknown 
enzymatic steps, three distinct alkaloid classes are derived. Tabersonine, catharanthine and 
ajmalicine each represent a different alkaloid class. Tabersonine is further converted to 
vindoline or 19-O-acetyl horhammercine (Figure 61). Vindoline and catharanthine can be 
dimerised to yield the anti-cancer agent vinblastine. At the beginning of this work five out of 
nine monoterpene genes leading to secologanin were unknown, no gene responsible for the 
formation of the three different alkaloids classes after strictosidine deglycosylation was known 
and two steps in vindoline as well as a step in 19-O-acetyl horhammercine biosynthesis were 
missing (Figure 61). 
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Figure 61 Known genes C. roseus alkaloid biosynthesis at the start of this thesis 
Steps involved in the synthesis of alkaloids in C. roseus known at the start of this thesis. Black arrows 
represent single enzymatic steps. Dashed arrows represent an unknown number of enzymatic steps. 
Question marks represent unknown enzymatic steps. In bold are the genes of which the physiological 
function had been tested using the VIGS system. Black (top row) arrows represent at the time known 
iridoid biosynthesis genes: G8H, geraniol 8-hydroxylase; ISY, iridoid synthase; LAMT, loganic acid 
methyltransferase and SLS, secologanin synthase. Grey arrows represent then known downstream 
alkaloid biosynthesis genes: TDC, tryptophan decarboxylase; STR, strictosidine synthase; SGD, 
strictosidine -glucosidase; T19H, tabersonine/lochnericine 19-hydroxylase (CYP71BJ1) and MAT, 
minovincinine 19-hydroxy-O-acetyltransferase. Black arrows (middle row) represent then known 
vindoline biosynthesis pathway: T16H, tabersonine 16-hydroxylase 1 (CYP71D12); 16OMT, 16-
hydroxytabersonine O-methyltransferase; NMT, 16-methoxy-2,3-dihydro-3-hydroxytabersonine N-
methyltransferase; D4H, desacetoxyvindoline-4-hydroxylase and DAT, deacetylvindoline 4-O-
acetyltransferase. 
Additionally, only DAT, D4H, NMT 121 and ISY 30 had been subjected to gene silencing to confirm 
their physiological function in planta (Figure 61). All other known C. roseus alkaloid 
biosynthesis genes had been discovered before the VIGS system was established, or were 
expressed predominantly in tissues that were not accessible for silencing with the current VIGS 
protocol, like the root specific T19H 79.  
5.1.1 Aim  
This thesis focuses on exploring C. roseus alkaloid metabolism with an emphasis on gene 
discovery. The mining of existing transcriptomic data 65 and newly established genomic data 68 
were utilised to ultimately identify candidates for missing steps in alkaloid biosynthesis in C. 
roseus, with a particular emphasis on finding the missing enzymes in vindoline biosynthesis, by 
testing identified candidates employing VIGS for targeted gene silencing. 
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As presented in Chapter 2 VIGS is suitable for the in planta functional characterisation of 
alkaloid biosynthesis genes. The work presented in Chapter 3 highlights how VIGS can 
additionally be utilised to test candidates for the discovery of new genes by screening for a 
specific change in metabolite content of silenced tissue. 
The aim of this last chapter is to present how VIGS can be used to screen a large set of 
candidates for which a general involvement in the pathway is suspected without prior 
knowledge as to where in the pathway the candidate would be potentially involved. This 
includes unknown steps in the seco-iridoid pathway as well as further downstream where an 
unknown amount of unidentified enzymatic steps is responsible for the formation of three 
different alkaloid scaffolds from the precursor deglycosylated strictosidine (Figure 6) 
A VIGS experimental pipeline was set up and optimised. Once this was established, the 
pipeline was maintained by continuously testing new gene candidates and over the course of 
this thesis 28 different genes were silenced. The VIGS pipeline was employed to screen of 
candidate genes for their potential involvement in alkaloid biosynthesis in C. roseus by 
investigating if their targeted expression reduction would lead to significant changes in alkaloid 
content and composition. At the start of this thesis much progress had been made in the 
discovery of the missing monoterpene biosynthesis steps (personal communication Dr. 
Nathanial Sherden, Dr. Fernando Geu-Flores, Dr. Wesley Glenn, O’Connor lab) therefore 
discovery of genes responsible for this upstream part of the pathway was of lowest priority. 
In this chapter, the optimisation of the VIGS pipeline is described, and the candidates selected 
for screening are provided. The motivation that was used to select the particular candidate is 
presented. The results of some of the more important gene candidates are discussed in more 
detail. The findings are discussed in the greater context of gene function screening by targeted 
gene silencing in plant secondary metabolism.  
5.2 Results and Discussion 
For every VIGS candidate, data from five to eight plants was collected. Each VIGS experiment 
contained the same number of plants treated with an empty vector control. Plants were eight 
weeks old at the time of infection. At 21 days after infection the last two leaves to emerge 
above the pinch site were harvested from the C. roseus plants and milled under liquid 
nitrogen. Each tissue sample was split in two aliquots. From one, metabolites were extracted 
and analysed by LC-MS to assess potential changes in metabolite profile by comparing plants 
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silenced for a candidate gene to the empty vector control. The remaining tissue was used for 
RNA extraction for q RT PCR. Primers used for cloning can be found under Chapter 6, Table 37. 
Sequences of the candidate genes used for VIGS can be found under Appendix 9.4. The VIGS 
candidates, reason for selection of candidates and results are summarised in the following 
table (Table 28).  
Table 28 VIGS candidates 
Candidates for VIGS experiments with contig number, annotation and reason for silencing/ origin of 
contig. A: Functional in planta validation of known pathway genes. B: Co-localisation with known 
alkaloid pathway genes on the C. roseus draft genome. C: Co-localisation and co-expression with known 
alkaloid pathway gene SGD on the C. roseus genome D: Co-expression analysis in scope of search for 
T3O (Chapter 3). E: Co-expression analysis, Subset_A: P450 candidates for missing step in vindoline 
biosynthesis (Chapter 3). F: Co-expression analysis Subset_A: Reductase candidates for missing step in 
vindoline biosynthesis (Chapter 3). 
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C36 CRO_032842 secologanin synthase/ cytochrome P-450 protein 3 yes (Chapter 5.3.1.)
C38 CRO_006099 strictosidine synthase 3 yes (Chapter 5.3.1.)
C39 CRO_006098 tryptophan decarboxylase 3 yes (Chapter 5.3.1.)
C16 CRO_017449 cytochrome P450, family 71, subfamily B (B) 2 no (Chapter 5.3.2.)
C18 CRO_011779 cytochrome P450, family 71, subfamily B 2 yes (Chapter 5.3.3.)
C2 CRO_027093 cytochrome P450, family 71, subfamily B, polyp. 1 no
C6 CRO_027095 NAD(P)-binding Rossmann-fold superfamily 1 no
C7 CRO_027094 Haloacid dehalogenase-like hydrolase (HAD) 1 no
C8 CRO_003636 cytochrome P450, family 97, subfamily B, polyp. 1 no
C9 CRO_021613 cytochrome P450, family 97, subfamily B, polyp. 1 no
C45 CRO_019099 alpha/beta-Hydrolases superfamily protein (C) & (D) 3 yes (Chapter 5.3.4.)
C43 CRO_016518 HXXXD-type acyl-transferase family protein 2 no
C46 CRO_016488 Chalcone-flavanone isomerase family protein 3 no
C3 CRO_026945 cyclase family protein 1 no
C4 CRO_026235 cinnamyl alcohol dehydrogenase 1 no
C10 CRO_010055 cytochrome P450, family 721, subfamily A, polyp. 1 no
C12 CRO_019049 cytochrome P450, family 78, subfamily A, polyp. 1 no
C30
partial: CRO_002621, 
CRO_015047, 
CRO_023156, 
CRO_031187 
cytochrome P450, family 71, subfamily B, polyp. 1 no
C44
CRO_013485 & 
CRO_023307
cytochrome P450, family 76, subfamily C, polyp. 1 no
C47 CRO_003361 cytochrome P450, family 76, subfamily C, polyp. 2 no
C48 CRO_027850 cytochrome P450, family 71, subfamily B, polyp. 1 no
C41 CRO_016423 methylenetetrahydrofolate reductase 1 no
C14 CRO_021541 (T3R) elicitor-activated gene 3-2 1 no
C53 CRO T030221 12-oxophytodienoate reductase 1 no
C32 CRO T002544 NAD(P)-linked oxidoreductase superfamily 1 no
C15 CRO_012109 NAD(P)-linked oxidoreductase superfamily 2 no
C13 CRO_008301 elicitor-activated gene 3-2 1 no
C5 CRO_001335 NAD(P)-binding Rossmann-fold superfamily 1 no
(A)
(E) 
(F)
 (D)
(C)
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5.2.1 VIGS for gene function validation in planta 
Three VIGS candidates were chosen to establish an efficient VIGS pipeline. These are known 
alkaloid biosynthesis genes acting at the central section of alkaloid biosynthesis in C. roseus. 
Tryptophan decarboxylase (TDC) 36 catalyses the conversion of tryptophan to tryptamine, 
loganin is cleaved by secologanin synthase (SLS) 35 to yield the iridoid terpene secologanin, 
after which strictosidine synthase (STR) 189 condenses secologanin and tryptamine to form the 
central metabolic intermediate, strictosidine 18 (Figure 62). None of these genes had ever been 
silenced in planta previously. 
 
Figure 62 Products and substrates of central enzymes in C. roseus alkaloid biosynthesis 
Secologanin is a glycosylated iridoid terpene derived from geraniol by a nine-step biosynthetic pathway. 
The final enzyme in this seco-iridoid pathway is the cytochrome P450 SLS (secologanin synthase). 
Tryptamine is synthesised from the decarboxylation of tryptophan by the enzyme TDC (tryptophan 
decarboxylase). Secologanin and tryptamine are condensed by STR (strictosidine synthase) to form 
strictosidine. After deglycosylation of strictosidine and rearrangement to 4,21-dehydrogeissoschizine. C. 
roseus can produce bisindole alkaloids such as vinblastine and vincristine, as a result of the 
condensation of catharanthine, an iboga alkaloid, and vindoline, an aspidosperma alkaloid. 
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For all three genes a section of the respective gene was cloned into pTRV2, the plasmid was 
used to transform A. tumefaciens strain GV3101 and eight week old plants were pinched in 
three subsequent experiments. It had been established in the course of this thesis that four 
almost identical paralogs for SLS exist that share between 94 and 98% sequence identity on 
nucleotide level and are all expressed in C. roseus leaves. This high similarity ensures that any 
VIGS construct ultimately targets the expression of all four SLS paralogs simultaneously. 
Successful silencing was confirmed by qRT PCR for all three genes. Expression was normalised 
to the expression of a known C. roseus housekeeping gene30,121, the 40S ribosomal protein 9 
(Rps9). A 43%, 72% and 66% decreased expression for TDC, SLS and STR respectively could be 
observed (Figure 63). 
 
Figure 63 Silencing of TDC, SLS and STR 
Relative expression of TCD, SLS and STR in silenced tissues compared to EV tissue (n=6). Expression was 
normalised to expression of CrRPS9. Data presented is the mean + SEM. Efficiency for qRT PCR primer is 
110% (STR), 106.8% (SLS) and 104.3% (TDC). 
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VIGS reduces the transcription but the effect is a “knock-down” and not a “knock-out” effect. 
The results are within the expected range of in literature reported values for silencing of C. 
roseus genes that varies from 45% 30 to 80% reduction 32. Interestingly the downregulation of 
all paralogs of SLS was successful. The primer pair for the qRT PCR experiments was designed 
to ensure the transcriptional abundance of all four paralogs would be detected equally. 
For the known metabolites secologanin, strictosidine, catharanthine, tabersonine, vindoline 
and vindorosine (Figure 16) the peak area was manually extracted from the LC-MS data, 
normalised and the mean was compared to the mean of the empty vector control tissue. Three 
subsequent silencing experiments were conducted. Over this period the protocol was 
optimised in a way that would ensure identical treatment for all samples by randomisation at 
all crucial steps and minimal time delay in sample preparation to ensure maximum 
homogeneity of the results. Only data that has a p-value of <0.05 is considered. All 
experiments included eight plants per treatment. 
 
5.2.1.1 TDC silencing results 
Although silencing of TDC results in the smallest decrease in expression, it results in one of the 
strongest phenotypes when comparing the results of the three genes. Of the investigated six 
metabolites secologanin, strictosidine, catharanthine, tabersonine, vindoline and vindorosine 
three to four are significantly changed in silenced tissue of three separate VIGS experiments 
(Figure 64). 
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Figure 64 TDC silencing effect on leaf metabolite content in three TDC VIGS experiments 
Relative metabolite content of silenced plants as mean peak area calculated from extracted ion 
chromatograms of corresponding compounds, normalised by fresh sample weight and internal standard, 
relative to that determined in EV control tissues (normalised to 1). Compounds significantly changed in 
TDC silenced plants in comparison to EV control plants (n=8). Error bars represent + SEM. P-value was 
calculated using Student’s t test (*p<0.05, **p<0.01, ***p<0.005). A: First experiment. B: Second 
experiment. C: Third experiment. 
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The substrate for the enzyme TDC is the amino acid tryptophan. While no accumulation of 
tryptophan was observed, this is expected for a substrate that can be metabolised in so many 
different ways in plants. Additionally, neither tryptophan nor tryptamine, the TDC substrate 
and enzymatic product, are detectable with the standard LC-MS method used. The formation 
of strictosidine, from which all downstream alkaloids originate requires the condensation of 
tryptamine and secologanin. In two experiments strictosidine is significantly decreased and 
secologanin significantly increased. This indicated that the reduced availability of tryptamine, 
the TDC enzymatic product, limits the formation of strictosidine. In turn this leads to the 
decreased accumulation of downstream alkaloids such as catharanthine, tabersonine, 
vindoline and vindorosine. In contrast, secologanin accumulates since not enough tryptamine 
is available. 
 
5.2.1.2 SLS silencing results 
Strong effects of silencing could also be observed for silencing SLS. Levels of secologanin, 
strictosidine, catharanthine, tabersonine, vindoline and vindorosine were variable among the 
three VIGS experiments. However, the appearance of loganin, the substrate for SLS that is 
normally below the detection limit, was found to be significantly increased in all SLS silenced 
tissues, which provides the strongest evidence of silencing success (Figure 65). 
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Figure 65 SLS silencing effect on leaf metabolites in three subsequent VIGS experiments 
Relative metabolite content of silenced plants as mean peak area calculated from extracted ion 
chromatograms of corresponding compounds, normalised by fresh sample weight and internal standard, 
relative to that determined in EV control tissues (normalised to 1). Compounds in SLS silenced plants in 
comparison to empty vector control plants (n=8). The new loganin peak corresponds to the mass of m/z 
413 (Na+ adduct). Error bars represent + SEM. P-value was calculated using Student’s t test (*p<0.05, 
**p<0.01). A: First experiment. Although the decrease in secologanin is not significant here it was later 
found significant using a second LC-MS measurement on a different instrument (Xevo, Waters) applying 
a loganin and secologanin specific MRM method. B: Second experiment. C: Third experiment. 
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Secologanin synthase is a cytochrome P450 enzyme 35 that catalyses the last step in the seco-
iridoid biosynthesis pathway, the oxidative ring cleavage converting loganin into secologanin 
(Figure 66). 
 
Figure 66 Secologanin synthase catalysed reaction in C. roseus alkaloid biosynthesis 
To confirm the results for loganin accumulation and secologanin decrease the Waters Xevo TQ-
S mass spectrometer (Milford, MA, USA) equipped with an electrospray (ESI) source was used 
and analysis was carried out by monitoring specific mass transitions for loganin and 
secologanin. For this purpose a method was developed using commercial standards. Flow 
injection of individual compounds was used to optimize the multiple reaction monitoring 
(MRM) automatically using the Waters Intellistart software. As expected SLS silenced tissue 
displays a strong accumulation of loganin and a reduction of secologanin (Figure 67). 
 
Figure 67 Loganin and secologanin in SLS VIGS tissues 
Relative loganin and secologanin content as determined by monitoring specific mass transitions for 
loganin and secologanin/ MRM method. Displayed is relative metabolite content as mean peak area in 
SLS silenced plants in comparison to EV control plants (n=8). The tissues correspond to the tissues of the 
first VIGS experiment. Error bars represent + SEM. P-value was calculated using Student’s t test 
(**p<0.01). 
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VIGS results for SLS have been subsequently published by another group after our initial 
experiments. Here comparable results to the ones obtained in the course of thesis are 
reported, including the appearance of loganin and the significant reduction of secologanin, 
catharanthine and vindoline 32. 
5.2.1.3 STR silencing results 
The effect of silencing STR results in a much weaker metabolic change compared to the effects 
observed for SLS and TDC silencing. Again the results were variable among the experiments 
(Figure 68). The enzyme STR catalyses the Pictet-Spengler condensation of secologanin and 
tryptamine to form strictosidine, the central metabolic intermediate and key branch point in 
the alkaloid pathway of C. roseus (Figure 69). It is not clear why reduction of the expression of 
the STR gene only leads to a minimally changed metabolite phenotype but it highlights the 
challenges of interpreting VIGS data during functional screening. 
 
Figure 68 Significant changes in STR silenced leaf tissue 
Relative metabolite content of silenced plants as mean peak area calculated from extracted ion 
chromatograms of corresponding compounds, normalised by fresh sample weight and internal standard, 
relative to that determined in EV control tissues (normalised to 1). Content displayed for vindorosine in 
the second VIGS experiment and secologanin in the third experiment of STR silencing in comparison to 
EV control plants (n=8, n=5). Error bars represent + SEM. P-value was calculated using Student’s t test 
(*p<0.05, **p<0.01, ***p<0.005). A: Second VIGS experiment. B: Third VIGS experiment. No statistically 
significant changes were noted in the first VIGS experiment. 
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Figure 69 Strictosidine catalysed reaction in monoterpene alkaloid biosynthesis 
 
5.2.1.4 Summary of metabolic profiles with TDC, STR and SLS silenced tissue 
The three known pathway genes TDC36, STR189 and SLS35 were silenced to validate their 
physiological role in C. roseus leaf tissue and to establish a robust VIGS system for further 
applications. Reduction of expression of silencing target genes could be confirmed with qRT 
PCR. The TDC, STR and SLS silenced plants show a 43%, 72% and 66% decreased expression of 
the respective target gene. The successful gene silencing of the target genes TDC, STR and SLS 
had the expected significant effects on alkaloid metabolism in the silenced tissues compared 
to empty vector treated tissues, though the results showed variability. 
The successful downregulation of TDC gene expression expectedly caused the decrease of 
downstream alkaloids (Figure 64). The three SLS VIGS experiments show a weaker overall 
response to the silencing. Only the vindoline content shows reduced levels consistently (Figure 
68). The interpretation of the VIGS phenotype in the TDC and SLS silencing experiments is 
strengthened by the observation of accumulation of the expected substrates. In the TDC VIGS 
experiments secologanin is significantly increased, likely due to the reduced availability of 
tryptamine to react with secologanin to form strictosidine. In SLS silenced tissues, loganin, the 
substrate for SLS, accumulates to substantial levels compared to empty vector controls. In 
combination with the decrease of downstream alkaloids the evidence strongly supports the 
physiological relevance of SLS and TDC in alkaloid metabolism in leaves of C. roseus. The 
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minimal VIGS phenotype of the STR silencing clearly shows some of the major limitations of 
the VIGS system. 
In conclusion it was established that the number of plants and method used for silencing was 
sufficient for the observation of statistical significant changes. Previous VIGS studies in C. 
roseus had used the plant variety “Little Bright Eyes” 30,121. The new variety “SunStorm Apricot” 
used in all experiments conducted in the scope of this thesis proved more homogeneous in 
growth and alkaloid content. 
 
5.2.2 VIGS experiment following gene clustering analysis 
The obtained C. roseus genome assembly was used for a detailed analysis of the genomic 
context of the 25 known alkaloid biosynthesis genes. Gene clustering was observed in the C. 
roseus draft genome and the resulting candidate genes have been published 68. The most 
relevant candidates were investigated separately. A contig annotated as sinapyl alcohol 
dehydrogenase, located on one the SLS genomic scaffolds, has been characterised as the 
corynanthe biosynthetic gene THAS 37. The MATE transport protein encoding gene located on 
the TDC/ STR genomic contig has been successfully silenced and the results suggest that this 
acts as a secologanin transporter (Dr. Richard Payne, submitted). 
For the 25 investigated alkaloid pathway genes 90 transcripts could be identified as co-located, 
meaning that they can be linked to the known alkaloid pathway genes by their physical 
proximity on the C. roseus draft genome. All 90 contigs were investigated manually. In a first 
step, a BLASTn search was conducted against the NCBI database to confirm the annotation. 
Furthermore it was investigated if the contig represents a full open reading frame or if the 
contig is likely a partial/ pseudogene. The confirmed annotation and the expression profile for 
each contig served as the basis for which contig would be relevant for testing with VIGS. 
5.2.2.1 Contigs with cytochrome P450 annotation 
Specific attention was paid to contigs annotated as members of the cytochrome P450 gene 
family because eight of the known monoterpene indole alkaloid biosynthesis enzymes in C. 
roseus are cytochrome P450 enzymes (Figure 70) including the T3O gene reported in this thesis 
(Chapter 3) and the functionally identical (Chapter 2) and physically clustered (Chapter 5) 
T16H1 and T16H2. 
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Figure 70 Cytochrome P450 known in MIA biosynthesis in C. roseus 
P450s of the monoterpene indole alkaloid pathway in C. roseus. Dashed arrows indicate unknown 
numbers of enzymatic steps. Black top row arrows represent iridoid biosynthesis genes: G8H, geraniol 8-
hydroxylase; IO, iridoid oxidase and SLS, secologanin synthase. Grey arrows represent downstream 
alkaloid biosynthesis genes: T19H, tabersonine/lochnericine 19-hydroxylase Black arrow middle row 
represent vindoline biosynthesis pathway: T16H1, tabersonine 16-hydroxylase 1; T16H2, tabersonine 
16-hydroxylase 2 and T3O 16-methoxytabersone 3-oxygenase. 
 
It is believed that indeed P450 enzymes and their huge diversification is one the major driving 
forces in phytochemical diversity with members of this large super family of monooxygenase 
are present in most domains of life such as plants, animals, fungi, bacteria and even viruses 226. 
P450s typically catalyse a variety of hydroxylation reactions but there is ample evidence for 
unusual P450 reactions such as oxidative rearrangement of carbon skeletons or C-C bond 
cleavage, specifically in plant secondary metabolism 227. The details of the mechanism 
underlying these complex reactions are often not very well understood. Additionally P450s are 
often implicated in plant chemical defence 228. 
 
Six of the 90 co-located contigs are annotated as cytochrome P450 (CRO_021081, 
CRO_006603, CRO_011779, CRO_025931, CRO_017449 and CRO_004355). 
CRO_021081 is located next to T19H, a gene involved in the root specific alkaloid 
biosynthesis79. CRO_021081 or candidate C72, has been investigated in this work using a yeast 
expression system as the candidate is not expressed in leaf tissue and was, according to its 
genomic location next to a root specific alkaloid pathway gene, implicated in root specific 
alkaloid production (Chapter 4).  
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CRO_006603, found on the STR_BAC, has been eliminated from VIGS experiments because of 
its very low gene expression. CRO_011779 was identified on the SGD_BAC and the results for 
this candidate (C18) are presented in the context the SGD_BAC and SGD MATE-pair assembly 
below (Chapter 5.3.3). 
Three P450s, CRO_025931, CRO_004355 and CRO_017449, were found in the context of the 
T16H2_BAC assembly. All three contigs are annotated as members of the cytochrome P450 
CYP71 family, the same family as the know alkaloid pathway genes T16H1 and T16H2 42. 
CRO_025931 is a partial (only 612 bp) duplication of T16H2, sharing 93.3% identity. It 
represents most likely a pseudogene with no full open reading frame. CRO_004355 is 
expressed at extremely low levels in the C. roseus tissues leaf, stem, flower, seedling or root, 
making it a very unlikely candidate for alkaloid biosynthesis. CRO_017449 is only 441 bp long 
and again does not represent a full gene. The 441 bp of this transcript can be found in three 
other transcripts (Table 29) suggesting either an assembly fragment or a pseudogene. 
 
Table 29 Nucleotide similarity in % between CRO_017449 and related transcripts 
 CRO_T017449 
CRO T014272 100% 
CRO T014273 98.60% 
CRO T017449 100% 
CRO T022496 100% 
 
Despite the fact that CRO_017449 (named C16), and all transcripts relating to C16 (Table 29), 
have relatively low expression values in the alkaloid producing relevant tissues such as flower, 
leaf, seedling, stem and root (Figure 71), a 208 bp long section was cloned into the VIGS vector 
and 8 plants infiltrated with A. tumefaciens harbouring the resulting C16 construct. 
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Figure 71 Expression (log₂FPKM) of CRO_017449/ C16 and related transcripts 
Expression values (FPKM) for eight tissues and/or treatments for the contig CRO_017449 and its related 
contigs in comparison to the known pathway genes 16OMT to which CRO_017449 is co-located in the C. 
roseus draft genome. Gene expression is displayed for the tissues: A (flower), B, C and D (sterile 
seedlings treated with MeJA 0, 6 and 12 h), E (mature leaf), F (young leaf), G (stem) and H (root). 
 
The LC-MS measurements of candidate C16 silenced tissues in comparison to the empty vector 
did not show any new peaks or significant changes of known metabolite peaks (Table 28). The 
VIGS experiment was not repeated and unless additional evidence is uncovered, this gene is 
assumed not to play a role in MIA biosynthesis. 
5.2.2.2 Expression values of co-localised contigs 
Of the 90 contigs identified to be located in close proximity on the draft C. roseus genome to 
known alkaloid pathway genes, we considered only contigs that can be assessed using VIGS, 
and therefore excluded all transcripts that display an expression in young leaves of less than 1 
(log₂FPKM), reducing the number from 90 to only 32 (Error! Not a valid bookmark self-
reference.). The remaining 32 contigs include for example the ISY paralog for which VIGS had 
been reported 181. So far only a single contig (CRO_011779/ C16/ Chapter 5.3.2.1) has been 
tested in the VIGS pipeline as reported above, as the annotation of the other candidates do 
not suggest an involvement in alkaloid biosynthesis. 
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Table 30 Annotation and expression values for 32 contigs 
Functional annotation of 32 contigs that are located in physical proximity to known alkaloid pathway 
genes with an expression value of >1 log₂FPKM in young leaves. Highlighted in yellow is VIGS candidate 
C18. 
    mature leaf young leaf 
CRO_026512 oligopeptide transporter 0.000 1.295 
CRO_029921 Syntaxin/t-SNARE family protein 0.249 1.395 
CRO_025030 expansin A1 0.875 3.544 
CRO_009298 hypothetical protein 1.140 1.864 
CRO_006609 Polynucleotidyl transferase, ribonuclease H  1.769 2.635 
CRO_011779 cytochrome P450, family 71, subfamily B 1.771 2.263 
CRO_025462 iridoid synthase paralog 2.205 3.189 
CRO_006605 Galactosyltransferase family protein 2.321 2.665 
CRO_005951 glyoxalase II  2.380 3.422 
CRO_015508 LOB domain-containing protein 2.519 1.998 
CRO_015513 Glycosyl hydrolase family 35 protein 2.629 4.781 
CRO_029918 TBP-associated factor 2.748 2.833 
CRO_015512 Family of unknown function (DUF566)  2.846 3.040 
CRO_027004 UDP-glucosyl transferase 2.893 3.764 
CRO_015509 nucleic acid binding 3.046 3.383 
CRO_015507 salt tolerance zinc finger 3.247 4.901 
CRO_029922 ankyrin repeat family protein 3.571 4.108 
CRO_011780 Peptidase C78, ubiquitin fold modifier-specific 3.578 4.006 
CRO_021079 Peptidase family M48 family protein 3.672 3.779 
CRO_027001 UDP-glucosyl transferase 3.698 4.388 
CRO_029919 casein kinase alpha 3.796 4.416 
CRO_015221 DUF1649 domain containing protein 3.819 3.820 
CRO_029920 Peroxisomal membrane 22 kDa (Mpv17/PMP22) 4.340 4.227 
CRO_025459 cytochrome B5 isoform B 4.356 5.437 
CRO_025460 glycine-rich protein 4.701 5.473 
CRO_006608 aconitase 4.731 4.929 
CRO_006607 Ubiquitin-like superfamily protein 4.753 4.373 
CRO_005950 Ribosomal protein L18ae family 4.812 5.835 
CRO_004424 RNA polymerase I-associated factor PAF67 4.901 5.211 
CRO_025458 alpha/beta-Hydrolases superfamily protein 4.928 2.782 
CRO_015511 adenine phosphoribosyl transferase 5.859 6.386 
CRO_021078 DEAD box RNA helicase (PRH75) 7.136 7.545 
 
5.2.3 VIGS experiments following analysis of SGD genomic context 
A C. roseus Mate pair library was obtained and in combination with the previously generated 
sequencing data 68 a new improved assembly was created by Robin Buell and co-workers at 
Michigan State University (MSU, East Lansing, USA) (data not publicly available). 
The analysis of this unpublished assembly was restricted to the SGD gene primarily because 
this data became available only at a late point of this work. SGD is the only gene that failed to 
be assembled into a single contig in the initial assembly based on the Illumina sequencing data 
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68. The deglycosylation of strictosidine is a crucial step in the biosynthesis of alkaloids in C. 
roseus as the resulting aglycone undergoes a sequence of unknown enzymatic reactions that 
are the basis for downstream differentiation of the pathway yielding the different alkaloid 
classes 18 (Chapter 1, Figure 6). Therefore, this is a potentially interesting place to search for 
gene clustering. 
The SGD containing scaffold resulting from the Mate pair enhanced assembly has a length of 
1,026,926 bp with 88 individual transcripts mapping to this sequence. The SGD gene is located 
between position 231,468 and 294,861. Closer inspection of this genomic context revealed 
that the assembly results in three SGD versions in this area of which only one represents the 
full open reading frame of the SGD gene. 
For further analysis, all transcripts between position 1 and 800903 bp, a total of 68 transcripts, 
were considered. For those 68 transcripts the expression values in the tissues flower, sterile 
seedling (control, plus methyl jasmonate for 5 days or 12 days), mature and immature leaf, 
stem and root were investigated. A total of 35 transcripts were not followed up as they were 
either not expressed at all in those tissues or expressed with a value of less than 1 log₂FPKM in 
young leaf. The remaining 33 transcripts were subjected to hierarchical clustering applying 
Pearson correlation (average linkage distance) in the MultiExperiment Viewer (MeV v.4.8) 
(Figure 72). The results were analysed and a set of VIGS candidates defined. 
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Figure 72 Hierarchical clustering of 33 transcriptome contigs related to SGD 
Expression values for 33 C. roseus transcriptome contigs. Tissues are A (flower), B (sterile seedling 
control), C (sterile seedling plus methyl jasmonate for 5 days), D (sterile seedling plus methyl jasmonate 
for 12 days), E (mature leaf), F (immature leaf), G (stem) and H (root). Orange arrow highlights candidate 
C45 and blue arrow the two partial SGD.  
 
As described above, of the 90 contigs that were found to be co-localised with one of the 25 
known pathway genes in the older version of the C. roseus genome, candidate C18 (Figure 72, 
CRO_011779) was identified based on its physical closeness to SGD and its annotation as 
cytochrome P450 enzyme. C18 was also observed on the SGD contig of the Mate pair 
enhanced assembly. Further candidates chosen based on a combination of their annotation, 
actual physical distance to SGD and/or their co-expression with SGD were C2 (CRO_027093), 
C6 (CRO_027095), C7 (CRO_027094), C8 (CRO_003636) and C9 (CRO_021613) (Figure 72), 
while C45, selected for co-localisation with SGD, had already been chosen as part of a list of 
co-regulated genes.  
VIGS experiments were conducted. However, only silencing C18 (Figure 73) and C45 (Figure 74) 
led to significant changes. 
156 
 
 
 
Figure 73 C18 silencing effect on leaf metabolites 
Normalised peak area of compounds ajmalicine and serpentine of plants of two independent (n=5 and 
n=8) C18 silencing experiments in comparison to EV control plants. Error bars represent + SEM. P-value 
was calculated using Student’s t test (*p<0.05, ***p<0.00001). 
 
 
Figure 74 C45 silencing effect on leaf metabolites 
Normalised peak area of (n=6) plants infected with C45 silencing construct in comparison to EV control 
plants for compounds: A (catharanthine), B (tabersonine), C (strictosidine), D (vindorosine), E 
(vindoline), F (secologanin). Error bars represent + SEM. P-value was calculated using Student’s t test 
(***p<0.0005). 
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C18 
The first silencing of C18 displayed two major changes, the significant increase of ajmalice and 
the significant decrease of serpentine. However in a second experiment, although the same 
general trend in the data is visible, the data is not significant (Figure 73). No other metabolite 
in influenced significantly. Ajmalicine is the precursor of serpentine in C. roseus biosythesis and 
the enzyme/s catalysing this reaction are unknown 18. However, this is an oxidatve 
transformation and could be catalysed by a P450. 
 
Figure 75 Reaction ajmalicine to serpentine 
C18 is only expressed at relatively low levels (Figure 51). A BLASTn search against the C. roseus 
transcriptome 68 suggests that the observed change is not caused by cross-silencing. The 
biochemical function of this gene will be subjected to further analysis in future studies. 
C45 
One of the 33 SGD co-localised contigs (Figure 72), candidate C45, had also been identified as 
co-expresssion analysis of transcriptomic data 65. This makes C45 the only candidate that has 
been discovered twice, via co-expression analysis and as a co-localised gene with a known 
pathway gene. SGD contains two contigs, CRO_019099 and CRO_027160 that are both 
annotated as alpha/beta-Hydrolases superfamily protein (Figure 72). C45 can be associated 
with both of these contigs as closer investigation revealed that the only difference between 
both contigs is that CRO_019099 is about 200 bp longer than CRO_027160 while the total 948 
bp of CRO_027160 are 100 % identical to CRO_019099. Both contigs are immediately adjacent 
to each other on a single genomic scaffold of the C. roseus mate pair enhanced genome 
assembly (data not shown).  
VIGS experiments with this candidate reproducibly led to an approximately 50% reduction of 
catharanthine production. Unfortunately a BLASTn search of the 307 bp long section of this 
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gene used for silencing revealed that the C. roseus transcriptome contains several contigs that 
share sufficient sequence similarity to result in cross silencing. Future efforts will focus on 
identifying the enzymes that generate the putative substrate for this hydrolase 
(stemmadinine), which will then allow biochemical assay with each of the highly similar 
hydrolase genes for activity. 
5.2.4 VIGS experiments of candidates resulting from co-expression analysis 
Transcriptomic data 65 was analysed for gene co-expression in a search for a missing step in 
vindoline biosynthesis. In the course of this thesis 11 candidates displaying a strong co-
expression with known vindoline biosynthesis genes were selected and tested using VIGS, 
including the newly discovered T3O gene described in Chapter 3 146 (Table 28). 
T3O must work in partnership with a reductase (Figure 33). The discovery of this gene, T3R, 
was reported during the course of this thesis 48. This gene was present in our list of candidates 
that co-expressed with vindoline biosynthetic enzymes, so we also silenced the T3R gene. The 
published VIGS results 48 were compared to the T3R VIGS results obtained here. The published 
VIGS results for the T3R gene reports information on the levels of four compounds 48. No 
change in vindoline concentration is observed; secondly, a compound with a mass of m/z 
398.22, corresponding to desacetoxyvindoline (the T3R product) is reduced; thirdly, the 
alkaloid catharanthine is increased; finally three new compound peaks with a mass of m/z 383, 
corresponding to the T3R substrate, were detected. No values for the significance of those 
changes were provided in the published report. 
The data obtained for T3R silencing in the scope of this thesis are comparable. No significant 
decrease in either vindoline or vindorosine can be detected in T3R silenced tissue (Figure 76). 
Additionally neither the levels of tabersonine or 16-methoxytabersonine are changed (Figure 
77). 
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Figure 76 T3R silencing effect on vindoline and vindorosine 
Relative MIA content as mean peak area for vindoline and vindorosine in T3R silenced plants (n=8) in 
comparison to EV control plants (n=6). Error bars represent mean + SEM. P-value was calculated using 
Student’s t test. No significant differences. 
 
Figure 77 T3R silencing effect on tabersonine and 16-methoxytabersonine 
Relative MIA content as mean peak area for vindoline and vindorosine in T3R silenced plants (n=8) in 
comparison to EV control plants (n=6). Error bars represent mean + SEM. P-value was calculated using 
Student’s t test. No significant differences. 
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Applying the software for automated peak extraction on the metabolic data of eight samples 
for T3R silencing and six samples of EV control yielded peak areas for 791 different peaks. After 
data normalisation a calculation of the t-test revealed that 15 of the extracted peaks were 
significantly changed (p-value < 0.01) between T3R silenced and EV control tissues (Table 31). 
However applying the Benjamini-Hochberg method for False Discovery Rate (FDR) to correct 
the p-value for the occurrence of false positives 229 leads to none of the observed changes 
being significant at all in this dataset. This work highlights how a VIGS screen can lead to false 
negatives. 
 
Table 31 Significant changed peaks of T3R silenced tissues prior to FDR correction 
Mean peak area for T3R silenced in comparison to EV control tissues, elution time of peak and accurate 
mass of peak. Data is sorted by p-value starting with the lowest. In bold are masses that would 
correspond to the substrates of T3R in vindoline (m/z 383) or vindorosine (m/z 353) biosynthesis 
respective. 
m/z elution time average T3R average EV p-value 
353.1849 2.323 160168 12014 0.00020 
383.1971 2.66 79524 0 0.00162 
384.1962 2.35 34634 0 0.00174 
260.0718 2.339 24899 17202 0.00209 
354.1918 2.558 4523 0 0.00458 
383.1834 2.331 137652 5632 0.00463 
506.223 4.628 9697 12418 0.00517 
383.1899 3.487 7914 2334 0.00615 
427.0987 2.331 41886 32915 0.00714 
336.1735 1.411 6292 2649 0.00814 
195.0648 2.327 9967 3686 0.00837 
443.2171 4.722 6658 1199 0.00986 
512.2015 3.197 4216 882 0.01003 
 
5.2.5 Infiltration on three weeks old Catharanthus roseus seedlings 
VIGS in C. roseus can be optimised, for example in a recently report using a biolistic-mediated 
method by which the virus encoding plasmids are directly transferred into the plant tissue and 
Agrobacterium-mediated inoculation can be circumvented 94. Another alternative to pinching 
the stem is whole seedling infiltration instead of classical pinching. This could lead to silencing 
of root tissue, a part of the plant that is not silenced with the pinching method 93. 
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The currently employed VIGS system has two major limitations. First, no silencing of tissue 
below the pinching site can be achieved, therefore root or stem specific genes and metabolites 
cannot be investigated using gene silencing. Second, the current method requires eight week 
old plants, which makes the VIGS experiment time consuming, inflexible and low-throughput. 
To address these issues, we attempted to develop a VIGS method in which the entire plant 
would be affected by the virus and also would be considerably less time consuming. Whole 
plant infiltration as well as infiltration of seedlings and cuttings has proven successful for 
silencing in other systems 230 and was attempted for C. roseus here. 
5.2.5.1 Magnesium chelatase silencing of whole seedlings of Catharanthus roseus 
After applying the syringe press method, in which whole three week old C. roseus seedlings are 
fully submerged with A. tumefaciens harbouring the pTRVu_ChlH plasmid and pressure is 
applied to effectively infiltrate the whole seedling, the typical yellowing that results from 
successful silencing of the photoporphyrin IX magnesium chelatase subunit H gene occurred as 
early as one week after infiltration (Figure 78). Of initially 17 infiltrated plants only 11 survived, 
and of those 9 showed yellowing after one week. This was repeated twice with similar results. 
 
Figure 78 Successful silencing with syringe-press method in C. roseus 3 weeks old seedlings 
 
5.2.5.2 Metabolic phenotype of silenced whole seedlings of Catharanthus roseus 
As an initial test and proof of concept, plants were infiltrated with available VIGS vectors 
harbouring MIA genes. To investigate the root specific changes the samples were separated 
into two fractions, leaf and root, that were investigated separately. Although for each VIGS 
construct 6 -8 individual seedlings were harvested those samples were mixed resulting in a 
mixed leaf fraction and mixed root fraction for each VIGS vector and for the empty vector 
control. 
162 
 
 
First the T16H2 plasmid was used for infiltration. Classical T16H2 silencing, using the standard 
VIGS protocol as conducted in the work presented in Chapter 2, leads to a significant reduction 
of vindoline and accumulation of the substrate tabersonine and the alternative shunt products 
vindorosine. Similar results can be observed for the leaf fraction of the whole seedling T16H2 
silencing experiment in comparison to the leaf fraction infiltrated with an empty vector (Figure 
79). 
 
Figure 79 LC-MS profile of T16H2 VIGS and empty vector control seedling leaf tissue 
Extracted ion chromatogram for mixed sample (n=6) leaf tissue from T16H2 silenced whole seedling 
with increased peak area for tabersonine (m/z 337 at elution time 4.35) and vindorosine (m/z 427) 
compared to empty vector treated tissue. 
 
The obtained results are similar to results from the classic VIGS method. T16H2 silencing has 
expectedly no influence on stem or root tissue metabolite composition or content (data not 
shown) as these tissues do not express T16H and do not produce vindoline or vindorosine. 
Therefore it cannot conclusively be determine if the silencing was successful in those tissues. 
The SLS VIGS construct was tested using this method. Successful silencing of SLS with the 
classical VIGS method leads to significant decrease of various downstream products but most 
importantly to the emergence of a peak (m/z 413) that is below the detection limit in EV 
control samples (Chapter 5.3.1., Figure 67). Although the results from this first initial test for 
whole seedling infiltration are comparable to previous VIGS results with the same VIGS vector 
the results for root tissue are less clear (Figure 80).  
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Figure 80 LC-MS profile of SLS VIGS and empty vector control seedling leaf and root tissue 
Extracted ion chromatogram for mixed sample (n=6) leaf tissue from SLS silenced whole seedling and 
root tissue. A: Leaf tissue empty vector. No peak for loganin (m/z 413) is observed. Black peak is 
secologanin (m/z 411) in comparison to vindoline (light blue peak). B: Leaf tissue SLS silencing. New peak 
for loganin (m/z 413) is observed. Black peak is secologanin (m/z 411) in comparison to vindoline (light 
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blue peak). C: Root tissue empty vector. Small peak for loganin (m/z 413). Black peak is secologanin (m/z 
411) in comparison to catharanthine as roots contain no vindoline (m/z 337 at elution time 4.35, dark 
blue peak). D: Root tissue SLS silencing. Larger peak for or loganin (m/z 413). Black peak is secologanin 
(m/z 411) in comparison to catharanthine as roots contain no vindoline (m/z 337 at elution time 4.35, 
dark blue peak). 
 
Although a potential increase in loganin accumulation can be observed, the nature of the 
experiment, measuring a mixed sample of six individually silenced seedlings, allows no 
statistical analysis and so it cannot be determined if the observed larger peak for loganin is a 
result of an possibly increased variability of root tissue in general or indeed a silencing result. 
In general there are less examples for successful silencing of roots then there are for other 
tissues reported in the literature. In C. roseus it was shown that the here reported syringe-
press method for the infiltration of whole seedlings 93 led to accumulation of both pTRV1 and 
pTRV2 in root tissue, a prerequisite for virus assembly. However the only gene silenced is in 
this study is phytoene desaturase (PDS) a gene involved in carotenoid biosynthesis that, if 
silenced, causes sever albinism and is used as a visual marker for silencing success similar to 
magnesium chelatase 231, an approach that is however unsuitable for roots. Additionally the 
qRT PCR results presented in 93 do not provide a strong evidence of successful silencing in roots 
of C. roseus. This method has therefore to be tested further before it can be concluded if 
silencing of root specific genes is feasible as a tool to investigate the alkaloid production in 
C. roseus roots. 
5.3 Conclusion 
Since its establishment in 2011, VIGS in C. roseus has facilitated the discovery and investigation 
into physiological function of several alkaloid pathway genes. In 2012 it facilitated the 
discovery of ISY 30. In 2013 the role of T16H2 was investigated using VIGS 42. VIGS played an 
essential role in the discovery of a ATP-binding cassette transporter implicated in the transport 
of the C. roseus alkaloid catharanthine 46 and the discovery of 7DLGT 32 and 7DLH 31,33. In 2015 
VIGS helped clarify the role of THAS 37 the first C. roseus gene ever to be characterised to 
catalyse a reaction using the deglycosylated strictosidine intermediate. Testing candidate 
genes with the VIGS technique led to the discovery of T3R 48 and T3O 48,146, which completed 
the search for vindoline biosynthesis enzymes after decades of research. 
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In this chapter we outline the efficiency and limitations of the VIGS technique by silencing the 
three previously identified MIA biosynthetic genes SLS 35, TDC 36 and STR 189, that had been 
biochemically validated, but not subjected to in planta silencing. This initial investigation 
would test the robustness of the established VIGS procedure and additionally give insight into 
the role of the three tested known alkaloid biosynthesis genes in young leaf of C. roseus. These 
experiments on the whole suggest that the VIGS method produces reproducible, accurate 
results, but also highlights that false negatives can occur in this experimental technique. 
Additionally, this VIGS system was used in a general candidate screen. Based on the co-
expression data and genome data, 28 candidates were silenced in planta using VIGS. The vast 
majority of these candidates yielded negative results when silenced. However, two genes 
emerged from this screen that produced metabolic changes upon silencing for which follow up 
experiments are being planned. 
Many steps of alkaloid biosynthesis in C. roseus are co-regulated and this co-regulation is 
reflected in the co-ordinate expression of genes in available expression data. Moreover not 
just alkaloid biosynthesis is co-regulated, the production of its precursors is most likely 
controlled in a similar way. Tryptophan biosynthesis for example is strictly co-regulated in A. 
thaliana 140. The rational for choosing a VIGS candidate is in many cases its co-expression with 
known alkaloid pathway genes. The observed co-expression in C. roseus alkaloid biosynthesis is 
caused largely by the coordinate upregulation of alkaloid biosynthesis as reaction to the 
elicitation with for example methyl jasmonate 232,233. Therefore it is very possible that a chosen 
VIGS candidate gene, co-expressed with a known alkaloid biosynthesis genes, might be an 
essential part of the methyl jasmonate mediated defence and general stress response 234. 
Silencing such a gene can have unpredictable results as signalling pathways 235 as well as 
individual secondary metabolite pathways 236 are linked. In consequence a VIGS result for such 
a gene could result in a phenotype with significant changes of alkaloid profile, even if the gene 
is not actually part of alkaloid biosynthesis. Therefore VIGS results must be interpreted with 
caution. In principle, the successful silencing of a single step in a multistep pathway results in 
the reduction of the product of this step and the accumulation of the substrate. Without 
either, the interpretation becomes far more difficult. Still, in conclusion, as VIGS candidates are 
most of the time highly expressed and methyl jasmonate inducible genes with an annotation 
that suggests involvement in metabolism of secondary metabolites, the high number of VIGS 
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results without any significant changes is rather encouraging, as it speaks for the robustness of 
the system. 
While false positive results will possibly eventually be discovered during follow up experiments 
such as the heterologous expression, candidates that lead to false negative VIGS results are 
more in danger of simply being overlooked and not followed up. Over the course of testing 28 
candidates we have observed two genes, T3R 48 and STR 189, for which the function has in vitro 
been characterised, that produces no or only few statistically significant changes in metabolite 
profile upon silencing. This shows some limitations of VIGS as a system for gene function 
screening. Nevertheless, despite these caveats, VIGS remains the most powerful method to 
date to rapidly screen the function of putative metabolic gene candidates. 
Although heterologous expression of candidate genes in alternative hosts and testing their 
function by feeding various substrates is a valid method for gene discovery and 
characterisation, this approach lacks the explanatory power of a VIGS experiment, as a VIGS 
experiment is additionally able to demonstrate the in planta function of a gene. Currently, a 
single VIGS experiment requires at least a three month period. Efforts were made to perform 
VIGS using a new infiltration method that could shorten this time and also potentially silence a 
greater range of tissues compared to the standard pinching method. Testing the efficiency of 
this infiltration method using ChlH silencing as visual marker of silencing success in leaves led 
to 91% of plants showing yellowing. This is in accordance with previous finding for C. roseus 121. 
Testing the known pathway genes T16H 41 and SLS 35 leads to the expected and previously 
observed phenotype (Chapter 2, Chapter 5.3.1.) in leaf tissue, with the results being less clear 
in root tissue. This method effectively cuts the experimental time frame in half from currently 
11 weeks to 6 weeks with comparable results for leaf tissue. Of greater interest however is 
whether silencing of a root expressed gene is possible and would result in a metabolic 
phenotype and measurable expression reduction that would validate the involvement of this 
gene in alkaloid biosynthesis in C. roseus. 
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6 Discussion 
Alkaloids are complex secondary metabolites that often display potent bioactivity. Their 
biosynthesis in plants typically proceeds via intricate multistep enzymatic pathways. According 
to the literature more than 130 different alkaloids of monoterpene origin are produced by the 
plant C. roseus 19. All are derived from the central precursor molecule strictosidine that is 
formed as a condensation product of the terpenoid moiety secologanin and the indole moiety 
tryptamine, via a Pictet-Spengler condensation (Chapter 1, Figure 5) 18,24. The first gene 
successfully identified for strictosidine biosynthesis in C. roseus was TDC (tryptophan 
decarboxylase) reported almost three decades ago in 1989 36, STR (strictosidine synthase) was 
reported in 1992 237, SLS (secologanin synthase) was reported in 2000 35, followed by G8H 
(geraniol 8-hydroxylase) in 2001 28 and LAMT (loganic acid methyl transferase) in 2008 34. The 
remaining five steps were published over the course of just two years in 2012 and 2013 29–32 
leading to the complete elucidation of strictosidine biosynthesis in C. roseus and the 
knowledge being used to engineer this early part of alkaloid biosynthesis in S. cerevisiae 25 and 
N. benthamiana 29. The great acceleration in gene discovery in C. roseus was aided by two 
factors: the increased availability of comprehensive transcriptomic data and the observation 
that the genes of this pathway are tightly co-expressed 49.  
In C. roseus as well as other MIA producing plants strictosidine is deglycosylated by 
strictosidine β-D-glycosidase (SGD) and rearranges to 4,21-dehydrogeissoschizine that forms 
the structural basis for the diverse range of alkaloid scaffolds (Chapter 1, Figure 6). In C. roseus 
the highly reactive 4,21-dehydrogeissoschizine intermediate is transformed by an unknown 
number of subsequent reactions that lead to the molecular rearrangements necessary for the 
formation of the three distinct molecular backbones or skeletons, representing the three 
different classes of C. roseus alkaloids, namely the iboga, the corynanthe and the 
aspidosperma alkaloids. At the start of this work none of the enzymes involved in this complex 
transformation was known. 
Pathway elucidation of alkaloid production in C. roseus has been a focus of attention ever since 
the discovery in the 1960s of the anti-cancer properties of its compounds vinblastine and 
vincristine 18. These bisindole alkaloids form as a result of the coupling of the two main C. 
roseus monoterpene alkaloids vindoline (aspidosperma alkaloid) and catharanthine (iboga 
alkaloid). While catharanthine is a direct product of the reactions following the deglycosylation 
of strictosidine, vindoline originates from tabersonine and is the product of a set of seven 
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further enzymatic reactions, referred to as vindoline biosynthesis. Of those seven steps only 
five were known at the start of this thesis (Chapter 1, Figure 7).  
The first of two key aims of this thesis was to close this gap in vindoline biosynthesis by 
following the successful strategy applied in strictosidine biosynthesis gene discovery: the 
mining of transcriptomic data for co-expressed genes. The identified gene candidates were 
tested using VIGS. Biochemical analysis confirmed the activity observed in planta. 
The second aim of this thesis was to investigate gene clustering in C. roseus. It is a recent 
observation that in some plant secondary metabolic pathways the genes are located in close 
proximity on the genome. As a result of the increasing availability of plant genome 
information, this has now been reported for a variety of species and different classes of 
specialised metabolites 174. The successful identification of gene clustering can enhance 
pathway discovery 177,198,238,239. This is of particular interest for genes that might be difficult to 
discover with the co-expression approach as not all genes of a pathway are necessarily closely 
co-regulated. To investigate if any gene clustering in C. roseus can be observed, a draft genome 
sequence was obtained, as well as several BACs containing known genes of key steps in 
alkaloid biosynthesis in C. roseus. As with the co-expression approach identified candidates 
were predominantly tested using VIGS.  
An important consideration is that most studies that successfully applied co-expression 
analysis for gene discovery in C. roseus 31,32,79 had previously determined the most probable 
enzyme class of the missing step and therefore substantially limited otherwise lengthy 
candidate lists. However, limiting the search to a specific enzyme class can also be obstructive. 
The highly complex chemistry of plant secondary metabolite pathways has often evolved in 
only a small phylogenetic space, with enzymes catalysing unprecedented reactions, making an 
accurate judgment of the probable enzyme class impossible. The discovery of C. roseus iridoid 
synthase 30, representing a new class of enzymes, from a transcript that displayed highest 
sequence similarity to progesterone-5- reductase (P5bR), was aided by the fact that this 
transcript was very tightly co-expressed with known genes and that chemical understanding 
predicted a NADPH requiring enzyme for this step. Gene clustering, if observed, can therefore 
aid further gene discoveries by combining information of gene co-expression with gene 
clustering/ gene co-localisation. 
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6.1 Gene silencing and gene clustering 
The VIGS system is essential to the work presented in this thesis. No reliable protocol for the 
stable genetic transformation of C. roseus exists. Gene candidates for alkaloid biosynthesis 
have successfully been tested for example in alternative systems such as N. benthamiana 29 
and yeast 79. However such alternative systems always rely on the availability of the correct 
substrates, a difficult task as many intermediates of C. roseus are not commercially available or 
structurally so complex and/ or unstable that chemical synthesis is not always an option. 
Ultimately for the validation of in planta function of alkaloid pathway genes in C. roseus only 
VIGS is currently available. VIGS experiments are detailed in Chapter 2, Chapter 3 and 
Chapter 5. 
Chapter 2 describes the successful in planta functional validation of a tabersonine 16-
hydroxylase (T16H). In 1999 a publication reported a cytochrome P450 (T16H1) that had been 
cloned from a light induced C. roseus cell suspension culture and was characterised to catalyse 
the first step in vindoline biosynthesis, the 16-hydroxylation of tabersonine 41. In 2012 our 
collaborators (Vincent Courdavault, University Tours, France) had cloned a second version of 
this gene (T16H2) from C. roseus leaf tissue and in vitro characterisation revealed it had 
identical function to the previously discovered gene. Successful targeted gene silencing of this 
gene in C. roseus leaf tissue using VIGS was confirmed with q RT PCR and led repeatedly to a 
significant decrease of vindoline, the end product of the vindoline pathway. Close investigation 
revealed that reduction of vindoline levels was accompanied with the coinciding increase of 
vindorosine (des-methoxy-vindoline). Untargeted peak extraction of the obtained mass 
spectrometry data revealed several peaks with exact masses corresponding to intermediates 
of vindoline or vindorosine biosynthesis were significantly decreased or increased respectively, 
further strengthening the redirection of flux to the un-methoxylated product vindorosine as a 
result of the targeted gene silencing and therewith ultimately validating the essential function 
of T16H in C. roseus leaves. This highlights the explanatory power of VIGS as a tool for 
functional characterisation of known enzymes.  
Two independent approaches, remapping transcriptomic raw reads to the two T16H open 
reading frames, conducted as part of this thesis, and q RT PCR of both T16H versions on 
different C. roseus tissues in the lab of Vincent Courdavault came to the same conclusion. Both 
versions of this enzyme are active in C. roseus but the predominance of one paralog is tissue 
dependent 42. This observation has many implications especially for further pathway discovery. 
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Notably, the two functional and co-ordinately regulated versions of T16H are unsuitable 
candidates for co-expression analysis as none of the individual T16H expression profiles 
matches the expression profiles of downstream vindoline biosynthetic genes. 
It can further be speculated that T16H is potentially not the only enzyme in the pathway for 
which functionally identical paralogs exist. Indeed this was later reported additionally for ISY 
181 and SLS 68,213 and the genome sequence data presented in Chapter 5 shown for both T16H 
and ISY that the functional paralogs belong to recently duplicated gene pairs 68. 
In Chapter 3 VIGS was successfully employed to screen a number of candidates for missing 
steps in vindoline biosynthesis, leading to the discovery of tabersonine 3-oxygenase (T3O) 146. 
The selection of candidates was based two major assumptions: firstly, that the missing genes 
would co-express with known vindoline pathway genes (with the exception of T16H), and 
secondly that one of the genes would be annotated as a cytochrome P450 enzyme, since the 
proposed chemistry entailed formation of an epoxide, a reaction known to be catalysed by 
P450s (Chapter 3, Figure 24). The successful candidate could unambiguously be identified 
using VIGS, since silencing in this case significantly reduced both products of this pathway, 
vindoline and vindorosine. VIGS also resulted in the dramatic accumulation of a peak with a 
mass corresponding to the substrate of T3O. The identity of this peak could be further verified 
by consumption in assays with heterologously expressed T3O from yeast. The structural 
characterisation of the T3O reaction product carried out by Dr. Nathaniel Sherden concludes 
that in the absence of a partnering reductase the unstable intermediate does first form an 
epoxide, but then readily rearranges to a product with a new scaffold structurally similar to the 
alkaloid vincamine from the plant V. major, a close C. roseus relative. This is in accordance with 
previous publications that report that 2-imine,3-alcohols on the tabersonine framework are 
able to undergo acid catalysed rearrangements 148–151 and leads us to speculate on the possibly 
of a similar biosynthetic pathway for vincamine in V. major. 
While Chapter 2 and 3 highlight successful examples of how VIGS can be used for the 
validation of in planta function of known pathway genes as well as for a screening tool for 
unknown genes, Chapter 5 shows limitations to this system. Here the targeted silencing of 
three further known pathway genes, the previously identified MIA biosynthetic genes SLS 35, 
TDC 36 and STR 189, clearly shows that measurable downregulation of expression is not 
necessarily reflected in a strong and unambiguously interpretable VIGS phenotype. When both 
SLS and TDC are silenced, the respective substrates, loganin and secologanin, accumulate while 
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downstream alkaloids are significantly reduced. The result for SLS is especially interesting as it 
shows that gene silencing results in silencing of all four functionally redundant genes due to 
their high sequence identity. However, 60% reduction of STR expression leads to only minimal 
changes in alkaloid content. These results would have possibly been overlooked without prior 
knowledge of the in vitro confirmed function of this particular gene. In three subsequent 
experiments no significant accumulation of an STR substrate peak could be observed although 
the accumulation of secologanin, one of the two precursors for the STR catalysed reaction, has 
been observed previously in the TDC silencing experiments, showing that in principle 
secologanin accumulation in plant tissue is possible.  
A second example for a weak and therefore difficult to interpret VIGS phenotype is observed 
with the reductase T3R in vindoline biosynthesis. The VIGS phenotype observed allows for only 
a tentative interpretation of the in planta function of this gene only in combination with the in 
vitro results for this enzyme, which are required in this case to clearly demonstrate its 
involvement in vindoline biosynthesis 48. Interestingly our VIGS results match the results 
published for this gene by another group 48 despite the fact that they use a different C. roseus 
variety, which points to the general reproducibility of the VIGS system.  
Why STR or T3R silencing do not lead to the expected metabolic changes is not easy to answer. 
For both genes the reduction of expression was measured to be around 60%. One possibility is 
that the remaining levels of enzyme are efficient enough to carry out the reactions without an 
alteration of the metabolite flux. The existence of additional enzymes that can carry out the 
same reaction seems unlikely in these two cases. The reaction catalysed by STR is highly 
specific and while STR homologs are found in the plant, they are known to be inactive 
(O’Connor, personal communication). Obtaining knockouts for STR, perhaps in cell suspension 
or hairy root culture which are amenable to stable transformation 240, may clarify these points. 
This option however only applies to genes of the upstream part of alkaloid production as the 
metabolites produced in roots are significantly different in the downstream pathway. 
In the course of this thesis, a variety of P450 enzymes were functionally assayed by VIGS with 
no measurable positive results. While this could be due to the negative results sometimes 
exhibited in this silencing system, it must be noted that C. roseus produces far more than the 
major alkaloids such as catharanthine or tabersonine for which standards exist. Some 
publications state up to 130 different alkaloids 19 and new publications continuously report the 
isolation of more new compounds isolated from plants such as C. roseus with better extraction 
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methods applying mass spectrometry with higher sensitivity. Alkaloids, like many plant 
secondary metabolites, play essential roles in interaction with the environment 11 for example 
to attract pollinators 9 or most importantly as a means by which plants defend themselves 
against microorganisms and herbivores10. From an ecological point of view it appears logical 
not to “limit” this arsenal to a few major compounds as this holds the risk of potential 
predators overcoming a single defence. Therefore the possibility exists that some of the 
unsuccessfully tested genes might conduct interesting chemistry yet the metabolite profiling 
used in the VIGS system is simply not sensitive enough to detect changes in these minor 
products. However, using VIGS to screen for enzymes that conduct novel chemistry is an 
enormous challenge, as it requires the prediction of the structure of the substrates and 
products from the metabolomic analysis of VIGS tissue. Without a clear, statistically significant 
emergence of a new peak and/or reduction of a product, these results are not interpretable in 
the absence of other experimental evidence. 
Chapter 4 reports the analysis of a newly established resource, the C. roseus draft genome 
available as a searchable database (http://medicinalplantgenomics.msu.edu/). Together with 
six BAC sequences this data was used to investigate the genomic context of C. roseus 
biosynthesis with regards to gene clustering. Most importantly this analysis provides a list of 
90 transcripts that are in close proximity to the 25 known alkaloid pathway genes, a number 
that is challenging to be tested within the VIGS system. Therefore a combination of functional 
annotation and co-expression profiles were employed to pick initial candidates from this list. 
Despite all reported limitations and constraints, two candidates show tentative results. 
Preliminary VIGS results for a P450 candidate suggest a potential involvement of this gene in 
the biosynthesis of serpentine. A second candidate, selected primarily from the co-expression 
analysis conducted in Chapter 3 but also because of co-localisation with SGD, when subjected 
to VIGS, repeatedly results in catharanthine reduction. These candidates are the focus of 
further experiments by other group members.  
The analysis of gene clustering in the draft C. roseus genome revealed several small clusters 
consisting of three genes. TDC and STR are co-localised with a MATE transport protein and all 
three genes display very tight co-expression. The co-localisation of SLS with a genes annotated 
as a sinapyl-alcohol dehydrogenase has led to the discovery of THAS, the first enzyme reported 
to be involved in the formation of the different typical alkaloid scaffolds after the 
deglycosylation of strictosidine 37. The pair of T16H paralogs, which is a gene duplication, is 
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located next to 16OMT representing the first and second steps in vindoline biosynthesis. The 
duplication of a gene foremost removes the evolutionary constraint that is associated with the 
need to retain the original gene function. The common fate of duplicated gene pairs is very 
often the emergence of deleterious mutations leading to non-functionalisation of one of the 
copies241. It is also possible that both gene copies are maintained with their redundant 
function. Over time, changes in the regulatory or coding sequence can lead to functional 
divergence such as sub-functionalisation, where the original gene function is partitioned into 
the two copies, as is observed for T16H 42. Alternatively, the occurrence of an adaptive 
mutation in one of the duplicated genes that can lead to novel functions, so called neo- 
functionalisation. It has to be noted that a strong driver of enzyme recruitment and functional 
divergence is a change in transcription and/or translational level of the enzyme, as such 
changes might lead to the physiological relevance of a previous latent existing enzyme function 
242. 
Although some common features do exist between plant gene clusters identified to date, the 
relatively small number of clusters precludes development of a global definition and general 
rules for prediction of when clusters might be observed. Predictions as to how many more 
clusters might be found in plants is difficult. Much has been speculated about the significance 
and function of clustering. Several of the today known plant secondary gene clusters are 
responsible for the production of metabolites that have shown to confer resistance and 
therefore a selective advantage 111,116. It has been argued that organisation of biosynthetic 
pathways in clusters is driven by both the selective advantage and the beneficial role the 
pathway 101. However the basis of gene clustering might be rooted in many different 
evolutionary reasons.  
Extensive analyses in Arabidopsis thaliana revealed that in general genes from a specific 
pathway are more likely co-expressed then genes that are not part the same pathway, but also 
that only a small number of genes have many co-expression partners while most genes have 
less than 10 partners 130. Interestingly, in this study, genes that have fewer coexpression 
partners are often multi-copy genes, suggestive again of the evolutionary aspects that gene 
duplication and subsequent release of regulatory constraint play in the expansion of existing 
networks 130. Such an accumulation of duplicated genes can be observed for alkaloid 
biosynthetic enzymes in the C. roseus draft genome. For some of these like ISY an in vitro 
function redundancy has been shown, though VIGS failed to provide evidence for an 
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involvement of one of the paralogs in planta181 while the other paralog is clearly implicated in 
alkaloid biosynthesis 30. Others, like T16H1 and T16H2 could be examples of “evolution in 
progress”, where the differential regulation might, in the future, evolve into the development 
of an alternative pathway chemistry or the loss of the vindoline biosynthesis.  
Over the last decade many newly established plant biology techniques have been applied to C. 
roseus to decipher alkaloid biosynthesis. Some of these techniques and tools have played an 
active role in gene discovery while others supplied candidate lists for further research. 
Examples include EST sequencing of specific alkaloid biosynthesis relevant tissues such as the 
leaf epidermis 50, proteome mining of C. roseus hairy root cultures 233 or suspension cultures 
243, establishment of VIGS for C. roseus 121, the creation of larger transcriptomic resources 
facilitating co-expression analysis over multiple tissues and/or conditions 65, or for various 
members of the Catharanthus genus 70. Amongst those, the combination of co-expression 
analysis with knowledge of gene location have proven to be the most successful approach for 
identification of gene candidates and along with experimental validation by VIGS have led 
together to the successful engineering of the early part of C. roseus in N. benthamiana in 2014 
29 and S. cerevisiae in 2015 25 and that of vindoline biosynthesis in S. cerevisiae in 2015 48.  
 
6.2 Future directions 
The availability of transcriptomic and genomic data is crucial and has allowed, over the past 
decade, a rapid acceleration of discoveries in plant metabolism pathways 244. Automated 
genome mining for secondary metabolite clusters in plants, similar to existing solutions for 
discovery of microbial secondary metabolite gene clusters 245,246, may facilitate the more rapid 
application of the increasingly number of plant genomes that are publically available. With the 
establishment of more genomic data this might be feasible for plant gene clusters on a larger 
scale and for a more diverse range of gene clusters 176,177,238,239. This might enable the discovery 
of more of the shared features of these gene clusters that can in turn facilitate development of 
new strategies to identify these clusters. 
Experimental techniques for in planta screening, such as large scale VIGS experiments and the 
subsequently necessary metabolomics, are still a limiting factor and efforts have to be 
undertaken to streamline these methods as it is currently too time and labour intensive for 
high-throughput functional characterisation.  
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6.3 Outlook 
Undoubtedly, the vast majority of plant specialised metabolism remains an untapped resource 
247. Sequencing is no longer a limiting factor with steadily declining costs, increasing precision 
and fast turnaround times 248. Systems biology promises quick advances in gene and pathway 
discovery in plant specialised metabolism by combining –omics techniques such as genomics 
with metabolomics and transcriptomics 249. It has already has been shown that the information 
provided with the C. roseus draft genome accelerated discoveries related to secondary 
metabolism in plants, and it for example also facilitated the research into the transcriptional 
regulation of strictosidine biosynthesis 224. Future genome sequences of related species will 
shed light on the possible conserved evolution of the observed gene cluster. Better sequencing 
and improved assembly might eventually be able to answer the question if and how much 
more gene clustering can be observed in C. roseus.  
  
176 
 
 
7 Materials and Methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich and all restriction 
enzymes from New England BioLabs. 
 
7.1 Plant material 
All plant material used in this thesis was obtained from Catharanthus roseus variety “SunStorm 
Apricot” (Syngenta) and all VIGS experiments were conducted on this variety. The variety 
“Little Bright Eyes” was occasionally used when noted to compare alkaloid content between 
these two cultivars. All plants were grown in a walk in growth chamber at 25oC under 12 h 
days using the John Innes compost mix No. 2 (peat based). 
 
7.2 General methods for molecular biology 
7.2.1 Primers and sequencing 
All primers were supplied by Integrated DNA Technologies (IDT), except for primers used for 
USER cloning that were purchased from Sigma-Aldrich. Unless otherwise stated, all primers 
were designed using the OligoAnalyser 3.1 (https://www.idtdna.com/calc/analyzer) and 
optimised for a melting temperature of 55oC to 58oC. 
Sequencing was carried out by SourceBioscience (Cambridge) using plasmid DNA or purified 
PCR product as template. 
 
7.2.2 PCR and DNA purification 
Generally, each PCR reaction contained 1 µM of each primer, 1 mM dNTP mix, a suitable 
polymerase, template, and the manufacturers supplied buffer, as well as up to 3% DMSO and 
up to 3 mM MgSO4. The total PCR volume was adjusted to 20, 25 or 50 µl with water 
depending on the required amount of PCR product. Template amount was variable depending 
on the nature of the template. The amount of template cDNA was usually 1 µg and never more 
than 10% of total PCR volume. Plasmids as templates were used at 1 pg to 1 ng per reaction. 
For amplification from genomic DNA, 1 ng to 1 µg was used. For colony PCR, the template 
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consisted of 1 µl fresh bacterial or yeast culture or 1 µl of a single colony picked with a sterile 
toothpick and then diluted into 10 µl of water. 
For construction of VIGS plasmids, the X7 polymerase produced in house by Dr. Fernando Geu-
Flores following a published protocol 250. This polymerase is able to incorporate the Uracil 
Specific Excision Reagent (USER) compatible primers in combination with 5x HF Buffer (NEB, 
cat. No. B0518S) and up to 3% DMSO. 
Colony PCR to confirm cloning success was generally performed with Taq polymerase (GoTaq, 
Promega, cat. No. M5001), while standard amplification from cDNA or plasmid template was 
conducted with Pfu Ultra II polymerase (Agilent, cat. No. 600670) or KOD Hot Start polymerase 
(MerckMillipore, cat. No. 71086) and the PCR reaction mix adjusted to manufacturer’s 
instructions. 
All PCR reactions were carried out on a Veriti 96 Well Thermal Cycler (Applied Biosystems). For 
a general PCR, the stepwise gradient started with a melting period of 95oC for 2 minutes, 
annealing period of 55oC for 20 seconds and extension period of 72oC. The extension time was 
adjusted to the expected length of PCR product and the speed of the polymerase used. 
Standard PCR reactions were done with 30 cycles, colony PCR with up to 33 cycles. All PCR 
reactions were carried out with a final extension of 10 minutes at 72oC. 
For evaluation of the obtained band size, 2 µl of the PCR product were run at 100 V on a 1% 
(w/v) agarose gel using GelRed™ (Biotium cat. No. 41010) to stain the DNA. Gels were run in 
TAE buffer (40 mM Tris, 20 mM acetic acid, and 1 mM EDTA). Bands were visualised using the 
SYNgene bioimager. For gel extraction, the entire PCR reaction was run on a gel, excised and 
purified using a Nucleospin Gel and PCR clean-up kit (Machery-Nagel cat. No. 740609.50) in 
accordance with the manufacturer’s instructions. Normal PCR purification was done with the 
same kit. For the final elution from the column, 40 µl nuclease free H2O was used and the DNA 
was spectrophotometrically quantified on a nanodrop (NanoDrop, ND-1000). 
 
7.2.3 cDNA synthesis 
cDNA from C. roseus variety “SunStorm Apricot” used as PCR template was synthesised using 
the SuperScript® III First-Strand Synthesis System (cat. No. 18080-051). Unless otherwise 
stated the procedure followed the manufacturer’s instructions using total RNA as template, 
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Oligo(dT)20 as primer and the Superscript III reverse transcriptase (cat. No. 18080-044). The 
total RNA was obtained following the procedure described in section 7.3 below. Typically, RNA 
from young leaf tissue was used. However for cloning of specific genes that are not expressed 
in young leaves, other tissues were used for RNA extraction such as root tissue, flower tissue 
and stem as well as methyl jasmonate induced seedlings. C. roseus seedlings were grown in 
petri dishes on water soaked filter paper. The seeds were surface sterilised before germination 
using 70% ethanol for 30 seconds and subsequently soaked for 2 minutes in 5% 
natriumhypochlorite with 2% Tween 20 as detergent, while vortexed repeatedly. The seeds 
were rinsed three times with sterile water. Seeds were kept in the dark at room temperature 
and transferred to the growth chamber after seven days (germination had occurred), where 
they were kept for further two weeks. Methyl jasmonate was applied to the seedlings by 
spraying with 500 µM solution and induced seedlings were harvested 1 day after application. 
All tissue samples for RNA extraction were immediately snap frozen in liquid nitrogen after 
collection and kept at -80oC till use. 
 
7.2.4 Culture conditions and glycerol stocks 
E. coli cultures were cultured at 37oC, A. tumefaciens and S. cerevisiae were kept at 28oC. 
Liquid cultures were grown at appropriate temperatures and under constant shaking (200 
rpm). For long term storage at -80oC, glycerol stocks were made by adding 500 μl of a 
saturated culture to 500 μl of 50% glycerol (E. coli), to 500 μl of 80% glycerol (A. tumefaciens) 
or to 500 μl of 30% glycerol (S. cerevisiae). 
 
7.2.5 Growth media and selective media 
Growth media used in this thesis are summarised in Table 32. For selection of E. coli and A. 
tumefaciens appropriate antibiotics summarised in Table 33 were added to the media after 
autoclaving. 
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Table 32 Media composition 
Media Content 
LB 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
SOC 
2% (w/v) tryptone 
0.5% (w/v) yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
2xYT 
16 g bacto tryptone/ l 
10 g bacto yeast extract/ l 
5 g NaCl/ l 
YPD 
1% yeast extract 
2% peptone 
2% glucose 
SC-Ura (yeast selection media) 
0.67% yeast nitrogen base (without amino acids, with 
NH4SO4) 
dropout media without uracil (Formedium) 
2% glucose 
 
Table 33 Antibiotics used for selection 
Antibiotic Final concentration (µg/ml) 
carbenicillin 100 
kanamycin 50 
rifampicin 100 
gentamycin 50 
chloramphenicol 150 
 
7.2.6 Plasmid extraction 
Plasmid extraction for E. coli cultures for sequencing or for transformation into new hosts was 
done with a Miniprep kit (Qiagen, cat. No. 27104) in accordance with the manufacturer’s 
instructions. DNA was eluted from the silica membrane using 40 µl water and stored at -20oC 
for future use. 
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7.2.7 Competent cells 
For E. coli, commercially available chemically competent cells were used. For plasmid 
propagation either One Shot TOP10 (Invitogen, cat. No. 4040-10) or strain HST08, Stellar 
Competent Cells (TaKaRa, Clontech, cat. No. 636763) were used. 
For A. tumefaciens GV3101 electro competent cells were generated using the following 
protocol: Starting from a single colony of A. tumefaciens strain GV3101 a 5 ml LB overnight 
culture, supplemented with the antibiotics Gentamycin and Rifampicin was used to inoculate 1 
litre of LB media and grown at 28oC under constant shaking at 200 rpm to an OD of ~5x107 
cells/ml. All subsequent steps were conducted at 4oC. The culture was centrifuged at 3000 g, 
the supernatant discarded, and the cell pellet washed with 500 ml ice cold 10% glycerol. This 
wash step was repeated twice reducing the resuspension volume first to 250 ml 10% glycerol 
and next to 5 ml 10% glycerol. The final cell pellet was resuspended in 1 ml sterile ice cold 1 M 
sorbitol, and dispensed in 200 µl aliquots for long term storage at -80oC. 
For S. cerevisiae chemically competent cells were generated fresh every time a transformation 
was planned. A single colony was grown overnight at 28oC in 2 ml 2x YPD media. The culture 
was then pelleted by centrifugation and resuspended in 25 ml fresh 2x YPD media and then 
incubated at 28°C under constant shaking at 200 rpm for at least four hours. All subsequent 
steps were performed on ice or at 4°C. The culture was centrifuged at 3000 g for 10 min and 
the supernatant discarded. The pellet was washed twice with 250 ml ice cold water, aliquoted 
according to demand and used for transformation immediately. 
7.2.8 Transformation protocols 
For transformation into E. coli a maximum amount of 200 ng plasmid was mixed with 25 to 50 
µl chemically competent E. coli cells on ice. After heat-shock, 45 seconds in a 42°C water bath, 
the cells were immediately placed on ice and 150 µl SOC medium was added. Following 
transformation the mixture was kept at 37°C for 1 hour, before being spread on agar plates 
containing the appropriate antibiotic, and grown overnight at 37°C. Colony PCR confirmed 
transformation success and positive colonies were selected for overnight cultures. 
For transformation of A. tumefaciens, up to 300 ng of plasmid DNA were mixed with 50 µl of 
electro competent A. tumefaciens GV3101 in a 2 mm electroporation cuvette and placed on 
ice for 5 minutes. Using the Biorad micropulser (165-2100) the mixture was electroporated at 
2.2 kV and immediately after electroporation 200 µl SOC media were added to the cuvette and 
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the complete mixture transferred into a fresh tube and incubated at 28°C for 2 hours. This 
mixture was then spread onto LB agar plates containing rifampicin, gentamycin and the 
plasmid specific antibiotic selection marker kanamycin. The plates were incubated for two 
days at 28°C until individual colonies became visible. Colony PCR identified transformation 
success and positive colonies were selected for overnight cultures. 
A method modified after Giez (2007) 251 was employed for yeast transformation. Briefly, 100 to 
300 ng of plasmid DNA were mixed with 34 µl water, 36 µl 100 mM lithium acetate and 240 µl 
40% PEG 3350. The mix was vortexed and kept on ice. The yeast cells (45 µl of chemically 
competent S. cerevisiae prepared as described above) were mixed with 50 µl of a 2 mg/ml 
solution of single stranded carrier DNA (UltraPure salmon sperm DNA solution, ThermoFischer, 
cat. No. 15632011) and both mixes combined were vortexed again and incubated at 30°C for 
80 minutes. Over the course of the incubation, cells were vortexed briefly three times. The 
mixture was centrifuged at 3000 g for 15 seconds, the supernatant removed and the cells 
resuspended in 200 µl TE buffer. This solution was spread onto SC-Ura agarose plates for 
selection, with colonies appearing after two days of growth at 28°C. Colony PCR confirmed 
transformation success and positive colonies were selected for further cultures. 
7.2.9 Cloning and plasmids 
For protein expression in S. cerevisiae, the yeast strain WAT11 was transformed with the 
pXP218 144 expression vector. The commercial pJET1.2/blunt vector was used in E. coli for PCR 
cloning to identify the correct ORF if not previously known or for propagation prior to 
digestion. The pTRV2u plasmid 123 was used for preparation of the VIGS vector.  
Table 34 Plasmids used and individual selection markers 
plasmid selection marker 
pJET carbenicillin 
pTRV2u kanamycin 
pXP218 
minus Uracil (auxotrophic 
marker) 
 
7.2.9.1 Cloning into linearised pXP218 vector 
Cloning into pXP218 used sticky ends produced by restriction digestion to join vector and 
insert in the ligation reaction in a directional manner. The vector was isolated from a 5 ml 
overnight culture of E. coli. The concentration of the vector was determined using a nanodrop 
spectrophotometer (NanoDrop, ND-1000). A maximum of 1 µg of vector was digested with the 
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restriction enzymes SpeI and Xhol in a 50 µl reaction mix containing 5 µl 10x reaction buffer 
and 10 units of each enzyme for 60 minutes at 37°C.  Inserts were PCR products amplified 
using primer with the appropriate overhangs (Table 35) cut by the same restriction enzymes 
SpeI and Xhol. After restriction endonuclease digestion, the vector DNA was dephosphorylated 
using calf intestinal alkaline phosphatase (New England BioLabs, cat. No. M0290S) following 
the manufacture’s instructions. Both the linearised vector and the digested insert were run on 
a 1% (w/v) agarose gel and a band of the right size was cut from the gel and purified (Machery-
Nagel, cat. No. 740609.50) and the extraction product resuspended in 25 µl water. The vector 
and insert were mixed in a ratio of 1 to 3 for the cloning reaction. Cloning was carried out using 
the T4 DNA ligase (Invitrogen, cat. No. 15224-017) or, alternatively, T4 DNA ligase (Roche, cat. 
No. 10 481 220 001) according to the manufacturer’s instructions. Briefly, for the T4 DNA 
ligase (Invitrogen, cat. No. 15224-017), 4 µl T4 buffer were mixed with vector and insert, not 
exceeding 0.1 µg total DNA and 0.1 µl T4 ligase. After adding water to a total volume of 20 µl, 
the reaction was allowed to proceed for 1 hour at room temperature prior to transformation 
of E. coli as described above. 
Table 35 Primers used for cloning genes into the pXP218 yeast expression vector 
Cloning/restriction sites are in bold. 
name   sequence 
CRO_021081 fw TTATTACTACTAGTATGGATGCTTTGCTTAATCCTGT 
CRO_021081 rev AATCTAATCTCGAGTTAAGCACCTGAAGAATTTGGCCTCA 
T19H fw TTATTACTACTAGTATGTTGTCTTCATTGAAAGATTTCTTCG 
T19H rev ATCCATGCCTCGAGCTAAAAAATGGTAACCGGAGTTGC 
MAT fw TTATTACTACTAGTATGGACTCAATAACAATGGTTGAAACC  
MAT rev ATCCATGCCTCGAGTTAATTAGAAGCAAATGAAAGGAGC 
T3O fw TTATTACTACTAGTATGGAGTTTCATGAATCTTCTCCCTTC 
T3O rev AATCTAATCTCGAGTCATGCATAGGACGTAGCGATTAAA 
 
7.2.9.2 Cloning into pJET1.2/blunt 
The commercial vector pJET1.2 was used to amplify blunt end PCR products for sequencing 
and subcloning. Constructs in pJET1.2 were generated using the CloneJET PCR Cloning Kit 
(ThermoFischer Scientific, cat. No. 1231). Briefly, about 100 ng of PCR product (amount varies 
with length of PCR product) were mixed with 10 µl reaction buffer, 1 µl linearised cloning 
vector, 1 µl T4 DNA ligase, 1 µl PCR product and brought to a volume of 20 µl. After five 
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minutes at room temperature the mix was put on ice and then E. coli were transformed as 
described above. 
Table 36 Primers used for cloning genes into the pJET1.2/blunt vector 
name   sequence 
CRO_021081 fw ATGGATGCTTTGCTTAATCCTGT 
CRO_021081 rev TTAAGCACCTGAAGAATTTGGCCTCA 
T19H fw ATGTTGTCTTCATTGAAAGATTTCTTCG 
T19H rev CTAAAAAATGGTAACCGGAGTTGC 
MAT fw ATGGACTCAATAACAATGGTTGAAACC  
MAT rev TTAATTAGAAGCAAATGAAAGGAGC 
T3O fw ATGGAGTTTCATGAATCTTCTCCCTTC 
T3O rev TCATGCATAGGACGTAGCGATTAAA 
 
7.2.9.3 Cloning into the pTRV2u vector 
For all VIGS experiments a modified version of the original pTRV2 plasmid 90 was utilised. This 
modification introduced a USER cassette into the multiple cloning site of the original plasmid 30 
resulting in the pTRV2u vector that could be used for USER cloning123. USER cloning is a 
ligation-independent cloning technique that utilises PCR primer that contain a single 
deoxyuridine residue. The empty pTRV2u plasmid was linearised using the restriction enzyme 
AsiSI and overhangs created using the nicking enzyme Nt.BbvC1. E. coli containing the empty 
vector plasmid were grown up from a stock and plasmids extracted. A maximum of 1 µg of 
plasmid was digested in a 50 µl reaction mix containing 5 µl 10x reaction buffer and 10 units of 
each enzyme. Reaction was allowed to proceed overnight at 37°C. The linearised plasmid was 
subsequently gel purified and could be stored at -20°C until further use. For the preparation of 
the pTRV2 plasmid with inserts for VIGS, a 200 to 500 bp long section of the gene of interest 
was amplified with the deoxyuridine residue containing primer. The PCR product was purified 
from agarose gel and subsequently treated with USER enzyme in a mixture containing the PCR 
product and the linearised vector. This procedure leads to the generation of 8 nucleotide 3’ 
overhangs, which can complement the ends of a USER compatible linearised vector 123 and 
allows for transformation of E. coli without prior ligation. The reaction had a volume of 10 µl 
and was kept at 37oC for 40 minutes. Subsequently it was cooled on ice before the reaction 
mixture was used to transform 40 µl TOP10 E. coli by heat shock. SOC media (200 µl) was then 
added to the E. coli and they were incubated at 37°C for 1 hour, spread onto kanamycin 
selective agar plates and incubated at 37°C overnight. Colony PCR identified transformation 
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success and positive colonies were selected for overnight cultures. Plasmids were extracted 
from a positive colony. Correct inserts were confirmed by sequencing. Agrobacterium 
tumefaciens strain GV3101 was transformed as described above. 
Table 37 Primers used for cloning into the pTRV2u vector 
Cloning sites are in red. 
C2 fw GGCGCGAUGCT GAATCATCCTCATCAACAATG 
C2 rev GGTTGCGAUGATCTCTTCCGATTGCCCAAC 
C3 fw GGCGCGAUACTATAATTTCTCCGAGCTGAAAT 
C3 rev GGTTGCGAUCAGACAAGTAATCAATTCCAACAA 
C4 fw GGTTGCGAUAATGTTGGTACATGCATTCTG 
C4 rev GGCGCGAUGAAGCTAGTTGTTGTTGGTGC 
C5 fw GGCGCGAUAAC TCC GGC CAT TTG GTA TC 
C5 rev GGTTGCGAUATCTTTAATAGAAAGTGGCAAATGGTGC 
C6 fw GGCGCGAUACTTCATATCAGATGGCTCACC 
C6 rev GGTTGCGAUGCAGGTAAGCAGCTGCAAA 
C7 fw GGCGCGAUTTC TTC CTC CAC TTT CTG CTC TC 
C7 rev GGTTGCGAUAATCTACATCCCAGGTGACAC 
C8 fw GGCGCGAUCAG AAG TTT GAC GTG GAG C 
C8 rev GGTTGCGAUCTTCAACCAAATTCCCTGAGC 
C9 fw GGCGCGAUCCTTTGTCGTTGTATCAGATCC 
C9 rev GGTTGCGAUGTACCATATACAGCCTTAATAACAGG 
C10 fw GGCGCGAUTTCAGTGTCATGATGTAATGCAGTTAAG 
C10 rev GGTTGCGAUAAGAATGGCAAAGTAAAGCACGAG 
C12 fw GGCGCGAUAAT CCA ATA GAA CAT CCA TAA AGT CTC CAG 
C12 rev GGTTGCGAUTCAATGGAGAGAAAAGGTGAGGT 
C13 fw GGCGCGAUTTGGTCTAGGTGGACTTGGT 
C13 rev GGTTGCGAUTGTTCTGCTGCAAAATCCAGCAT 
C14 fw GGCGCGAUAGTTAGAGTTGGTATAGTTGGTC 
C14 rev GGTTGCGAUGTTATGTTCTGCTGCAAAA 
C15 fw GGCGCGAUTGC CAC CGT TGG AAG AAC  
c15 rev GGTTGCGAUCATGGCCTTCCATGTACCTTGTA 
C16 fw GGCGCGAUGAC AAG ATT TGT AAT AAG TTG ATG GAA TCA ACT  
C16 rev GGTTGCGAUCCATTTGGTGCTGGACGAAG 
C18 fw GGCGCGAUATT TAT GCA AAC TCA TGG CCT AAA CTT TGC  
C18 rev GGTTGCGAUAACTTCTTTGCTTTGGGCCTCAATG 
C20 fw GGCGCGAUTGAGCAAATTGATGACGTCATGCA  
C20 rev GGTTGCGAUAAGGGAATATCAAGGTCAAGATCACCAC 
C30 fw GGCGCGAUACCAGGTCCAAGAACACTACC 
C30 rev GGTTGCGAUGTAATCTCCATACTGAGCAAAGGTAACAC 
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C32 fw GGCGCGAUGTGGTGTATTGGCAAACTTCCAG 
C32 rev GGTTGCGAUCTTTCACAAAGTAGTTTCTTGGCAATACA 
C36 fw GGCGCGAUTGGTCCAAACACAGAAGAATCATTTC   
C36 rev GGTTGCGAUGATGATGAACCTTAGCATATCTGTGATT  
C38 fw GGC GCG AUC TTC GCC TAC GCA TCT CCC TTC TGG A      
C38 rev GGT TGC GAU TTG TAT TCA TGA TTT CTT CCA CAC CTT  
C39 fw GGC GCG AUA TGG AAT CGA ACG AGT TGA CTC ACT  
c39 rev GGT TGC GAU TCG GTA CCA CAA TTT CGA ATC TGG    
C41 fw GGC GCG AUATGAAGGTGATAGAGAAGATCAACGAT 
C41 rev GGTTGCGAUCAGGCAAATCCACCTTCCACCT 
C43 fw GGCGCGAUAGC TCG AGT TCA TTC CCA ACT CTC A 
C43 rev GGTTGCGAUCATAGGCGGAAAATGATGGGATCC  
C44 fw GGCGCGAUAAAGAACCTCCAGCGAGCA 
C44 rev GGTTGCGAUCGAGTCAAGCTGTGCTACTGA 
C45 fw GGC GCG AUACA CTT CGT AGC CGA AAC CAA AGT TA 
C45 rev GGT TGC GAU GTTGTGAACAATATTAGCACCAGGACTG 
C46 fw GGCGCGAUAGC TCG AGT TCA TTC CCA ACT CTC A 
C46 rev GGTTGCGAUCATAGGCGGAAAATGATGGGATCC  
C47 fw GGCGCGAUGCT TCC CTA CTT GCA AGC AAT AGT TA 
C47 rev GGTTGCGAUCCGCCAACTGGACAGTCATG 
C48 fw GGCGCGAUGCC TAG CTT CAA GAA CAG GAT GC 
C48 rev GGTTGCGAUATCCTAAGTATTGGTCCGAACCTGA 
C53 fw GGC GCG AUTACCCAATGACACCTGGTAT 
C53 rev GGTTGCGAUGGTTAATCCCTTGTCTGTCG 
T16H2 fw GGCGCGAUTGATTGGAAACTTGCCAGTGATGA 
T16H2 rev GGTTGCGAUATGGATTAGCAACGAAATCTTCCGTA 
 
Table 38 Primers used for colony PCR and sequencing 
plasmid name sequence 
pJET pJET fw CGACTCACTATAGGGAGAGCGGC 
pJET pJET rev AAGAACATCGATTTTCCATGGCAG 
pXP218 pXP218 fw GGACCTAGACTTCAGGTTGTCTAACTC 
pXP218 pXP218 rev TTTACAGATCATCAAGGAAGTAATTATCTAC 
pTRVu pTRV2u fw GATGGACATTGTTACTCAAGGAAGC 
pTRVu pTRV2u rev GTAGTTTAATGTCTTCGGGACATGC 
 
7.3 Virus induced gene silencing (VIGS) 
Construction of VIGS plasmids and cloning are described in section 7.2. Subsequent RNA 
extraction and qRT PCR experiments are described in section 7.3.  VIGS experiments were 
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conducted using eight week old C. roseus plants 121. To silence whole plants including tissues 
such as roots of C. roseus an existing protocol was modified protocol 93. 
7.3.1 VIGS on Catharanthus roseus: eight week old plants pinching method 
Eight week old plants were used for VIGS of C. roseus. Briefly, 5 ml cultures from A. 
tumefaciens glycerol stocks harbouring the pTRV1, the pTRV2_EV and the pTRV2 constructs 
containing the insert of choice were grown overnight. Each experiment included pTRV2_ChlH 
as a visual marker of silencing success, visible as yellowing of green tissue. The overnight 
cultures were centrifuged and resuspended in A. tumefaciens infiltration buffer (10 mM MES, 
10 mM MgCl2, 100 µM acetosyringone, pH 5.5) to an optical density of 0.7 at 600 nm. The 
cultures were incubated for an additional two hours at room temperature. Prior to pinching 
using forceps just below the top leaf pair of each plant A. tumefaciens carrying pTRV2 
constructs were mixed with an equal volume of the A. tumefaciens pTRV1 culture. Plants were 
kept for 21 days in the growth chamber, until the seedlings infiltrated with the pTRV-ChlH 
vector displayed substantial yellowing of leaves. The last leaf pair to emerge above the 
inoculation site was harvested from each plant after the plants were visually inspected for any 
other physiological changes in colour or shape. About 30-50 mg tissue were harvested from 
each plant and immediately frozen in liquid nitrogen. Per construct up to eight plants were 
harvested. The tissues were homogenised using a cryo bead mill (Cryomill, Retsch, Germany). 
Each sample was subsequently divided into two equal batches of milled tissue, one for RNA 
and one for metabolite extraction to obtain maximum comparability between gene expression 
levels and metabolic phenotype of each plant sample. 
 
7.3.2 VIGS on Catharanthus roseus: young seedling syringe-press method 
For an alternative VIGS method, three to four week old seedlings were used which were grown 
until the point where the first pair of true leaves had not fully emerged above the cotyledons. 
After carefully extracting these seedlings from the soil, the roots were washed with water to 
remove excess soil. The plants were placed in a 50 ml syringe with its front opening sealed off. 
The syringe was filled with the mixture of pTRV1 and pTRV2 plasmid of interest containing A. 
tumefaciens that was prepared as described above and the syringe plunger was pressed tree 
times firmly into the syringe creating pressure for up to 15 seconds. The plants were washed in 
water before replanting into soil.  
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7.3.3 Sample preparation for mass spectrometry 
For each sample between 10-25 mg of fresh harvested, frozen in liquid nitrogen and ground 
tissue was weighed, collected into 200 µl methanol containing 40 µM caffeine as an internal 
standard and incubated at 57°C for 2 hours. After a 30 minute centrifugation step at 5000 g, an 
aliquot of the supernatant, mixed with an equal volume of water, was analysed by LC-MS. 
7.4 General methods for analytical chemistry/ mass spectrometry 
This section describes the instruments and methods used to analyse alkaloid content and 
composition of plant tissues as well as enzyme assays. 
7.4.1 Analysis of VIGS samples 
Liquid Chromatography Mass Spectrometry (LC-MS) to analyse all VIGS experiments used 
either a Surveyor high performance liquid chromatography (HPLC) system attached to a 
DecaXPplus ion trap MS (Thermo-Finnigan) or a Nexera/Prominence UHPLC IT-TOF. All 
compounds of interest ionise comparably on both machines and do not interfere with the 
general result of individual VIGS experiments (Dr. Lionel Hill, Dr. Richard Payne, personal 
communication). For all experiments caffeine was used as an internal standard and peak areas 
were normalised to the fresh weight of the sample.  
All analyses were performed in positive ion mode. The injection volume was 2 µL for all 
samples. 
Surveyor HPLC system attached to a DecaXPplus ion trap MS (Thermo-Finnigan) 
VIGS samples analysed on the Thermo-Finnigan instrument with Deca XP ion trap detector 
were separated using a Phenomenex Luna C18 column (100 x 2.00 mm, 3 µm) with a binary 
solvent system consisting of acetonitrile (ACN) and 0.1% formic acid in water (12% ACN for 1 
minute, 12 to 25% in 7 minutes, 25 to 50% in 4 minutes, 50 to 100% in 2 minutes, 100% for 7 
minutes, 100 to 12% in 2 minutes, 12% for 6 minutes). Flow rate was set to 0.5 ml per minute. 
Metabolites were detected by positive mode electrospray ionisation (ESI). MS spectra were 
collected from m/z 100-1000. Spray chamber conditions were 350°C capillary temperature, 50 
units sheath gas, 5 units aux gas, and a spray voltage of 3.8 kV using a steel needle kit. 
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Nexera/Prominence UHPLC IT-ToF (Shimadzu) 
VIGS samples that were analysed on the Shimadzu LC-MS system attached to an ion-trap ToF 
mass spectrometer were separated with a Phenomenex Kinetex C18 100Å (100 × 2.10 mm, 
2.6 µm) column using a binary solvent system consisting of acetonitrile (ACN) and 0.1% formic 
acid in water (10 to 25% ACN in 5 minutes, 25 to 100% ACN in 1 minute, 100% ACN for 1.5 
minutes, 100 to 10% in 0.5 minutes, 10% for 2 minutes). Flow rate was set to 0.5 ml per 
minute. 
Metabolites were detected by positive mode electrospray ionisation (ESI). Full MS spectra 
were collected from m/z 100-1000 Spray chamber conditions were 250°C curved desorbation 
line temperature, 300°C heat block, 1.5 l/min nebulizer gas, and drying gas “on”.  The 
instrument was calibrated immediately before use, using sodium trifluoroacetate as a mass 
standard according to the manufacturer’s instructions. 
7.4.2 Analysis of enzymatic assays and yeast cultures 
Liquid Chromatography Mass Spectrometry (LC-MS) analysis of all enzyme assays and yeast 
cultures used a Waters Xevo TQ-S mass spectrometer (Milford, MA, USA) equipped with an 
electrospray (ESI) source. Peaks were separated with a BEH Shield RP18 (50 x 2.1 mm; 1.7 μm) 
column (Waters) using a binary solvent system consisting of acetonitrile (ACN) and 0.1% formic 
acid in water (12 to 25 % ACN in 50 seconds, 25 to 50% ACN in 180 seconds, 50 to 100% ACN in 
130 seconds, 100% for 130 seconds, 100 to 10% in 30 seconds, 10% for 2 minutes).  
Metabolites were detected by positive mode electrospray ionisation (ESI). Full MS spectra 
were collected from m/z 100-800. Capillary voltage was 2.5 kV in positive mode, the source 
was kept at 150°C, desolvation temperature was 500°C, cone gas flow was 50 litre per hour, 
and desolvation gas flow 900 litre per hour. Flow rate was set to 0.6 ml per minute. 
For loganin and secologanin analysis was carried out by monitoring specific mass transitions. 
Methods were developed using commercial standards. Flow injection of individual compounds 
was used to optimize the multiple reaction monitoring (MRM) automatically using the Waters 
Intellistart software. Loganin and secologanin were monitored using the following parameters: 
secologanin: m/z 227.1>107.1 (Cone 20, Collision 18), loganin: m/z 229.1>81.1 (Cone 14, 
Collision 20), m/z 229.1>109.1 (Cone 12, Collision 12). Data was processed using MassLynx 4.1 
and TargetLynx software (Waters). 
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7.4.3 Accurate mass measurements 
Accurate mass measurements were done at the JIC mass spectrometry facility by Lionel Hill. 
Tissue samples were run on a Surveyor LC system attached to an LTQ Orbitrap (Thermo). 
Separation was performed on a 100 × 2 mm 3 µm Luna C18 column (Phenomenex) using a 30 
minute gradient of acetonitrile versus 0.1% formic acid in water (0 to 12% in 1 minute, 12 to 
25% in 7 minutes, 25 to 50% in 4 minutes, 50 to 100% in 2 minutes, 100% for 7 minutes, 100 to 
12% in 2 minutes, 100% for 2 minutes).  Flow rate was set to 0.5 ml per minute. 
The instrument was set up to collect full scan FT-MS data at from m/z 100-1000, and data-
dependent MS2 of the most abundant ions at an isolation width of m/z 3.0 and collision 
energy of 35%. The instrument was calibrated according to the manufacturer’s instructions at 
the start of the sequence. 
7.4.4 Data extraction and analysis 
Mass spectrometry data were analysed using extracted ion chromatogram and individual peak 
area was calculated using the appropriate software for each instrument. For the Thermo-
Finnigan instrument peak areas were calculated with the Thermo, Xcalibur Roadmap 2.2 
SP1.48 software. For the Shimadzu LC-MS-IT-TOF mass spectrometer peak areas were 
calculated using the Shimadzu LC-MS solution software version 3.80.409. For the Waters Xevo 
TQ-S mass spectrometer the Waters, MassLynx V4.1 SNC 714 software was used. 
Extraction of all peaks from the mass spectrometry data was performed with the software tool 
XCMS. The raw data files obtained by mass spectrometric measurements from the Thermo-
Finnigan instrument and Shimadzu-IT-TOF mass spectrometer data were converted to mzXML 
files, the required file format for XCMS analysis. File conversion was done with a free online 
version of readW (http://sourceforge.net/ projects/sashimi/files/). Peak extraction was done 
using R (version 2.8.0) with the additional packages XCMS, http://www.bioconductor.org/. 
XCMS 252 enables to visualise changes in specific metabolites by identifying the relative 
metabolite ion intensities after correcting for potential retention time shifts by automated 
calculation of a nonlinear retention time correction profile. The data obtained in this fashion 
were normalised by weight of tissue sample. This method can also be applied for comparing a 
treatment with a control. The mean peak area for each treatment was calculated from the 
normalised data, the fold change between VIGS-gene of interest and VIGS-EV controls, as well 
as a t-test were calculated between the two sets.  
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The raw data files obtained by mass spectrometric measurements from the Shimadzu-IT-TOF 
mass spectrometer were used directly in the Profiling Solution (Shimadzu) software for 
automated peak extraction. Here the software standard parameters were used. Only 
alteration was to increase the ion intensity to 50000 counts to focus on larger, more reliable 
peaks. Only data obtained during the gradient from 10 to 25% ACN were considered. As with 
all other metabolic data the so obtained peak areas were normalised by weight of tissue 
sample and used for further statistical analysis. 
7.4.5 Statistical analysis 
Significant differences in peak area were calculated in Microsoft Excel using the Students’s T-
test. Only p-values of less than 0.01 were considered significant. For automated peak 
extraction additionally Benjamini-Hochberg false discovery rate was calculated 229. 
 
7.5 Quantitative Real Time Polymerase Chain Reaction (qRT PCR) 
To investigate the altered expression of genes in silenced tissue qRT PCR was conducted on six 
to eight individual samples per treatment. 
7.5.1 RNA extraction 
Material for RNA extraction was either milled (RETSCH mill, Germany) or ground under liquid 
nitrogen. RNA extraction was carried out using the Qiagen RNeasy plant mini kit (cat. No. 
74904), including the on-column DNase digestion using the Qiagen RNase-Free DNase set (cat. 
No. 79254). The amount of tissue used was < 100 mg per sample. For each VIGS candidate, 
tissue samples from 6 to 8 plants were selected for RNA extraction. As control, the same 
amounts of empty vector control sample were used. RNA quality was assessed on a 1% 
agarose gel and the concentration measured on a nanodrop spectrophotometer (NanoDrop, 
ND-1000). 
7.5.2 cDNA synthesis for qRT PCR 
For qRT PCR the obtained RNA was used to synthesise cDNA for each replicate using the Biorad 
iScript cDNA synthesis kit (cat. No. 170-8891). Briefly, the 5x iScript reaction mix, iScript 
reverse transcriptase, nuclease free H2O and 1 µg RNA from each VIGS sample were mixed to 
yield a total volume of 20 µl. The mixture was incubated for 5 minutes at 25°C, 30 minutes at 
42°C, and a final 5 minutes at 85°C, resulting in the formation of the cDNA which was used for 
qPCR. 
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7.5.3 Primers for qRT PCR 
Primers for qRT PCR were designed to specifically amplify a fragment of approximately 100 bp 
of the gene of interest. Only primers that successfully and specifically amplified a DNA 
fragment of expected size in a standard PCR using C. roseus cDNA were considered further. 
 
Table 39 Primers used for qRT PCR of target genes 
STR q RT PCR fw CGCAGATGGTTCCTTTGTTG 
STR q RT PCR rev GGCAGTGCAGAGTTCTTAGT 
TDC q RT PCR fw TATCCGGTCCTTAGCGAAGT 
TDC q RT PCR rev GCCACTTGAAGCTGAGGAAT 
SLS q RT PCR fw GGCCAAAACTTTGCACTTCT 
SLS q RT PCR rev GGAGCATGAACATAGGATGG 
T3O q RT PCR fw GGCAACTCCCAGATGGTTCTACT 
T3O q RT PCR rev TCATGCATAGGACGTAGCGATTAAATGAA 
T16H2 q RT PCR fw ATCAACTCACAGTGGCAGTC 
T16H2 q RT PCR rev GACTTGAGGACTTGTGATTGGC 
G8H q RT PCR fw CATTTATTAGGCGACCAACC 
G8H q RT PCR rev GAACTTCTTTCGCCATTGTT 
DAT q RT PCR fw GGTTTCAATTTATTTCTCACGTAC 
DAT q RT PCR rev AACTATCAGAAAGGTAAGCATCGA 
D4H q RT PCR fw ATAGTTAATCATGGGATTCCACAAGATGTT 
D4H q RT PCR rev  GTTCATGAAACTTACGAACTCCATCTAC 
 
 
Suitable qRT PCR primers for each target gene were tested for their efficiency to amplify the 
gene in a linear relationship for a given cDNA concentration range. For this purpose cDNA from 
the VIGS-EV and the relevant target VIGS-pTRV2 constructs was pooled and a serial dilution of 
the pooled cDNA was generated at concentrations of 1:5, 1:10, 1:20, 1:80, 1:320. A qRT PCR 
reaction for each primer pair was performed in technical triplicate at each concentration step 
and the Cq plotted against log[cDNA]. Only primer pairs that gave a linear regression (R2) value 
of 0.99 were used in this study. For target genes with lower expression the serial dilution was 
changed to 1:2, 1:4, 1:8, 1:16, 1:32. Only primers with an efficiency value between 98-110% 
were used in this study and the individual efficiency values were incorporated in the 
calculation of normalised expression. 
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7.5.4 qRT PCR experiments 
To assess the level of silencing of different target genes in silenced and unsilenced tissue, 
material from six to eight independently silenced plants was compared to six to eight plants 
treated with the empty vector control plasmid. The qRT PCR reaction was performed in 
technical duplicate. Generally, the cDNA concentration was optimised according to the results 
of the primer testing to ensure that the Cq value for each gene analysed in the experiment 
would be between 20-30 cycles in the actual qRT PCR reaction. 
All melting curves generated in each experiment as well as the initial primer testing were 
inspected visually to ensure that the primer pair was specific in its amplification with only one 
amplified target in the cDNA. A single transition in the melting curve indicated a specific 
binding of the primer to only the desired target. 
 
Table 40 Reference gene primer for qRT PCR 
qRT PCR-Rbps9_fwd TTGAGCCGTATCAGAAATGC  
qRT PCR-Rbps9_rev CCCTCATCAAGCAGACCATA  
qRT PCR-EF1a_fwd TCAGGAGGCTCTTCCTGGTGA  
qRT PCR-EF1a_rev AGCTCCCTTGGCAGGGTCAT  
 
The relative quantification of gene expression was calculated using the expression values of a 
reference gene for normalisation of the data. The reference gene used in all experiments was 
the 40S Ribosomal protein 9 (Rps9) or Elongation Initiation Factor 4a (EIF4a). These reference 
genes have previously been established for their suitability for use in VIGS qRT PCR 
experiments in C. roseus 30,121. 
 
All qRT PCR measurements were done using the CFX96 touch Real-Time PCR system (BioRad) 
and the SYBR Green I dye, a cyanine dye that preferentially binds to double stranded DNA. 
Each reaction was performed in a total volume of 25 µl consisting of a normalised 
concentration of cDNA, 0.2 mM of appropriate forward and reverse primer and the 
SsoAdvanced SYBR Green Supermix (BioRad, cat. No. 1725271) containing dNTPs, Sso7d fusion 
polymerase, MgCl2, SYBR® Green I and ROX normalisation dyes. The qRT PCR reaction was 
initiated by a denaturation step at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 
60°C for 1 minute. The resulting data were analysed using CFX software. 
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7.6 General methods for bioinformatics 
7.6.1 Geneious  
Primer design, identification of restriction sites and analysis of obtained sequencing data was 
performed with the Geneious software, version 7.0.6 253. This software was also used for BLAST 
search254 against the various datasets utilised in this thesis. Unless otherwise stated, this was 
done using the default setting for the blastn or Megablast search functions. For an alignment 
of two or more sequences, unless otherwise stated, the default setting of the Geneious 
software was used which is a Smith-Waterman local alignment with a cost matrix of 65% 
similarity (5.0/-4.0). For mapping of two or more sequences, unless otherwise stated, the 
default setting of the Geneious software was used.  
7.6.2 Mapping individual reads and visualisation 
For mapping raw sequencing, data files were downloaded from NCBI. Using the JIC cluster, raw 
reads were mapped onto reference sequences using Bwa 255 version 0.7.12, and default 
parameters. Results were sorted using samtools 256 version 0.1.19. Mapping results were 
visualised and manually inspected using the Tablet version 1.15.09.01, James Hutton Institute 
257. Data sources employed for mapping are given in Table 41. 
Table 41 Sequencing data employed in mapping 
SRR122239 SRX047002: Catharanthus roseus Flowers RNA-Seq (CRA_AA) 
SRR122251 SRX047016: Catharanthus roseus Mature Leaf RNA-Seq (CRA_AM) 
SRR122252 SRX047017: Catharanthus roseus Immature Leaf RNA-Seq (CRA_AN) 
SRR122253 SRX047018: Catharanthus roseus Stem RNA-Seq (CRA_AO) 
SRR122254 SRX047019: Catharanthus roseus Root RNA-Seq (CRA_AP) 
SRR122255 SRX047020: Catharanthus roseus Hairy Root (TDCi) RNA-Seq (CRA_AQ) 
SRR122243 SRX047007: Catharanthus roseus Sterile Seedlings RNA-Seq (CRA_AE) 
SRR122244 SRX047009: Catharanthus roseus Sterile Seedlings RNA-Seq (CRA_AF) 
SRR122245 SRX047010: Catharanthus roseus Sterile Seedlings RNA-Seq (CRA_AG) 
SRR122257 SRX047022: Catharanthus roseus Wild Type Hairy Root RNA-Seq (CRA_AS) 
7.6.3 Co-expression analysis 
For the analysis of co-expression in a large transcriptomic dataset comprising 23 different 
tissues and/or treatments 65 , the MeV (MultiExperiment Viewer, version 4.9.0) software was 
employed to perform hierarchical clustering 25868. The standard settings for hierarchical 
clustering, the Pearson correlation with average linkage clustering, was used. Prior to co-
expression analysis, the larger datasets were filtered to reduce the number of contigs in the 
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individual study. Different hierarchical clustering dendrograms were generated using different 
statistical distance metrics for the clustering algorithm. The position of known pathway genes 
in those dendrograms were analysed and co-expression analysis applying different 
combinations of tissues and/or treatments, depending on scientific question, repeated. 
 
7.7 Protein expression in Saccharomyces cerevisiae 
Enzyme expression in S. cerevisiae was performed using the yeast strain WAT11. This yeast 
strain harbours the A. thaliana cytochrome P450 reductase 143 making WAT11 particularly 
suitable for the expression of plant cytochrome P450 enzymes. For enzyme expression, WAT11 
was transformed 251 with the plasmid pXP218 144 containing the enzyme of interest or an 
empty plasmid as control (Table 42). 
Table 42 WAT11 strains harbouring C. roseus genes. 
 
strain name gene included 
WAT11+pEV empty vector 
WAT11+pT3O T3O  JN613016.1 
WAT11+pT19H T19H AF253415.1 
WAT11+pMAT MAT HQ901597.1 
WAT11+C16 CRO_021081 (sequence in appendix) 
 
 
General information on methods such as preparation of competent yeast cells and yeast 
transformation, cloning of genes into the yeast expression vector, primers, media and growth 
conditions are given above. All LC-MS analyses described in this section are conducted using an 
AQUITY UPLC with a Xevo TQ-S mass spectrometer equipped with a BEH Shield RP18 1.7 μm 
column (Waters) as described in Section 7.4.2. 
For the characterisation of the cytochrome P450 T3O in Chapter 3 a second yeast strain was 
employed. This strain had been engineered 146 using the commercial parent strain BY4741 
(EUROSCARF, Frankfurt, Germany) to constitutively express known vindoline biosynthesis 
genes T16H, 16OMT, NMT, D4H and DAT 34,41,43–45 integrated into its genome. Additionally it 
contains the C. roseus cytochrome P450 reductase 259. The engineering was done by Dr. 
Stephanie Brown (O’Connor lab). This yeast strain (strain A) was additionally transformed to 
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contain a T3O expressing plasmid or alternatively an empty plasmid (strain_A+pT3O or 
strain_A+pEV). 
7.7.1 Large scale liquid cultures and product extraction 
For the production of 16-methoxytabersonine, the expected substrate of the T3O catalysed 
reaction, a 500 ml YPD media culture of strain A was started from a single colony and grown to 
an OD of 0.5 under constant shaking at 30 °C. At that point the culture was supplemented with 
tabersonine (AvaChem Scientific) to a final concentration of 120 µM. Conversion of 
tabersonine was monitored every 24 hours by LC-MS. After 48 hours no tabersonine could be 
detected and the enzymatic product was extracted from the liquid fraction using 3 x 400 ml 
ethyl acetate (EtOAc). The combined EtOAc fractions were dried with Na₂SO₄ and 
concentrated to a yellow oil. As judged by NMR the product eluted as the salicylic acid salt. It 
was therefore re-dissolved in a small volume of EtOAc and filtered through K₂CO₃. The final 
amount of product recovered was 3.9 mg. 
To obtain the uncharacterised product of the T3O catalysed reaction, a 500 ml culture of strain 
A supplemented with 120 mM tabersonine was grown and monitored as described above. In 
parallel, from a single colony of the WAT11+pT3O yeast, a 10 ml culture was grown to an OD of 
1 in the appropriate selective media SC-Ura supplemented with 2% (w/v) glucose. After 24 
hours the cells were spun down at 3000 g for 3 minutes, the pellet was washed with sterile 
water and spun down again. The pellet was used to start a 500 ml culture of SC-Ura 
supplemented for induction with 1% (w/v) galactose and 1% (w/v) glucose and grown to an OD 
of 0.5. At full conversion of tabersonine to 16-methoxytabersonine in the culture of strain A, 
both cultures were spun down and the supernatant (media fraction) of the strain A culture was 
added to the pelleted WAT11+pT3O cells. This culture was allowed to continue to grow under 
constant shaking at 30 °C. It was monitored by LC-MS till almost full conversion of the 16-
methoxytabersonine was observed. Subsequently the T3O enzymatic product was extracted 
using 3 x 400ml EtOAc. The combined EtOAc fractions were dried with Na₂SO₄ and 
concentrated to a yellow oil. The oil was subjected to silica column chromatography. It was 
first eluted with EtOAc. Elution was continued with 10% MeOH in CH₂Cl₂. As judged by LC-MS, 
the product eluted in the last EtOAc fractions and the early 10% MeOH fractions. Consequently 
these fractions were combined, concentrated, and subjected to preparative HPLC using a C18 
column and an increasing gradient of acetonitrile in 0.1% formic acid/water. All resulting 
product-containing fractions were pooled and concentrated to give 10 mg product. 
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7.7.2 Structural elucidation of products obtained from yeast culture 
The product of the first culture was confirmed to be 16-methoxytabersonine by comparing the 
obtained nuclear magnetic resonance (NMR) spectra, as 1H-13C 2D heteronuclear single-
quantum correlation (HSQC) experiments, to reported literature values 147. Data were recorded 
on a Bruker Avance III 400 NMR spectrometer, operating at 400 MHz for 1H and 100 MHz for 
13C respectively. 
The T3O reaction product was analysed and characterised using data obtained from infrared 
spectroscopy (IR), high resolution mass spectroscopy (HRMS) and 1H/13C/15N NMR by Dr. 
Nathaniel Sherdan 146. 
7.7.3 Yeast microsomal extraction 
For yeast microsomal preparation a protocol modified after ref. 145 was used. The buffer TE (50 
mM Tris, pH 7.4, 1 mM EDTA), TEK (0.1 M KCl in TE), TES-B (0.6 M sorbitol in TE) and TEG (20% 
glycerol in TE and a complete protease inhibitor tablet) were prepared prior to microsomal 
extraction. The yeast strain WAT11 expressing the desired cytochrome P450 enzyme was 
grown up from a single colony in a 10 ml overnight culture in the selective yeast media SC-Ura 
supplemented with 2% (w/v) glucose. This pre-culture was spun down, the supernatant 
discarded and the pellet washed twice with water before resuspension in 200 ml of selective 
induction media SC-Ura plus 1% (w/v) galactose and 1 % (w/v) raffinose, to induce production 
of recombinant genes. The culture was grown for 48 hours before it was centrifuged for 5 
minutes at 2000 g. The supernatant was discarded and the pellet resuspended in 5 ml buffer 
TEK and left for 5 minutes at room temperature. 
All subsequent steps were carried out on ice or at 4oC. After a second centrifugation step at 
2000 g for 5 minutes the pellet was resuspended in 2 ml cold buffer TES-B. The cells were lysed 
using a cell disruptor applying 25 KPSI twice. The lysate was centrifuged for 10 minutes at 11 
000 g to separate un-lysed cells and cell debris (pellet) from the microsomal fraction 
(supernatant). The supernatant was collected and spun down 180 minutes at 35 000 to 40 000 
g. The resulting pellet was carefully resuspended in a small volume (150–300 μl) TEG by gently 
stirring it with a pipette tip. After 10 minutes on ice, aliquots of the resuspended pellet were 
transferred to fresh 1.5-mL tubes and stored at –80oC for further use. 
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7.7.4 Bradford assay to determine protein concentration 
The total protein concentration of the yeast microsomal fraction was assessed using the 
Bradford method 260. Microsomal protein content was determined using Bradford reagent 
(SIGMA, cat. No. B6916). A standard curve for absorbance relative to protein concentration 
was generated using known concentrations of bovine serum albumin (BSA) in the range of 62.5 
µg/ml to 1 mg/ml, with each concentration measured in triplicate at 595 nm. 
7.7.5 Yeast microsomal enzymatic assays 
Assays consisted of substrate, 55 µg microsomal protein extraction, 1 mM NADPH, 4 mM DTT 
and 100 mM phosphate buffer pH 7.0 in a total volume of 100 µl. The assays were stopped by 
adding 1 volume of methanol. Substrates such as commercially available tabersonine, 
ajmalicine and serpentine were used. Additionally, 5 µl aqueous leaf extract prepared as 
described below were also used as a substrate. 
Aqueous leaf extracts were obtained by incubating approximately 100 mg of leaf tissue in 
which the T3O gene had been silenced with VIGS tissue with 2 ml methanol for 60 minutes at 
57°C. The methanol extract (500 l) was applied onto a C18 column (Kinetex, 100 x 2.1 mm, 
C18, 1.7 µm), eluted with 500 l of water and assayed with extracted microsomes. 
7.8 Methods for whole genome sequencing and BAC library 
Sequencing was carried out at The Genome Analysis Centre (Norwich, UK, 
http://www.tgac.ac.uk/main-icons/platforms/sequencing-platforms/) after constructing a 
single TruSeq genomic DNA library that was sequenced on an Illumina HiSeq and required a 
minimum of 5 µg high quality genomic DNA. Genomic DNA extraction is described under 7.8.1. 
For the construction of a mate pair library further material was obtained but only a crude DNA 
extraction was performed and can be found under 7.8.2, as the following steps were 
conducted at our collaborator Robin Buell’s Lab at the Department of Plant Biology of the 
Michigan State University (MSU, East Lansing, USA). 
7.8.1 Genomic DNA extraction for sequencing 
Material for whole genome sequencing was obtained from purified nuclei of four individual 
plants. Young leaves of 12 week old plants of C. roseus “SunStorm Apricot” was harvested, 
using primarily young leaves. Plants were grown in a growth chamber at 25°C with 12 h 
light/12 h dark as previously described. Prior to tissue harvest plants were kept in the dark for 
two days to reduce levels of metabolites such as carbohydrates or polyphenols contained in 
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tissue 261. The material combined was 27 g of young leaf tissue. A modified protocol was used 
218,262,263. 
7.8.1.1 Isolation of nuclei, DNA extraction and dialysis 
The tissue was ground to a fine powder under liquid nitrogen. Prior to extraction 500 ml of TKE 
buffer with 0.1 M Tris, 1 M KCL, 0.1 M EDTA (the pH was not adjusted) and subsequently 1000 
ml of a modified sucrose-based extraction buffer (SEB) 10% v/v TKE, 500 mM sucrose, 4 mM 
spermidine, 1 mM spermine tetrahydrochloride, 1.2 g/L PEG 8000 and 0.2% v/v ß-
mercaptoethanol (BME) was prepared fresh. The SEB buffer was prepared fresh and adjusted 
to pH 9.5 with HCl. The SEB with BME mixture had to be stored on ice. 
SEB buffer with 10% v/v Triton X-100 (15 ml per gram of leaf tissue) was added to the 
powdered material and gently stirred. The mixture was kept on ice for further 10 minutes. 
Using a funnel the mixture was filtered through two layers of Miracloth (Merck Millipore, cat. 
No. 475855-1R) squeezing gently to obtain more nuclei. 1/20 volume of SEB + BME/Triton was 
added to the filtered mixture and left on ice for further 10 minutes with 20 seconds of gentle 
swirling every 2 minutes. The mixture was transferred into 250 ml polypropylene centrifuge 
tubes and centrifuged at 650 g for 20 minutes at 4oC. The supernatant was pipetted off 
without disturbing the pellet. A small amount of SEB + BME (<1 ml) was added to the pellet 
and the nuclei were resuspended by gently shaking. More SEB + BME was added to a total 
volume of 20 ml. This wash step was repeated twice. From a 20% (w/v) aqueous solution, SDS 
was added to a final concentration of 2% (w/v) to lyse the nuclei. The content of the tube was 
mixed by gentle inversion. The tube containing the nuclear lysate was heated in a water bath 
to 60°C for 10 minutes and then left to cool to room temperature. Sodium perchlorate was 
added to a final concentration of 1 M. The lysate was spun down in a swinging bucket rotor at 
500 g for 20 min at 10°C to pellet the starch grains. The supernatant was transferred to a new 
15 ml polypropylene tube using a 1000 µl plastic pipette tip from which the bottom third had 
been cut off to minimize shearing of the DNA. To extract the DNA the nucleic acid solution was 
mixed with an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1). To minimize 
shearing of DNA while mixing the organic and aqueous phases, a test tube rocker (VariMix, 
Thermo Scientific) was used at 18 cycles per minute for 15 minutes. The mixture was 
centrifuged at 3000 g in a swinging bucket rotor for 10 minutes. The upper aqueous phase was 
transferred into a new sterile polypropylene tube to perform a second extraction as described 
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above. The so obtained aqueous phase was dialysed for 16 hours into 5 l of 10 mM Tris-HCl, 1 
mM disodium EDTA (TE) buffer (pH 7.0) at 4°C under constant gentle stirring using. 
7.8.1.2 RNase & proteinase digestions, extraction and precipitation 
The dialysed DNA sample was treated with RNase A/T1 mix (Thermo Fischer Scientific, cat. No. 
EN 0551) to remove RNA from the DNA sample. According to manufacturer’s instructions 20 µl 
of RNase A/T1 mix were used for each ml of DNA sample and incubated at 37°C for 60 minutes. 
Next the DNA sample was supplemented with 150 µg/ml Proteinase K (Roche, cat. No. 
03115887001) and incubate at 37°C for 60 minutes to inactivate proteins such as RNases and 
DNases. Two more phenol/chloroform/isoamyl alcohol extractions followed as described 
above. The aqueous phase was transferred to a clean tube to determine volume and one-tenth 
volume of 3 M sodium acetate (pH 5.2) was added. The solutions were mixed by inverting the 
tube several times. Two volumes of ethanol were added and mixed thoroughly. The 
precipitated DNA was collected by centrifuging the mixture again at 20 000 g and 4°C for 30 
minutes. The supernatant was discarded, 1 ml 70% ethanol added and the centrifugation 
repeated. The supernatant was discarded and the remaining pellet allowed to air dry for 2 
hours at room temperature. The pellet was resuspended in 100 µl water. The DNA 
concentration was quantified (Qubit, Thermo Fischer Scientific) to be 10.8 ng/µl. Therefore the 
extraction of 27 g young leaf C. roseus tissue resulted in 10.8 µg high molecular weight DNA. 
The DNA quality was checked for evidence of shearing or RNA contamination. For this purpose 
200 ng of genomic DNA were run on a 0.6% agarose gel. 
7.8.2 Material for mate pair library 
Prior to extraction, 200 ml of 2 x CTAB buffer were prepared using 4 g 
cetyltrimethylammonium bromide (CTAB), 5 M NaCl, 1 M Tris-HCl (pH 8.0) and 0.5 M EDTA. 
Additionally 1% (w/v) of polyvinylpyrrolidinone (PVP) and 0.5% (w/v) activated charcoal were 
added 264. Obtained from the same set of plants as described above, 5 g of young leaves were 
harvested and ground under liquid nitrogen. CTAB buffer (10 ml) was added after all liquid 
nitrogen had evaporated. The mixture was incubated in a water bath at 65°C for 1 hour and 
mixed by inverting every 10 minutes. After cooling to room temperature the mixture was 
shaken using a test tube rocker (VariMix, Thermo Scientific) at 18 cycles per minute for 10 
minutes. An equal volume of chloroform/ isoamyl alcohol (24:1) was added. The sample was 
spun down for 10 minutes at 2000 g and the supernatant was transferred to a fresh tube. An 
equal volume of isopropanol was added and the centrifugation repeated. The DNA formed a 
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pellet that was extracted and transferred to a tube containing 70% ethanol. The mixture was 
inverted several times to wash the DNA and spun down for 15 seconds. The ethanol was 
removed and the pellet was left to dry at room temperature for 2 hours. The dried pellet was 
resuspended in TE buffer and sent to the Buel laboratory for sequencing. 
7.8.3 Test PCRs to verify C. roseus assembly 
After receiving the assembled draft genome of C. roseus the scaffolds were inspected manually 
for clustering of known pathway genes. To verify the most important of these findings, PCR 
from genomic DNA was employed to further strengthen the evidence for the existence of the 
clustering evident in the draft genome of C. roseus. Primer employed for this purpose are given 
in Table 43. 
Table 43 Primers for verifying observed clustering of pathway genes 
Target gene Primer name   Target band size 
TDC TDC fw TAC TTG GAT GGA ATC GAA CG 
6849 bp 
STR STR rev GAA TTC TGA TGG CCA TTT TT 
7.8.4 Methods specific for BAC library 
BAC library construction was carried out at Bio S&T Inc. (Montreal, Canada). Briefly, for library 
construction the pIndigo-BAC5-HindIII vector (Epicentre Technologies) was employed. High 
molecular weight DNA was cloned into the HindIII site of this plasmid. The obtained clones 
were maintained in the E. coli strain DH10B. The library was pooled in a 96-well plate with 
each well containing approximately 500 independent primary clones. The library was 
confirmed to have 10x coverage and an average insert size of 155 kb (personal 
communication, Areti Karadimos). The company Bio S&T required a small amount of genomic 
DNA to serve as a positive control when screening the BAC library. This was taken from the 
remaining material of the genomic DNA extraction described above. 
7.8.5 Plant material 
Plant material was harvested from the same plants as were used for the whole genome 
sequencing material to ensure consistency of obtained sequence data. As described before 
plants were kept in the dark for two days prior to tissue harvest. Young leaves (25 g) were 
immediately frozen in liquid nitrogen and sent to Bio S&T Inc. (Montreal, Canada). 
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7.8.6 Gene specific primer for BAC library screening 
Screening the BAC library required gene specific primers that bind exclusively to the target 
gene and produce a band of a size between 200 to 500 bp. For the identification of suitable 
primers that would amplify specific bands of the desired length the same genomic DNA 
prepared for the whole genome sequencing project served as template.  
For the initial screen for three pathway genes the assembly of the whole genome sequence 
was not yet available, therefore the exact intron exon structure of the target genes was 
unknown and many primer pairs had to be tested. Especially for SGD this required substantial 
optimisation. The final band for SGD was only 167 bp long as no primer pair resulting in a 
longer band could be obtained. 
 
Table 44 Primers for screening the C. roseus BAC library 
Primer sequences and expected band size for screening of the C. roseus BAC library. Three gene were 
targeted in the initial screen (SGD, T16H2 and ISY), a second screen was targeted at the genes STR and 
MATE, while the failure to retrieve SGD in the first round resulted in an additional screening for this 
gene with a second primer pair. 
Target Primer Sequence Band size 
SGD 
BAC_SGD fw GGA CGA CTT TCA ATG AAC CAC ATA C 
167 bp 
BAC_SGD rev CCT ATA TAC TTC CAC AGC AGC TTT GT 
T16H2 
BAC_T16H fw TGA TTG GAA ACT TGC AGT GAT GA 
265 bp 
BAC_T16H rev TAC AAT GGA TTA GCA ACG AAA TCT TCC GTA GC 
ISY 
BAC_ISY fw TTG AGT ACA TCC AAT GTG ATG TCT CA 
422 bp 
BAC_ISY rev TGT ACT GAC AAT GTT CAT. CAT. ACT ACA TGG 
MATE 
BAC_MATE fw GCC AAG TGT CCT TAG TCC TAT CAC TAT ATA G 
377bp 
BAC_MATE rev TCT AAC CCT AAC AGG CAT. TGT TAT TAT GTT TG 
STR 
BAC_STR fw TTG AAT GGC ACT TCT TGC ACA CT 
150 bp 
BAC_STR rev ACC ATT GTG TGG GAG GAC ATA TGA TA 
SGD 
BAC_SGD (2) fw ATG GTG TGA ATG TAA AAG GAT TCT TTG TT  
362 bp 
BAC_SGD (2) rev TTG CTT ATT GAA GTA CCT TAA AGA GCG GT 
 
7.8.7 Testing BAC integrity 
An E. coli LB stab of each of the by Bio S&T Inc. positively identified BAC clone was received 
together with 20 µl of a plasmid DNA of the same clone as positive control. Before large scale 
BAC plasmid extraction, the integrity of the received BACs was tested by colony PCR by 
restriction digestion with NotI.  
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For each clone the LB stab material was transferred to a selective plate (LB agar with 12.5 mg/l 
chloramphenicol) and grown overnight at 37°C to obtain single colonies. From those colonies 
10 ml overnight liquid cultures were prepared (LB with 12.5 mg/l chloramphenicol). The 
overnight cultures were tested by PCR to verify the right insert using the same gene specific 
primers as for the screening of the BAC library (Table 44). Glycerol stocks were made of 
positive cultures. 
Starting either from glycerol stocks with a fresh 10 ml overnight culture or from the overnight 
culture directly, a protocol modified after 265 was employed. Briefly after spinning down the 
culture (3000 rpm, 10 minutes at 4°C) the obtained pellet was resuspended in 200 µl 
resuspension buffer P1 (Qiagen, cat. No. 19051, without added RNAse) and transferred to a 1.5 
ml Eppendorf tube. The cells were lysed with 400 µl of Buffer P2 (Qiagen, cat. No. 19052) and 
neutralised by adding 300 µl of buffer P3 (Qiagen, cat. No. 19053). After centrifuging (3000 
rpm, 10 minutes at 4°C), the supernatant was transferred to a new Eppendorf tube and to 
precipitate the DNA, 600 µl of 100% isopropanol were added, mixed by inversion and 
subsequently centrifuged at high speed (13,000 rpm, 10 minutes at 4°C). The supernatant was 
removed and the pellet was washed with 500 µl 70% EtOH and centrifuged again. After 
removal of the supernatant the pellet was dried using a Savant SC210A speed vac concentrator 
for 15 minutes at medium setting. The pellet was resuspended in 50 µl LB buffer and left at 
room temperature for one hour. RNA was removed by adding 2 µl 10 mg/ml RNAase (RNAase 
A, Qiagen, cat. No. 19101) for one hour at 37°C. The DNA concentration of each extraction was 
measured on a nanodrop spectrophotometer (NanoDrop, ND 1000).  
It was found that the yield for each BAC and each individual extraction was highly variable and 
the obtained material amount often insufficient for downstream applications. Additionally 
glycerol stocks of previously positive colonies did not maintain the plasmid consistently. 
Therefore the small scale extraction was optimised by starting two to three 10 ml overnight 
cultures from the same initial colony. To avoid loss of plasmid, enough material from the 10 ml 
cultures was kept to start one or two 500 ml cultures per construct, depending on yield of 
individual candidates, for the large scale BAC plasmid extraction. 
7.8.8 Large scale BAC plasmid extraction for sequencing 
Once it was confirmed the BAC culture contained the expected BAC and that the integrity of 
the BAC had not been compromised, one or two 500 ml cultures for each candidate were 
started and grown overnight for 12 to 16 hours. For extraction of the plasmid, the Large-
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Construction Kit (Qiagen, cat. No. 12462) was used according to manufacturer’s instructions. 
After pelleting the bacteria and alkaline lysis of the pellet, the DNA was precipitated with 
isopropanol and washed with 70% ethanol before being treated with ATP-dependent 
exonuclease to minimise contamination with genomic DNA and nicked BAC plasmids. Instead 
of the supplied Qiagen-tip 20 columns, the Qiagen-tip 500 columns (Qiagen, cat. No. 10262) 
were used for efficient binding, washing and subsequent elution of BAC DNA in this large scale 
application. The eluted DNA was precipitated a second time with isopropanol, centrifuged and 
the resulting pellet washed with 70% ethanol, dried and finally resuspended in TE buffer and 
concentration of DNA was determined using a nanodrop spectrophotometer (NanoDrop, ND 
1000).  
7.8.9 BAC sequencing and assembly 
BAC sequencing was conducted by the group of Robin Buell from Michigan State University 
(MSU, East Lansing, USA). Briefly, from the obtained BAC DNA a single TruSeq DNA library was 
constructed and sequenced on a MiSeq (150-nt or 250-nt paired end reads).  
After sequencing data was received, the BAC assemblies were performed using MIRA, version 
4.0rc4 (http://sourceforge.net/projects/mira-assembler). The total amount of sequencing data 
was reduced for optimal assembly and only the first 50 000 read pairs of each dataset were 
used for further processing. Each read was aligned to the vector sequence (EU140754.1) and 
the genome sequence of E. coli strand K12, sub-strand DH10B (CP000948.1). Only reads with a 
BLASTN hit 266 with an e-value less than 1E-10 to the vector within 1 kb distance to the 
restriction site and reads without any hit to E. coli or vector were used in the assembly. 
Remaining vector parts were clipped from the assembled scaffolds. The assembly was 
repeated using the first 100 000 read pairs but this did not change the assembly result 
significant and was there for discarded. The assembly data for the T16H BAC and the SGD BAC 
are deposited to NCBI under ERX556143 and ERX556142 as part of the publication of the C. 
roseus genome 68. 
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9 Appendix 
 
9.1 Additional data for Chapter 4 
Sequence for gene expressed in yeast in Chapter 4.2.13. 
>CRO_021081 
ATGGATGCTTTGCTTAATCCTGTTTTAATCATCACAATAGCTTTTGCTATCGGTTTCACAGTATGTTTCTT
GAAGATTATGAATCCAGGATTACCGGGGAAGAAAAGGAGGTATCATCCTGTTGTTGGCACCATCTTCA
GCCTGCTATTTAACTTCCACAGGCTGCATGATTATATGGCTGATTTGGCAAGCAAATACAAGACATATA
GACTGCTTAACTTTTTCCAGAGGGACTTGATTTATACTGCAGACCCTGCAAATGTTGAATACATTCTGAA
AACAAATTTTCCCAACTATGGCAAGGGATTGTACCACCATGGCATTTTGAAAGATCTTCTTGGCGATGG
TATTTTCACAGTGGACGGTGAAAAGTGGCGACATCAGAGGAAGACATCAAGCTATGAATTCTCCACCA
AAATACTGAGGGACTTCAGCAGTGGAGTGTTTAAAGTCATTGCAGTAAAGCTTTCTAATATAATTTCTG
AAGCTTCATCGTCAGATCAAATTATAGAAATCCAAGATTTGTTCATGAAGTGCACTCTTGACTCGGTCTT
TAAGGTTGTTCTTGGTGTTGATCTGGACAGCATGTGTGGAACTCATGAAGAAGGCACACATTTTTCCCA
GTGTTTCGATGAAGCAAGTGCGATAACCATGTTCCGGTATGCTGATGTATTCTGGAAATTGAAAAGGAT
ATTGAACATTGGATCAGAAGCAATATTGAAGAAAAATATCAAAGTGATTGATGAATATGTTTACAAGAT
TCTCAAAAGCAAAACTGAGTCACTTGATGATAGCCCTATGAGAAAGAAAGAAGACCTTTTGTCAAGATT
TCTGGAAACGAACGAAACAGATCCCAAGTATCTAAAAGATATCATCCTTAGCTTCATAATTGCTGGGAA
GGACACTACTGCCAGCACTCTTTCCTGGTTCTTCTACATGATTTGCAGCTACCCTCACCTACAAGAAAAA
ATCGCTGACGAAGTGATGAAAGCGACAAATGTCCAGGAGAAGAATTTCTCCATTAGTGAATTAGCAAA
CAGCATCACAGAAGAAGCCTTGGACAAAATGCAGTATCTTCACGCAGCCTTAACCGAAACACTCAGACT
CTATCCTTCAGTTCCTGTGGATGGTAAGGTGTGCTTTTCGGATGATATATTTCCGGATGGATACTGTGTC
AAGAAAGGAAATGTTGTATCATACGTACCGTGGTCTATGGGCAGGATGAAATTCATATGGGGAGATGA
TGCTGAAGCTTTCAGACCAGAAAGATGGCTAGATGAAAATGGCGTCTTCAAACAAGAAAGCCCATTCA
AATTCACAGCATTCCAGGCAGGGCCAAGGATCTGTTTAGGGAAGGAATTTGCTTACAGGCAGATGAAG
ATCTTCTCAGCTGTCTTGTTGGGCAGTTTCATGTTCAAGTTGAGTGATGAACAGAGAACTGTGAGCTAC
AGAACAATGCTGACGCTGCACATCAATGGAGGATTACATATTCGTGCTTTCCTGAGGCCAAATTCTTCA
GGTGCTTAA 
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9.2 Additional data for Chapter 5 
Sequences of all VIGS candidates used for silencing. 
VIGS C2: 
GCTGAATCATCCTCATCAACAATGGAATGGGCAATGTCTGAAATGATAAAAAATCCAAGAATAATGAA
GAGGGCACAAAAAGAGGTTAGAGAAGTCTATAATAAAGAAGGAAATGTGGATGAATCAAAGCTTCA
TGAATTAAAATACCTTCAAGCCATTATTAAAGAAACTCTAAGACTTCATCCAAGTGTTCCACTTTTGATT
CCAAGAGAATCTCGTGAAGAATGTGAAATTAAAGGGTATAGAATACCAGCTAAATGTAGGGTTCTGG
TTAATGGTTGGGCAATCGGAAGAGAT 
VIGS C3: 
ACTATAATTTCTCCGAGCTGAAATTACCTGTTCATGCTGGTACCCATGTAGATGCACCAGGGCATATGT
ATGATAATTACTTTGATGCCGGATTTGATGTGGATTCTCTTGACCTAAGAGTCCTAAATGGTCCTGCAT
TGCTAATTGATGTTCCAAGGGAGAAGAACATAACTGCTGATGTCATGAAGTCCTTACACATCCCTAGG
GGAGTGAGACGAGTACTTTTTAGAACATTAAACACTGACAGGCGGCTGATGTACAAGAAGGAGTTCG
ACACAAGTTATGTGGGATTCATGAAGGATGGAGCACAGTGGCTTGTGGATAACACTGATATCAAACT
TGTTGGAATTGATTACTTGTCTG 
VIGS C4: 
GAAGCTAGTTGTTGTTGGTGCACCAAATAAACCAGTTGAATTAGATATTCTATTTCTTGTCATGGGAAG
GAAAATGCTCGGAACATCTTCTGTTGGGGGAGTGAAGGAGACACAAGAGATGATCGATTTTGCAGCA
AAACATGGTATAGTTGCAGATGTAGAAGTTGTGGAAATGGAGAATGTGAACAATGCAATGGAGCGG
CTTGCGAAGGGGGATGTTAGATATAGATTTGTTCTTGATATTGGGAATGCAACAGTAGCTGTCTGATA
AATAATGTTTAATGCAATTCTTTATTTAGTTGTTGCCACAAATTCACCCAGAATGCATGTACCAACATTT 
VIGS C5: 
AACTTCGGCCATTTGGTATCCATGTTATAAATGTAGTACCTGGAGCAGTGAGGTCTAACATAGGAAAT
TCAGCTATTGCAAATTACAGTAAGATGCCAGAATGGAAGATATACAAGCAATTTGAAGAAGCAATTCG
AGCAAGAGCGTTTCTTTCACAGGGCCTGAAAGCAACCCCGGCAGAAGAGTTTGCAAGAAAGACGGTG
AATGTTGTGCTGAAGAAGAATCCCCCAGCTTGGTTCTCTGCAGGACAGTACTCAACAGTAATGTCAAT
CATGCACCATTTGCCACTTTCTATTAAAGA 
VIGS C6: 
ACCATACTTCATATCAGATGGCTCACCAATCAATAGTTTTGAGTTTATTCGTCCATTACTTAAGAGCCTG
GATTACGAACTACCGAGTAGGTCAGTAGCCGTTTCCCATGCACTTGTTTTGGGAAATTTCTTTACAGCT
CTCTACTCTGTTATGTATCCATGGTTGAATCAAAAGTGGCTTCCGCAGCCCTTCATCCTTCCTGCTGAA
GTCTACAAGGTTGGCGTAACGCATTACTTTTCGTTTTTGAAAGCAAGAGAGGAGCTTGGCTACATCCC
GATGGTGAGCCCTAAAGAGGGTATGGCTGCAACCATCTCATATTGGCAAGATAAGAAGAAGAGAGA
ATTGGATGGACCTACAATATATGCATGGTTATTTGCAGTGATTGGAATGTTGCTATTATTTGCAGCTGC
TTAC 
VIGS C7: 
TTCTTCCTCCACTTTCTGCTCTCAAAACCCACGCAGTCCCTCTGCTTTTACCTCTGGAACTGCAAATGCA
AACAGGGGTTTTTTATCATCGAGATTATTCTCTGCTTTGTCACTGAGAAACTCGGCAAGTTTTGGTAAT
TTGAAGGGAAAATGTAAAATCGGTGGGCGTGGAATTGGAATTATGTGCTCTGCTGCTACTGTTCCGCA
GGCTCTGCTGTTTGATTGTGATGGTGTTCTTGTTGATACTGAGAAAGATGGCCATCGCATTTCTTTCAA
TGACACGTTTGCTGAAATGGAATTGGGTGTCACCTGGGATGTAGATT 
VIGS C8: 
CAGAAGTTTGACGTGGAGCTGAAGGGATCACCGGAGGATGTAGAACTTGTTACCGGAGCAACAATCC
ATACAAAAAATGGATTGTGGTGCAGATTGAGGAAGAGGTGAAATTCCAGGATAAAGTCCTCTGATGA
AGAAGAGGTTTGAGACATTTTGGTAGCAATTTCTTTCTAAAACTAGTGTACATAACCTGTGTAAACTAT
AGGCATGACAATGTGGGGAGAAGTAAAATTTTCAAGTGGATAAAGATTCTCTTTTAATGCTTCTCTCTC
CACATGAAACTGTGATCAAAATCCTTGTTGCCTAAGTTGTATAATACAGTTTTGCTCAGGGAATTTGGT
TGAAG 
222 
 
 
VIGS C9: 
CCTTTGTCGTTGTATCAGATCCTATTGTTGCAAGATACATTCTTCGCGAAAATGCATTTTCTTATGACAA
GGGGGTTCTTGCAGAAATTCTAGAACCAATCATGGGAAAAGGGCTAATACCTGCAGACCTTGATACTT
GGAAACAAAGGAGAAGAGTCATTGCTCCTGGATTTCACGCATTATACTTGGAAGCCATGGTCAAAGTT
TTTATGGACTGTTCAGAACGAACAACATCAAAATTTGTAAGGCTTCTTGAGAAAGAAGAGTCAAAAG
GAGGGAAGACCATTGAGCTGGATCTTGAAGCAGAATTTTCCAGCTTAGCACTAGATATTATTGGGCTT
GGAGTTTTCAATTATGACTTTGGCTCTGTTACCAAAGAATCTCCTGTTATTAAGGCTGTATATGGTAC 
VIGS C10: 
TTCAGTGTCATGATGTAATGCAGTTAAGGMCACATAGAACTGTGTATCAGCTGGAATGTTTAGYTTTC
CCAACTTGATATCCTTTGATGTTTTCCTCGTCTGWTGGACTRCTGGTGGATAGAGCCGAAGCGTTTCG
TTCAGTATCATCGTCACAAGCTTAAAATCATTTAGGRTCTCTGCATTTGGAAGCACATTGCCCTTGCAA
ACCTGCAAAACTTCTTCTCGTGCTTTACTTTGCCATTCTTG 
VIGS C12: 
TCAATGGAGAGAAAAGGTGAGGTTGAGATTAAAAAAGTGTTGCATTTTGGGTCTTTAAACAATGTCAT
GATGAGTGTGTTTGGAAAATGCTATGATTTTTGTGAAAAAAGTGGAAATACTGAAGGGTTTGAACTA
GAAAGTTTGGTAAATGAAGGGTATGAGTTGTTGGGTATTTTTAACTGGAGTGATCATTTTCCTGTGTT
GGGTTGGTTGGACATGCAAGGTGTGAGGAAGAGGTGCAAGGCTTTGGTTAGTAGAGTCAATGTTTAT
GTTGAGAAAATCATAGAGGAGCACAGGCAGAAAAGGGCTGAGAATGGCGGAAGAATTTCTGAGTCT
GAGGATTATATTAATTCTGGTACTGGAGACTTTATGGATGTTCTATTGGATT 
VIGS C13: 
GTTGGTCTAGGTGGACTTGGTCATTTAGCTGTGAAGTTTGGCAAGGCTTTTGGGGCCAAAGTCACTGT
AATTAGTACCTCTCCAAGCAAGAAAGATGAAGCTATCAATTTTCTTGGTGCTGATGGCTTCTTGGTCAG
CGGTGATGCTGAACAAATGCAGGCTGCTGCTGGAACCTTGGATGGGATTATTGATACCGTGCCTGTT
GTCCATTCTATTGAGACCTTGCTATGGCTTTTGAAGAATCATTCCAAGCTTGTTTTGGTTGGAGCTACA
GGGGGCTCATTCGATTTGCCAATTCTTCCTTTAGCAATGGGCAGAAGAACTGTGGCTTCAAGCATTGG
TGGAAGTACGAAGGAGGCTCAAGAGATGCTGGATTTTGCAGCAGAACATAA 
VIGS C14: 
GAGTTAGAGTTGGTATAGTTGGTCTAGGAGCAGTTGGACATTTAGCTATTAAATTTGCAAAAGCTTTT
GGTGCTAGGGTTACTTTGATCAGTTCATCCCCTGGAAAAAAGGATGAGGCTTTTCAGAAATTTGGTGT
AGATTCTTTCTTGGTCAGCAGTAATGCAGAGGAAATGCAGGCTGCAGCTGAAACTCTGGATGGTATCC
TAGACACTGTACCAGTGGTTCACCCCCTTGAGCCACTCTTTGCTTTACTGAAACCTCTTGGGAAACTTA
TCATTATAGGTGAACCGCATAAGCCTTTTGAGGTATCCGCAATGTCCCTCATGGAGGGTGGAAAAATA
ATTAGCGCGAGTACGGGTGGAAGTATAAAGGACACACAAGAGATAGTCGATTTTGCAGCAGAACATA
AC 
VIGS C15 : 
CACCGTTGGAAGAACTAACCGCAATCTTCTTAGATGCAATAAAGGTTGGTTACCGGCACTTCGACACG
GCTTCGAGTTACGGCACAGAGGAGGCACTTGGTAAAGCCATAGCTGAGGCTATAAACAGCGGTTTGG
TTAAAAGTAGGGAGGAATTCTTCATCAGTTGTAAGCTGTGGATTGAAGATGCAGATCATGACCTTATC
TTGCCTGCCCTCAACCAGTCACTTCAGATTCTTGGGGTTGATTATTTGGATCTATATATGATACACATG
CCGGTGAGAGTGAGGAAAGGTGCTCCCATGTTCAATTATTCAAAAGAGGATTTCCTTCCATTTGACAT
ACAAGGTACATGGAAG 
VIGS C16: 
CCATTTGGTGCTGGACGAAGAATTTGCCCCGGCATGTCATTTGCCATACCTAATGTTACGTTGCCGCTG
GCACAATTATTGTTACACTTCGATTGGAAATCAGCCGATGGTAAACTCGAAGATTTGGACATGACTGA
AGGTTCGAGTTTGACAGTTAGACGAAAGAATGAACTAGAGTTGATTCCATCAACTTATTACAAATCTT
GTC 
VIGS C18: 
TTTATGCAAACTCATGGCCTAAACTTTGCGGATAGGCCACAGACTGTTATTGCCAAGATCATGATGTAC
AATTGTTCAGGCGTTACACTTTCAATGTACGGCGATTATTGGAGAAAATTGCGGCAAATTTATGTCAC
GGAATTACTTAACACAAAAAGTGTACAATCATTTTCTTCCATCATGGAAGAAGAGCTCATTCTTATGGT
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TAAATCTATTGAGTCAGAAGTTGGGAAACCTATGGAATTGATTGAGAAAATTCGGTCATATTTATTTG
ACACACTTTGTAGATCAGCACTTGGTAAAATACATGGTAAAGGGAAGGAGACATTAATTGAGATAAG
CAGAGAAATGGTGGCACTTTCTGGAGTACAAACNCTAGAAGATATTTTTCCTTCAGTGAAGTTATTTTC
ATATTTGAATCCATTGAGGCCCAAAGCAAAGAAG 
VIGS T3O: 
TTGAGCAAATTGATGACGTCATGCACAAATTCAATTATTAATAAAGTAGCTTTTGGTAAAGTACGTTAT
GAACGGGAGGTGTTTATTGATCTAATTAATCAAATATTAGCATTAGCAGGCGGTTTTAAGCTGGTTGA
TCTGTTTCCGTCCTACAAGATACTTCATGTTCTTGAAGGTACAGAACGTAAGCTGTGGGAAATCCGCG
GTAAGATTGACAAGATTTTGGATAAAGTCATAGACGAGCACAGAGAAAATTCGTCAAGAACTGGAAA
GGGCAACGGTTGTAATGGCCAGGAAGATATAGTTGATATTTTACTTAGGATTGAAGAGGGTGGTGAT
CTTGACCTTGATATTC 
VIGS C30: 
ACCAGGTCCAAGAACACTACCCTTAATTGGAAACCTTCATCAACTCTCGGGACCTTTACCTCATCGTAC
CCTAAAAAATTTGTCCGATAAACATGGTCCTTTGATGCACGTGAAAATGGGCGAACGTTCGGCAATTA
TAGTATCAGATGCAAGAATGGCAAAAATAGTTCTTCATAATAACGGTTTAGCCGTTGCAGATCGGTCA 
VIGS C32: 
TAACAGCAAGAACTTCATTGATGCTTTCCCCAGCCACCTCATTAATAGGAACTGCATCACTAATCTCTT
GCAAATCTTGTTTTGTCAGCTTTACTTTCACTGCACCAACGTTATCGTGAAGATTTTTAATCTTCGTGGT
ACCAGGAATAGGTACCACATCATCGCCCTGATGAAGAACCCAAGCAAGAGAAAGTTGAGCAGGAGTA
CATCCATGCTTTTGTGCCAAGGCTTCTATACGATAATATATTTGCTTGTTCTTTTCAAGGTTCTCCCCTGT
AAATCTGGGATGTATTGCCAAGAAACTACTTTGTGAAAGGCTTTCCGTAACAGCCTTCCCAGCAAAAA
GACC 
VIGS C36: 
ATGGTCCAAACACAGAAGAATCATTTCCCCTGCCTTCACTCTTGAGAAACTAAAGTCAATGTTGCCGGC
TTTTGCCATATGCTATCATGACATGTTGACGAAATGGGAGAAATTAGCAGAAAAAGAAGGATCCCAT
GAAGTTGATATCTTCCCCACATTTGATGTTTTGACAAGTGATGTAATTTCAAAGGTTGCATTTGGTAGC
ACATACGATGAAGGAGGCAAAATCTTCAGACTATTGAAAGAACTCATGGATCTCACAATTGATTGCAT
GAGAGATGTCTACATCCCAGGGTGGAGCTACTTGCCAACCAAGAGGAACAAGAGGATGAAAGAAAT
TAACAAAGAAATCACAGATATGCTAAGGTTC 
VIGS C38: 
CTTCGCCTACGCATCTCCCTTCTGGAACAAAGCTTTTTGTGAGAACAGCACCGATCCAGAGAAAAGAC
CATTGTGTGGGAGGACATATGATATTTCCTATGACTATAAGAACAGCCAAATGTACATTGTTGATGGC
CATTACCATCTTTGTGTGGTTGGAAAAGAAGGTGGGTATGCCACACAACTAGCCACAAGTGTGCAAG
GAGTGCCATTCAAATGGCTCTATGCAGTAACTGTTGATCAGAGAACAGGGATTGTTTATTTCACTGAT
GTTAGCTCCATACATGATGACAGTCCCGAAGGTGTGGAAGAAATCATGAATACAA 
VIGS C39: 
TGGAATCGAACGAGTTGACTCACTGAGTCTGAGTCCACACAAATGGCTACTCGCTTACTTAGATTGCA
CTTGCTTGTGGGTCAAGCAACCACATTTGTTACTAAGGGCACTCACTACGAATCCTGAGTATTTAAAAA
ATAAACAGAGTGATTTAGACAAAGTTGTGGACTTCAAAAATTGGCAAATCGCAACGGGACGAAAATT
TCGGTCGCTGAAACTTTGGCTCATTTTACGTAGCTATGGAGTTGTTAATTTACAGAGTCATATTCGTTC
TGACGTCGCAATGGGCAAAATGTTCGAAGAATGGGTTAGATCAGACTCCAGATTCGAAATTGTGGTA
CCGA 
VIGS C41: 
ATGAAGGTGATAGAGAAGATCAACGATGCCATTGCCGCTGACAAGGTGGTCTTCTCGTTCGAGTTTTT
TCCACCGAAGACTGAGGACGGAGTGGAGAATCTGTTCGAGAGAATGGACCGTATGGTAGCTCACAAT
CCTTCCTTCTGTGATATCACTTGGGGAGCTGGAGGATCCACTGCGGATCTGACTTTGGAGATCGCTAA
CAGAATGCAGAACATGGTTTGTGTGGAAACTATGATGCATCTCACTTGCACCAATATGCCTGTGGAGA
AGATCGACCACGCTCTCGATAGTATTAAATCCAATGGCATCCAGAACGTGCTCGCTCTTCGAGGTGAT
CCTCCTCATGGTCAGGATAAGTTTGTTCAGGTGGAAGGTGGATTTGCCTG 
VIGS C43: 
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AGCTCGAGTTCATTCCCAACTCTCAGAAGCAATTAAAAATGTCGCCATAGATGAACTCAATCAATACCT
GCCATTCCAACCTTATCCCGGTGGGGAGGAAAGTGGGTTGAAAAAAGATATCCCCTTAGCTGTAAAA
ATCAGTTGTTTCGAATGTGGCGGAACAGCAATTGGGGTCTGTATTTCCCACAAGATTGCCGATGCGTT
GTCCTTGGCTACCTTCCTCAATTCATGGACCGCAACATGCCAGGAAGAGACTGATATTGTTCAACCTAA
TTTCGATCTGGGATCCCATCATTTTCCGCCTATG 
VIGS C44: 
TTATCAAGTAGAACAATTCTCAATGCAATTCAAGCACAAGATCATCATAAATATTCTATGGCGTGGTTA
CCGGTGTCAGCAGAATGGCATAAGCTTCGTAAGATAAGTAAGGAACAGATGTTTTCAGCAGCACAGC
TTGACTCGAGACAAAATTTTCGTCAAGAAAAATTTAAAGAGTTACGCGAATATTTGCATCTTTACAGTT
TTAATAGAGAATTTGTTAATATTGGTAAAGCTGCTTTTACAACTTCTTTGAATTTAATTTCAACTACCAT
GTTTTCAAAAGATTTTGCTACTTATGATTCAAATTCATCTCAAG 
VIGS C45: 
ACACTTCGTAGCCGAAACCAAAGTTATTGGGGTTTCGATTGAATATAGACTTGCCCCAGAGCACCTTTT
ACCCGCAGCTTATGAAGATTGTTGGGAAGCCCTTCAATGGGTTGCTTCTCATGTGGGTCTCGACAATT
CCGGCCTAAAGACAGCTATTGATAAAGATCCATGGATAATAAACTATGGTGATTTCGATAGACTGTAT
TTGGCGGGTGACAGTCCTGGTGCTAATATTGTTCACAAC 
VIGS C46: 
AAGCCATTGTCTTTGTTCGGTCACGGAATAACTGACATTGAGATTCATTTCCTTCAAATTAAGTTCACT
GCTATTGGGGTTTATCTCGATCCGGCAATCGTCACTCATTTACAGAAATGGAAGGGCAAGAAAGGTTC
TGAACTTGCCGGCGACGATGAGTTTTTTGATGCCGTTATTTCAGCTCCTGTGGAAAAGTTATTGAGAA
TTGTTGTGATTAAGGAGATAAAGGGTTCCCAATATGGAGCCCAGCTTGAAAGTGCAGTGAGGGATCG
ATTGGCAGAAGAAGATAAATATGAAGATGAAGAGGAAGAAGCACTTGAGAAAATTCTTGAATTTTTG
CAATCTAAATATTTCAGCAAAGATTCAATCCTCACTTATTATTTTCCTGCTAATTCTTCAACTGCTGAGA
T 
VIGS C47: 
CTATTGCTTGCAAGTAGGGAAGCCTCGAGATATCTGATTCATGAATGATTTCCTTCTCCCCGATGACTT
GATGGAGTTCAGCTCTAACTCTTTCTAATTTTTCAGGGTTGCGTAATAACTCTGCCATAGCCCATTCCA
GCGTGGTCGATGTTGTTTCAGTCCCTCCTAGAAATAAATCCAAAAGCATGTGCTTGAGCTCATTGAGG
CTGAACTCAGACTCATTATTGGCACTGTGATTGAGAAGAGCTTCTAGTAAATCATTTTTCTTTGAAGTG
TCCAATGAACCTCTCATCATCAGTCGCTCATTAATA 
VIGS C48: 
ATCCTAAGTATTGGTCCGAACCTGAAGAATTCAAACCCGAAAGATTTATTGATTCTCGTATTGATTATA
AAGGTAATGATTTTGAGTACATACCATTTGGTGCCGGAAGAAGGATTTGTCCTGGTATGTCATTTGCT
ATACCTAATGTGGCTTTACCATTGGCACAATTGTTGTTTCATTTTGATTGGAAAGTTGACGATGATGCT
GGGAAATTAGAAGATTTGGACATGGTTGAGCATCCTGTTCTTGAAGCTAGGCG 
VIGS T16H2: 
TTGGAAACTTGCCAGTGATGAAACAAATATTGATAAATTAGACATGACGGAGAGTAGAGGAGTAACA
GTTAGAAGAGAAGATGATTTGTGTCTGATTCCATTTCCTTATTCTGCTTCTTCTCTCAAAGGTAAATATT
AGATGGAGACAACATCACCAAATAATTGAAGACCAAGATTGTAGGTCATGAATAGTTGTCGGTCAAG
AAATGGTGGCAAAAATTGCGATGGAAGATTTCGTTGCT 
VIGS C53: 
TACCCAATGACACCTGGTATATGGACTAAAGAACAAGTTGAGGCCTGGAAACCTATTGTAGATGCAGT
TCATGCCAAAGGTGGTGTCTTCTTTTGCCAGATAGGGCATGTTGGAAGAGTTTCAAATTACAGTTATC
AGCCAAATGGGCAGGCGCCAATCTCTTCGACAGACAAGGGATTAACC 
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Manuscript and supplementary data for “A pair of tabersonine 16-hydroxylases initiates the 
synthesis of vindoline in an organ-dependent manner in Catharanthus roseus.” 
Manuscript and Supplement data for “Discovery of a P450-catalyzed step in vindoline 
biosynthesis: a link between the aspidosperma and eburnamine type alkaloid scaffolds.” 
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biosynthesis” 
